<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://m2.mtmt.hu/xsl/gui3.xsl" ?>
<myciteResult>
  <serverUrl>https://m2.mtmt.hu/</serverUrl>
  <labelLang>hun</labelLang>
  <responseDate>2026-09-22 02:45</responseDate>
  <content>
    <publication>
      <otype>JournalArticle</otype>
      <mtid>34189818</mtid>
      <status>VALIDATED</status>
      <published>true</published>
      <comment>Institute for Pathophysiology, West German Heart and Vascular Center, University of Duisburg-Essen, Essen, Germany            
            Laboratory of Pharmacology, Faculty of Pharmacy, National and Kapodistrian University of Athens, Athens, Greece            
            The Hatter Cardiovascular Institute, University College London, London, United Kingdom            
            Chair of Cardiovascular Disease, Department of Internal Medicine and Specialties, University of Genova, Genova, Italy            
            Department of Cardiology, Institute for Clinical Medicine, Aarhus University, Aarhus N, Denmark            
            Department of Physiology, University of South Alabama, Mobile, AL, United States            
            William Harvey Research Institute, Queen Mary University of London, Heart Centre, Charterhouse Square, London, United Kingdom            
            Department of Pharmacology and Pharmacotherapy, Semmelweis University, Budapest, Hungary            
            Department of Cardiovascular Medicine, Mayo Clinic College of Medicine and Science, Rochester, MN, United States            
            School of Cardiovascular and Metabolic Medicine &amp; Sciences, King's College, London, United Kingdom            
            Cardiovascular &amp; Metabolic Disorders Program, Duke-National University of Singapore Medical School, National Heart Research Institute Singapore, National Heart Centre, Yong Loo Lin School of Medicine, National University Singapore, Singapore            
            Centro Nacional de Investigaciones Cardiovasculares (CNIC), IIS-Fundación Jiménez Díaz University Hospital, and CIBERCV, Madrid, Spain            
            Department of Medicine, University of Cambridge, Cambridge, United Kingdom            
            Department of Translational Research, Comprehensive Heart Failure Center, University Clinic Würzburg, Würzburg, Germany            
            Institute for Physiology, Justus-Liebig -Universität, Giessen, Germany            
            Division of Cardiothoracic Surgery, Alpert Medical School of Brown University and Rhode Island Hospital, Providence, RI, United States            
            King's College London British Heart Foundation Centre of Excellence, London, United Kingdom            
            Heart Center Leipzig at University of Leipzig and Leipzig Heart Science, Leipzig, Germany            
            Dipartimento di Scienze Biomediche, Università degli studi di Padova, Padova, Italy            
            Pharmahungary Group, Szeged, Hungary            
            Cited By :1            
            Export Date: 1 December 2023            
            Correspondence Address: Heusch, G.; Institute for Pathophysiology, Hufelandstr. 55, Germany; email: gerd.heusch@uk-essen.de            
            Correspondence Address: Di Lisa, F.; Dipartimento di Scienze Biomediche, Via Ugo Bassi 58/B, Italy; email: fabio.dilisa@gmail.com            
            Chemicals/CAS: acetylcysteine, 616-91-1; ascorbic acid, 134-03-2, 15421-15-5, 50-81-7; calcium ion, 14127-61-8; cangrelor, 163706-06-7, 163706-36-3; colchicine, 64-86-8; cyclosporine, 59865-13-3, 63798-73-2, 79217-60-0; cysteine, 4371-52-2, 52-89-1, 52-90-4; delcasertib, 949100-39-4, 949100-40-7; elamipretide, 736992-21-5, 2244098-12-0; enalaprilat, 76420-72-9; endothelin 1, 117399-94-7; fibroblast growth factor 2, 106096-93-9; glyceryl trinitrate, 55-63-0, 80738-44-9; hydrogen sulfide, 15035-72-0, 7783-06-4; metoprolol, 37350-58-6; nitric oxide, 10102-43-9; nitrite, 14797-65-0; reduced nicotinamide adenine dinucleotide phosphate oxidase, 9032-22-8; scatter factor, 67256-21-7, 72980-71-3; somatomedin C, 67763-96-6; Reactive Oxygen Species</comment>
      <unhandledTickets>0</unhandledTickets>
      <deleted>false</deleted>
      <lastRefresh>2026-09-02T16:14:18.814+0000</lastRefresh>
      <lastModified>2023-11-24T09:42:55.783+0000</lastModified>
      <created>2023-10-11T12:52:48.057+0000</created>
      <creator>
        <snippet>true</snippet>
        <mtid>10066331</mtid>
        <familyName>Vida</familyName>
        <givenName>Zsuzsa Ágnes</givenName>
        <link>/api/admin/10066331</link>
        <otype>Admin</otype>
        <label>Vida Zsuzsa Ágnes (DE/ÁOK/ElettI Admin 5, admin)</label>
        <published>true</published>
      </creator>
      <lastDuplumSearch>2026-06-16T09:31:35.463+0000</lastDuplumSearch>
      <validated>2023-11-24T09:42:56.134+0000</validated>
      <validator>
        <snippet>true</snippet>
        <mtid>10080205</mtid>
        <familyName>Szalóky-Siki</familyName>
        <givenName>Ágnes</givenName>
        <link>/api/admin/10080205</link>
        <otype>Admin</otype>
        <label>Szalóky-Siki Ágnes (SE_KK_Admin5_SZSA, admin)</label>
        <published>true</published>
      </validator>
      <core>true</core>
      <publicationPending>false</publicationPending>
      <type>
        <snippet>true</snippet>
        <mtid>24</mtid>
        <code>24</code>
        <link>/api/publicationtype/24</link>
        <otype>PublicationType</otype>
        <label>Folyóiratcikk</label>
        <listPosition>1</listPosition>
        <published>true</published>
        <oldId>24</oldId>
        <otypeName>JournalArticle</otypeName>
      </type>
      <subType>
        <snippet>true</snippet>
        <mtid>1134514</mtid>
        <nameEng>Survey paper</nameEng>
        <docType>
          <snippet>true</snippet>
          <mtid>24</mtid>
          <code>24</code>
          <link>/api/publicationtype/24</link>
          <otype>PublicationType</otype>
          <label>Folyóiratcikk</label>
          <listPosition>1</listPosition>
          <published>true</published>
          <oldId>24</oldId>
          <otypeName>JournalArticle</otypeName>
        </docType>
        <link>/api/subtype/1134514</link>
        <name>Összefoglaló cikk</name>
        <otype>SubType</otype>
        <label>Összefoglaló cikk (Folyóiratcikk)</label>
        <listPosition>102</listPosition>
        <published>true</published>
        <oldId>1134514</oldId>
      </subType>
      <category>
        <snippet>true</snippet>
        <mtid>1</mtid>
        <link>/api/category/1</link>
        <otype>Category</otype>
        <label>Tudományos</label>
        <published>true</published>
        <oldId>1</oldId>
      </category>
      <firstAuthor>Heusch, Gerd</firstAuthor>
      <title>Health position paper and redox perspectives on reactive oxygen species as signals and targets of cardioprotection</title>
      <journal>
        <snippet>true</snippet>
        <sciIndexed>true</sciIndexed>
        <link>/api/journal/10031450</link>
        <reviewType>REVIEWED</reviewType>
        <label>REDOX BIOLOGY 2213-2317</label>
        <published>true</published>
        <hungarian>false</hungarian>
        <oldId>10031450</oldId>
        <noIF>false</noIF>
        <mtid>10031450</mtid>
        <scopusIndexed>true</scopusIndexed>
        <eIssn>2213-2317</eIssn>
        <otype>Journal</otype>
        <lang>FOREIGN</lang>
      </journal>
      <volume>67</volume>
      <internalId>102894</internalId>
      <firstPageOrInternalIdForSort>102894</firstPageOrInternalIdForSort>
      <pageLength>46</pageLength>
      <publishedYear>2023</publishedYear>
      <abstractText>The present review summarizes the beneficial and detrimental roles of reactive oxygen species in myocardial ischemia/reperfusion injury and cardioprotection. In the first part, the continued need for cardioprotection beyond that by rapid reperfusion of acute myocardial infarction is emphasized. Then, pathomechanisms of myocardial ischemia/reperfusion to the myocardium and the coronary circulation and the different modes of cell death in myocardial infarction are characterized. Different mechanical and pharmacological interventions to protect the ischemic/reperfused myocardium in elective percutaneous coronary interventions and coronary artery bypass grafting, in acute myocardial infarction and in cardiotoxicity from cancer therapy are detailed. The second part keeps the focus on ROS providing a comprehensive overview of molecular and cellular mechanisms involved in ischemia/reperfusion injury. Starting from mitochondria as the main sources and targets of ROS in ischemic/reperfused myocardium, a complex network of cellular and extracellular processes is discussed, including relationships with Ca2+ homeostasis, thiol group redox balance, hydrogen sulfide modulation, cross-talk with NAPDH oxidases, exosomes, cytokines and growth factors. While mechanistic insights are needed to improve our current therapeutic approaches, advancements in knowledge of ROS-mediated processes indicate that detrimental facets of oxidative stress are opposed by ROS requirement for physiological and protective reactions. This inevitable contrast is likely to underlie unsuccessful clinical trials and limits the development of novel cardioprotective interventions simply based upon ROS removal.</abstractText>
      <fundings>
        <funding>
          <otype>Funding</otype>
          <mtid>2032479</mtid>
          <link>/api/funding/2032479</link>
          <label>Nemzeti Kardiovaszkuláris Laboratórium(RRF-2.3.1-21-2022-00003) Támogató: NKFIH</label>
          <published>false</published>
          <snippet>true</snippet>
        </funding>
      </fundings>
      <digital>true</digital>
      <printed>true</printed>
      <collaboration>INTERNATIONAL</collaboration>
      <sourceYear>2023</sourceYear>
      <foreignEdition>true</foreignEdition>
      <foreignLanguage>true</foreignLanguage>
      <fullPublication>true</fullPublication>
      <conferencePublication>false</conferencePublication>
      <nationalOrigin>true</nationalOrigin>
      <missingAuthor>false</missingAuthor>
      <oaType>GOLD</oaType>
      <oaCheckDate>2026-09-02</oaCheckDate>
      <oaFree>false</oaFree>
      <oaLink>http://www.journals.elsevier.com/redox-biology</oaLink>
      <citationCount>117</citationCount>
      <citationCountUnpublished>0</citationCountUnpublished>
      <citationCountWoOther>117</citationCountWoOther>
      <independentCitCountWoOther>89</independentCitCountWoOther>
      <nationalOriginCitationCount>4</nationalOriginCitationCount>
      <foreignEditionCitationCount>117</foreignEditionCitationCount>
      <doiCitationCount>117</doiCitationCount>
      <wosCitationCount>111</wosCitationCount>
      <scopusCitationCount>111</scopusCitationCount>
      <wosScopusCitationCount>117</wosScopusCitationCount>
      <wosScopusCitationCountWoOther>117</wosScopusCitationCountWoOther>
      <wosScopusIndependentCitationCount>89</wosScopusIndependentCitationCount>
      <wosScopusIndependentCitationCountWoOther>89</wosScopusIndependentCitationCountWoOther>
      <independentCitationCount>89</independentCitationCount>
      <selfCitationCount>28</selfCitationCount>
      <unhandledCitationCount>0</unhandledCitationCount>
      <citingPubCount>117</citingPubCount>
      <independentCitingPubCount>89</independentCitingPubCount>
      <citingPubCountWoOther>117</citingPubCountWoOther>
      <independentCitingPubCountWoOther>89</independentCitingPubCountWoOther>
      <unhandledCitingPubCount>0</unhandledCitingPubCount>
      <citedPubCount>29</citedPubCount>
      <citedCount>29</citedCount>
      <pubStats>
        <types>
          <type>Folyóiratcikk</type>
          <typeEng>Journal Article</typeEng>
          <code>24</code>
          <count>116</count>
        </types>
        <types>
          <type>Könyvrészlet</type>
          <typeEng>Chapter in Book</typeEng>
          <code>25</code>
          <count>1</count>
        </types>
        <types>
          <type>Könyv</type>
          <typeEng>Book</typeEng>
          <code>23</code>
          <count>0</count>
        </types>
        <types>
          <type>Egyéb konferenciaközlemény</type>
          <typeEng>Conference paper</typeEng>
          <code>31</code>
          <count>0</count>
        </types>
        <types>
          <type>Egyéb konferenciakötet</type>
          <typeEng>Conference proceedings</typeEng>
          <code>32</code>
          <count>0</count>
        </types>
        <types>
          <type>Oltalmi formák</type>
          <typeEng>Protection forms</typeEng>
          <code>26</code>
          <count>0</count>
        </types>
        <types>
          <type>Disszertáció</type>
          <typeEng>Thesis</typeEng>
          <code>28</code>
          <count>0</count>
        </types>
        <types>
          <type>Egyéb</type>
          <typeEng>Miscellaneous</typeEng>
          <code>29</code>
          <count>0</count>
        </types>
        <types>
          <type>Alkotás</type>
          <typeEng>Achievement</typeEng>
          <code>22</code>
          <count>0</count>
        </types>
        <types>
          <type>Kutatási adat</type>
          <typeEng>Research data</typeEng>
          <code>33</code>
          <count>0</count>
        </types>
        <citationTypes>
          <type>Folyóiratcikk</type>
          <typeEng>Journal Article</typeEng>
          <code>24</code>
          <countUnknown>0</countUnknown>
          <countIndependent>0</countIndependent>
          <countSelfCitation>0</countSelfCitation>
        </citationTypes>
        <citationTypes>
          <type>Könyvrészlet</type>
          <typeEng>Chapter in Book</typeEng>
          <code>25</code>
          <countUnknown>0</countUnknown>
          <countIndependent>0</countIndependent>
          <countSelfCitation>0</countSelfCitation>
        </citationTypes>
        <citationTypes>
          <type>Könyv</type>
          <typeEng>Book</typeEng>
          <code>23</code>
          <countUnknown>0</countUnknown>
          <countIndependent>0</countIndependent>
          <countSelfCitation>0</countSelfCitation>
        </citationTypes>
        <citationTypes>
          <type>Egyéb konferenciaközlemény</type>
          <typeEng>Conference paper</typeEng>
          <code>31</code>
          <countUnknown>0</countUnknown>
          <countIndependent>0</countIndependent>
          <countSelfCitation>0</countSelfCitation>
        </citationTypes>
        <citationTypes>
          <type>Egyéb konferenciakötet</type>
          <typeEng>Conference proceedings</typeEng>
          <code>32</code>
          <countUnknown>0</countUnknown>
          <countIndependent>0</countIndependent>
          <countSelfCitation>0</countSelfCitation>
        </citationTypes>
        <citationTypes>
          <type>Oltalmi formák</type>
          <typeEng>Protection forms</typeEng>
          <code>26</code>
          <countUnknown>0</countUnknown>
          <countIndependent>0</countIndependent>
          <countSelfCitation>0</countSelfCitation>
        </citationTypes>
        <citationTypes>
          <type>Disszertáció</type>
          <typeEng>Thesis</typeEng>
          <code>28</code>
          <countUnknown>0</countUnknown>
          <countIndependent>0</countIndependent>
          <countSelfCitation>0</countSelfCitation>
        </citationTypes>
        <citationTypes>
          <type>Egyéb</type>
          <typeEng>Miscellaneous</typeEng>
          <code>29</code>
          <countUnknown>0</countUnknown>
          <countIndependent>0</countIndependent>
          <countSelfCitation>0</countSelfCitation>
        </citationTypes>
        <citationTypes>
          <type>Alkotás</type>
          <typeEng>Achievement</typeEng>
          <code>22</code>
          <countUnknown>0</countUnknown>
          <countIndependent>0</countIndependent>
          <countSelfCitation>0</countSelfCitation>
        </citationTypes>
        <citationTypes>
          <type>Kutatási adat</type>
          <typeEng>Research data</typeEng>
          <code>33</code>
          <countUnknown>0</countUnknown>
          <countIndependent>0</countIndependent>
          <countSelfCitation>0</countSelfCitation>
        </citationTypes>
        <years>
          <year>2023</year>
          <publicationCount>0</publicationCount>
          <citationCount>1</citationCount>
          <independentCitationCount>0</independentCitationCount>
          <citingPubCount>1</citingPubCount>
          <independentCitingPubCount>0</independentCitingPubCount>
          <oaStats/>
          <oaStats2/>
        </years>
        <years>
          <year>2024</year>
          <publicationCount>0</publicationCount>
          <citationCount>34</citationCount>
          <independentCitationCount>23</independentCitationCount>
          <citingPubCount>34</citingPubCount>
          <independentCitingPubCount>23</independentCitingPubCount>
          <oaStats/>
          <oaStats2/>
        </years>
        <years>
          <year>2025</year>
          <publicationCount>0</publicationCount>
          <citationCount>49</citationCount>
          <independentCitationCount>36</independentCitationCount>
          <citingPubCount>49</citingPubCount>
          <independentCitingPubCount>36</independentCitingPubCount>
          <oaStats/>
          <oaStats2/>
        </years>
        <years>
          <year>2026</year>
          <publicationCount>0</publicationCount>
          <citationCount>33</citationCount>
          <independentCitationCount>30</independentCitationCount>
          <citingPubCount>33</citingPubCount>
          <independentCitingPubCount>30</independentCitingPubCount>
          <oaStats/>
          <oaStats2/>
        </years>
      </pubStats>
      <ratingsForSort>D1</ratingsForSort>
      <hasCitationDuplums>false</hasCitationDuplums>
      <importDuplum>false</importDuplum>
      <importOverwritten>false</importOverwritten>
      <importSkipped>false</importSkipped>
      <userChangeableUntil>2023-10-23T11:58:34.644+0000</userChangeableUntil>
      <directInstitutesForSort>Farmakológiai és Farmakoterápiás Intézet (SE / AOK / I)</directInstitutesForSort>
      <ownerAuthorCount>1</ownerAuthorCount>
      <ownerInstituteCount>17</ownerInstituteCount>
      <directInstituteCount>1</directInstituteCount>
      <authorCount>21</authorCount>
      <contributorCount>0</contributorCount>
      <hasQualityFactor>true</hasQualityFactor>
      <languages>
        <language>
          <otype>Language</otype>
          <mtid>10002</mtid>
          <link>/api/language/10002</link>
          <label>Angol</label>
          <name>Angol</name>
          <nameEng>English</nameEng>
          <published>true</published>
          <oldId>2</oldId>
          <snippet>true</snippet>
        </language>
      </languages>
      <authorships>
        <authorship>
          <otype>PersonAuthorship</otype>
          <mtid>110301660</mtid>
          <link>/api/authorship/110301660</link>
          <label>Heusch, Gerd ✉</label>
          <listPosition>1</listPosition>
          <share>0.048</share>
          <first>true</first>
          <last>false</last>
          <corresponding>true</corresponding>
          <familyName>Heusch</familyName>
          <givenName>Gerd</givenName>
          <authorTyped>true</authorTyped>
          <editorTyped>false</editorTyped>
          <otherTyped>false</otherTyped>
          <type>
            <otype>AuthorshipType</otype>
            <mtid>1</mtid>
            <link>/api/authorshiptype/1</link>
            <label>Szerző</label>
            <code>0</code>
            <published>true</published>
            <oldId>0</oldId>
            <snippet>true</snippet>
          </type>
          <published>false</published>
          <snippet>true</snippet>
        </authorship>
        <authorship>
          <otype>PersonAuthorship</otype>
          <mtid>110301661</mtid>
          <link>/api/authorship/110301661</link>
          <label>Andreadou, Ioanna</label>
          <listPosition>2</listPosition>
          <share>0.048</share>
          <first>false</first>
          <last>false</last>
          <corresponding>false</corresponding>
          <familyName>Andreadou</familyName>
          <givenName>Ioanna</givenName>
          <authorTyped>true</authorTyped>
          <editorTyped>false</editorTyped>
          <otherTyped>false</otherTyped>
          <type>
            <otype>AuthorshipType</otype>
            <mtid>1</mtid>
            <link>/api/authorshiptype/1</link>
            <label>Szerző</label>
            <code>0</code>
            <published>true</published>
            <oldId>0</oldId>
            <snippet>true</snippet>
          </type>
          <published>false</published>
          <snippet>true</snippet>
        </authorship>
        <authorship>
          <otype>PersonAuthorship</otype>
          <mtid>110301662</mtid>
          <link>/api/authorship/110301662</link>
          <label>Bell, Robert</label>
          <listPosition>3</listPosition>
          <share>0.048</share>
          <first>false</first>
          <last>false</last>
          <corresponding>false</corresponding>
          <familyName>Bell</familyName>
          <givenName>Robert</givenName>
          <authorTyped>true</authorTyped>
          <editorTyped>false</editorTyped>
          <otherTyped>false</otherTyped>
          <type>
            <otype>AuthorshipType</otype>
            <mtid>1</mtid>
            <link>/api/authorshiptype/1</link>
            <label>Szerző</label>
            <code>0</code>
            <published>true</published>
            <oldId>0</oldId>
            <snippet>true</snippet>
          </type>
          <published>false</published>
          <snippet>true</snippet>
        </authorship>
        <authorship>
          <otype>PersonAuthorship</otype>
          <mtid>110301663</mtid>
          <link>/api/authorship/110301663</link>
          <label>Bertero, Edoardo</label>
          <listPosition>4</listPosition>
          <share>0.048</share>
          <first>false</first>
          <last>false</last>
          <corresponding>false</corresponding>
          <familyName>Bertero</familyName>
          <givenName>Edoardo</givenName>
          <authorTyped>true</authorTyped>
          <editorTyped>false</editorTyped>
          <otherTyped>false</otherTyped>
          <type>
            <otype>AuthorshipType</otype>
            <mtid>1</mtid>
            <link>/api/authorshiptype/1</link>
            <label>Szerző</label>
            <code>0</code>
            <published>true</published>
            <oldId>0</oldId>
            <snippet>true</snippet>
          </type>
          <published>false</published>
          <snippet>true</snippet>
        </authorship>
        <authorship>
          <otype>PersonAuthorship</otype>
          <mtid>110301664</mtid>
          <link>/api/authorship/110301664</link>
          <label>Botker, Hans-Erik</label>
          <listPosition>5</listPosition>
          <share>0.048</share>
          <first>false</first>
          <last>false</last>
          <corresponding>false</corresponding>
          <familyName>Botker</familyName>
          <givenName>Hans-Erik</givenName>
          <authorTyped>true</authorTyped>
          <editorTyped>false</editorTyped>
          <otherTyped>false</otherTyped>
          <type>
            <otype>AuthorshipType</otype>
            <mtid>1</mtid>
            <link>/api/authorshiptype/1</link>
            <label>Szerző</label>
            <code>0</code>
            <published>true</published>
            <oldId>0</oldId>
            <snippet>true</snippet>
          </type>
          <published>false</published>
          <snippet>true</snippet>
        </authorship>
        <authorship>
          <otype>PersonAuthorship</otype>
          <mtid>110301665</mtid>
          <link>/api/authorship/110301665</link>
          <label>Davidson, Sean M.</label>
          <listPosition>6</listPosition>
          <share>0.048</share>
          <first>false</first>
          <last>false</last>
          <corresponding>false</corresponding>
          <familyName>Davidson</familyName>
          <givenName>Sean M.</givenName>
          <authorTyped>true</authorTyped>
          <editorTyped>false</editorTyped>
          <otherTyped>false</otherTyped>
          <type>
            <otype>AuthorshipType</otype>
            <mtid>1</mtid>
            <link>/api/authorshiptype/1</link>
            <label>Szerző</label>
            <code>0</code>
            <published>true</published>
            <oldId>0</oldId>
            <snippet>true</snippet>
          </type>
          <published>false</published>
          <snippet>true</snippet>
        </authorship>
        <authorship>
          <otype>PersonAuthorship</otype>
          <mtid>110301666</mtid>
          <link>/api/authorship/110301666</link>
          <label>Downey, James</label>
          <listPosition>7</listPosition>
          <share>0.048</share>
          <first>false</first>
          <last>false</last>
          <corresponding>false</corresponding>
          <familyName>Downey</familyName>
          <givenName>James</givenName>
          <authorTyped>true</authorTyped>
          <editorTyped>false</editorTyped>
          <otherTyped>false</otherTyped>
          <type>
            <otype>AuthorshipType</otype>
            <mtid>1</mtid>
            <link>/api/authorshiptype/1</link>
            <label>Szerző</label>
            <code>0</code>
            <published>true</published>
            <oldId>0</oldId>
            <snippet>true</snippet>
          </type>
          <published>false</published>
          <snippet>true</snippet>
        </authorship>
        <authorship>
          <otype>PersonAuthorship</otype>
          <mtid>110301667</mtid>
          <link>/api/authorship/110301667</link>
          <label>Eaton, Philip</label>
          <listPosition>8</listPosition>
          <share>0.048</share>
          <first>false</first>
          <last>false</last>
          <corresponding>false</corresponding>
          <familyName>Eaton</familyName>
          <givenName>Philip</givenName>
          <authorTyped>true</authorTyped>
          <editorTyped>false</editorTyped>
          <otherTyped>false</otherTyped>
          <type>
            <otype>AuthorshipType</otype>
            <mtid>1</mtid>
            <link>/api/authorshiptype/1</link>
            <label>Szerző</label>
            <code>0</code>
            <published>true</published>
            <oldId>0</oldId>
            <snippet>true</snippet>
          </type>
          <published>false</published>
          <snippet>true</snippet>
        </authorship>
        <authorship>
          <otype>PersonAuthorship</otype>
          <mtid>110301668</mtid>
          <link>/api/authorship/110301668</link>
          <label>Ferdinandy, Peter [Ferdinandy, Péter (Farmakológia, mol...), szerző] Farmakológiai és Farmakoterápiás Intézet (SE / AOK / I)</label>
          <listPosition>9</listPosition>
          <share>0.048</share>
          <first>false</first>
          <last>false</last>
          <corresponding>false</corresponding>
          <author>
            <otype>Author</otype>
            <mtid>10010125</mtid>
            <link>/api/author/10010125</link>
            <label>Ferdinandy Péter (Farmakológia, molekuláris medicina)</label>
            <familyName>Ferdinandy</familyName>
            <givenName>Péter</givenName>
            <published>true</published>
            <oldId>10010125</oldId>
            <snippet>true</snippet>
          </author>
          <familyName>Ferdinandy</familyName>
          <givenName>Peter</givenName>
          <authorTyped>true</authorTyped>
          <editorTyped>false</editorTyped>
          <otherTyped>false</otherTyped>
          <type>
            <otype>AuthorshipType</otype>
            <mtid>1</mtid>
            <link>/api/authorshiptype/1</link>
            <label>Szerző</label>
            <code>0</code>
            <published>true</published>
            <oldId>0</oldId>
            <snippet>true</snippet>
          </type>
          <published>false</published>
          <snippet>true</snippet>
        </authorship>
        <authorship>
          <otype>PersonAuthorship</otype>
          <mtid>110301669</mtid>
          <link>/api/authorship/110301669</link>
          <label>Gersh, Bernard J.</label>
          <listPosition>10</listPosition>
          <share>0.048</share>
          <first>false</first>
          <last>false</last>
          <corresponding>false</corresponding>
          <familyName>Gersh</familyName>
          <givenName>Bernard J.</givenName>
          <authorTyped>true</authorTyped>
          <editorTyped>false</editorTyped>
          <otherTyped>false</otherTyped>
          <type>
            <otype>AuthorshipType</otype>
            <mtid>1</mtid>
            <link>/api/authorshiptype/1</link>
            <label>Szerző</label>
            <code>0</code>
            <published>true</published>
            <oldId>0</oldId>
            <snippet>true</snippet>
          </type>
          <published>false</published>
          <snippet>true</snippet>
        </authorship>
        <authorship>
          <otype>PersonAuthorship</otype>
          <mtid>110301670</mtid>
          <link>/api/authorship/110301670</link>
          <label>Giacca, Mauro</label>
          <listPosition>11</listPosition>
          <share>0.048</share>
          <first>false</first>
          <last>false</last>
          <corresponding>false</corresponding>
          <familyName>Giacca</familyName>
          <givenName>Mauro</givenName>
          <authorTyped>true</authorTyped>
          <editorTyped>false</editorTyped>
          <otherTyped>false</otherTyped>
          <type>
            <otype>AuthorshipType</otype>
            <mtid>1</mtid>
            <link>/api/authorshiptype/1</link>
            <label>Szerző</label>
            <code>0</code>
            <published>true</published>
            <oldId>0</oldId>
            <snippet>true</snippet>
          </type>
          <published>false</published>
          <snippet>true</snippet>
        </authorship>
        <authorship>
          <otype>PersonAuthorship</otype>
          <mtid>110301671</mtid>
          <link>/api/authorship/110301671</link>
          <label>Hausenloy, Derek J.</label>
          <listPosition>12</listPosition>
          <share>0.048</share>
          <first>false</first>
          <last>false</last>
          <corresponding>false</corresponding>
          <familyName>Hausenloy</familyName>
          <givenName>Derek J.</givenName>
          <authorTyped>true</authorTyped>
          <editorTyped>false</editorTyped>
          <otherTyped>false</otherTyped>
          <type>
            <otype>AuthorshipType</otype>
            <mtid>1</mtid>
            <link>/api/authorshiptype/1</link>
            <label>Szerző</label>
            <code>0</code>
            <published>true</published>
            <oldId>0</oldId>
            <snippet>true</snippet>
          </type>
          <published>false</published>
          <snippet>true</snippet>
        </authorship>
        <authorship>
          <otype>PersonAuthorship</otype>
          <mtid>110301672</mtid>
          <link>/api/authorship/110301672</link>
          <label>Ibanez, Borja</label>
          <listPosition>13</listPosition>
          <share>0.048</share>
          <first>false</first>
          <last>false</last>
          <corresponding>false</corresponding>
          <familyName>Ibanez</familyName>
          <givenName>Borja</givenName>
          <authorTyped>true</authorTyped>
          <editorTyped>false</editorTyped>
          <otherTyped>false</otherTyped>
          <type>
            <otype>AuthorshipType</otype>
            <mtid>1</mtid>
            <link>/api/authorshiptype/1</link>
            <label>Szerző</label>
            <code>0</code>
            <published>true</published>
            <oldId>0</oldId>
            <snippet>true</snippet>
          </type>
          <published>false</published>
          <snippet>true</snippet>
        </authorship>
        <authorship>
          <otype>PersonAuthorship</otype>
          <mtid>110301673</mtid>
          <link>/api/authorship/110301673</link>
          <label>Krieg, Thomas</label>
          <listPosition>14</listPosition>
          <share>0.048</share>
          <first>false</first>
          <last>false</last>
          <corresponding>false</corresponding>
          <familyName>Krieg</familyName>
          <givenName>Thomas</givenName>
          <authorTyped>true</authorTyped>
          <editorTyped>false</editorTyped>
          <otherTyped>false</otherTyped>
          <type>
            <otype>AuthorshipType</otype>
            <mtid>1</mtid>
            <link>/api/authorshiptype/1</link>
            <label>Szerző</label>
            <code>0</code>
            <published>true</published>
            <oldId>0</oldId>
            <snippet>true</snippet>
          </type>
          <published>false</published>
          <snippet>true</snippet>
        </authorship>
        <authorship>
          <otype>PersonAuthorship</otype>
          <mtid>110301674</mtid>
          <link>/api/authorship/110301674</link>
          <label>Maack, Christoph</label>
          <listPosition>15</listPosition>
          <share>0.048</share>
          <first>false</first>
          <last>false</last>
          <corresponding>false</corresponding>
          <familyName>Maack</familyName>
          <givenName>Christoph</givenName>
          <authorTyped>true</authorTyped>
          <editorTyped>false</editorTyped>
          <otherTyped>false</otherTyped>
          <type>
            <otype>AuthorshipType</otype>
            <mtid>1</mtid>
            <link>/api/authorshiptype/1</link>
            <label>Szerző</label>
            <code>0</code>
            <published>true</published>
            <oldId>0</oldId>
            <snippet>true</snippet>
          </type>
          <published>false</published>
          <snippet>true</snippet>
        </authorship>
        <authorship>
          <otype>PersonAuthorship</otype>
          <mtid>110301675</mtid>
          <link>/api/authorship/110301675</link>
          <label>Schulz, Rainer</label>
          <listPosition>16</listPosition>
          <share>0.048</share>
          <first>false</first>
          <last>false</last>
          <corresponding>false</corresponding>
          <familyName>Schulz</familyName>
          <givenName>Rainer</givenName>
          <authorTyped>true</authorTyped>
          <editorTyped>false</editorTyped>
          <otherTyped>false</otherTyped>
          <type>
            <otype>AuthorshipType</otype>
            <mtid>1</mtid>
            <link>/api/authorshiptype/1</link>
            <label>Szerző</label>
            <code>0</code>
            <published>true</published>
            <oldId>0</oldId>
            <snippet>true</snippet>
          </type>
          <published>false</published>
          <snippet>true</snippet>
        </authorship>
        <authorship>
          <otype>PersonAuthorship</otype>
          <mtid>110301676</mtid>
          <link>/api/authorship/110301676</link>
          <label>Sellke, Frank</label>
          <listPosition>17</listPosition>
          <share>0.048</share>
          <first>false</first>
          <last>false</last>
          <corresponding>false</corresponding>
          <familyName>Sellke</familyName>
          <givenName>Frank</givenName>
          <authorTyped>true</authorTyped>
          <editorTyped>false</editorTyped>
          <otherTyped>false</otherTyped>
          <type>
            <otype>AuthorshipType</otype>
            <mtid>1</mtid>
            <link>/api/authorshiptype/1</link>
            <label>Szerző</label>
            <code>0</code>
            <published>true</published>
            <oldId>0</oldId>
            <snippet>true</snippet>
          </type>
          <published>false</published>
          <snippet>true</snippet>
        </authorship>
        <authorship>
          <otype>PersonAuthorship</otype>
          <mtid>110301677</mtid>
          <link>/api/authorship/110301677</link>
          <label>Shah, Ajay M.</label>
          <listPosition>18</listPosition>
          <share>0.048</share>
          <first>false</first>
          <last>false</last>
          <corresponding>false</corresponding>
          <familyName>Shah</familyName>
          <givenName>Ajay M.</givenName>
          <authorTyped>true</authorTyped>
          <editorTyped>false</editorTyped>
          <otherTyped>false</otherTyped>
          <type>
            <otype>AuthorshipType</otype>
            <mtid>1</mtid>
            <link>/api/authorshiptype/1</link>
            <label>Szerző</label>
            <code>0</code>
            <published>true</published>
            <oldId>0</oldId>
            <snippet>true</snippet>
          </type>
          <published>false</published>
          <snippet>true</snippet>
        </authorship>
        <authorship>
          <otype>PersonAuthorship</otype>
          <mtid>110301678</mtid>
          <link>/api/authorship/110301678</link>
          <label>Thiele, Holger</label>
          <listPosition>19</listPosition>
          <share>0.048</share>
          <first>false</first>
          <last>false</last>
          <corresponding>false</corresponding>
          <familyName>Thiele</familyName>
          <givenName>Holger</givenName>
          <authorTyped>true</authorTyped>
          <editorTyped>false</editorTyped>
          <otherTyped>false</otherTyped>
          <type>
            <otype>AuthorshipType</otype>
            <mtid>1</mtid>
            <link>/api/authorshiptype/1</link>
            <label>Szerző</label>
            <code>0</code>
            <published>true</published>
            <oldId>0</oldId>
            <snippet>true</snippet>
          </type>
          <published>false</published>
          <snippet>true</snippet>
        </authorship>
        <authorship>
          <otype>PersonAuthorship</otype>
          <mtid>110301679</mtid>
          <link>/api/authorship/110301679</link>
          <label>Yellon, Derek M.</label>
          <listPosition>20</listPosition>
          <share>0.048</share>
          <first>false</first>
          <last>false</last>
          <corresponding>false</corresponding>
          <familyName>Yellon</familyName>
          <givenName>Derek M.</givenName>
          <authorTyped>true</authorTyped>
          <editorTyped>false</editorTyped>
          <otherTyped>false</otherTyped>
          <type>
            <otype>AuthorshipType</otype>
            <mtid>1</mtid>
            <link>/api/authorshiptype/1</link>
            <label>Szerző</label>
            <code>0</code>
            <published>true</published>
            <oldId>0</oldId>
            <snippet>true</snippet>
          </type>
          <published>false</published>
          <snippet>true</snippet>
        </authorship>
        <authorship>
          <otype>PersonAuthorship</otype>
          <mtid>110301680</mtid>
          <link>/api/authorship/110301680</link>
          <label>Di Lisa, Fabio ✉</label>
          <listPosition>21</listPosition>
          <share>0.048</share>
          <first>false</first>
          <last>true</last>
          <corresponding>true</corresponding>
          <familyName>Di Lisa</familyName>
          <givenName>Fabio</givenName>
          <authorTyped>true</authorTyped>
          <editorTyped>false</editorTyped>
          <otherTyped>false</otherTyped>
          <type>
            <otype>AuthorshipType</otype>
            <mtid>1</mtid>
            <link>/api/authorshiptype/1</link>
            <label>Szerző</label>
            <code>0</code>
            <published>true</published>
            <oldId>0</oldId>
            <snippet>true</snippet>
          </type>
          <published>false</published>
          <snippet>true</snippet>
        </authorship>
      </authorships>
      <identifiers>
        <identifier>
          <otype>PublicationIdentifier</otype>
          <mtid>24499403</mtid>
          <link>/api/publicationidentifier/24499403</link>
          <label>DOI: 10.1016/j.redox.2023.102894</label>
          <source>
            <otype>PlainSource</otype>
            <mtid>6</mtid>
            <link>/api/publicationsource/6</link>
            <label>DOI</label>
            <type>
              <otype>PublicationSourceType</otype>
              <mtid>10001</mtid>
              <link>/api/publicationsourcetype/10001</link>
              <label>DOI</label>
              <mayHaveOa>true</mayHaveOa>
              <published>true</published>
              <snippet>true</snippet>
            </type>
            <name>DOI</name>
            <nameEng>DOI</nameEng>
            <linkPattern>https://doi.org/@@@</linkPattern>
            <publiclyVisible>true</publiclyVisible>
            <published>true</published>
            <oldId>6</oldId>
            <snippet>true</snippet>
          </source>
          <validState>IDENTICAL</validState>
          <idValue>10.1016/j.redox.2023.102894</idValue>
          <realUrl>https://doi.org/10.1016/j.redox.2023.102894</realUrl>
          <published>false</published>
          <snippet>true</snippet>
        </identifier>
        <identifier>
          <otype>PublicationIdentifier</otype>
          <mtid>24915016</mtid>
          <link>/api/publicationidentifier/24915016</link>
          <label>WoS: 001093377200001</label>
          <source>
            <otype>PlainSource</otype>
            <mtid>1</mtid>
            <link>/api/publicationsource/1</link>
            <label>WoS</label>
            <type>
              <otype>PublicationSourceType</otype>
              <mtid>10003</mtid>
              <link>/api/publicationsourcetype/10003</link>
              <label>Indexelő adatbázis</label>
              <mayHaveOa>false</mayHaveOa>
              <published>true</published>
              <snippet>true</snippet>
            </type>
            <name>WoS</name>
            <nameEng>WoS</nameEng>
            <linkPattern>https://www.webofscience.com/wos/woscc/full-record/@@@</linkPattern>
            <publiclyVisible>true</publiclyVisible>
            <published>true</published>
            <oldId>1</oldId>
            <snippet>true</snippet>
          </source>
          <validState>IDENTICAL</validState>
          <idValue>001093377200001</idValue>
          <realUrl>https://www.webofscience.com/wos/woscc/full-record/001093377200001</realUrl>
          <published>false</published>
          <snippet>true</snippet>
        </identifier>
        <identifier>
          <otype>PublicationIdentifier</otype>
          <mtid>24541765</mtid>
          <link>/api/publicationidentifier/24541765</link>
          <label>Scopus: 85173716036</label>
          <source>
            <otype>PlainSource</otype>
            <mtid>3</mtid>
            <link>/api/publicationsource/3</link>
            <label>Scopus</label>
            <type>
              <otype>PublicationSourceType</otype>
              <mtid>10003</mtid>
              <link>/api/publicationsourcetype/10003</link>
              <label>Indexelő adatbázis</label>
              <mayHaveOa>false</mayHaveOa>
              <published>true</published>
              <snippet>true</snippet>
            </type>
            <name>Scopus</name>
            <nameEng>Scopus</nameEng>
            <linkPattern>http://www.scopus.com/record/display.url?origin=inward&amp;eid=2-s2.0-@@@</linkPattern>
            <publiclyVisible>true</publiclyVisible>
            <published>true</published>
            <oldId>3</oldId>
            <snippet>true</snippet>
          </source>
          <validState>IDENTICAL</validState>
          <idValue>85173716036</idValue>
          <realUrl>http://www.scopus.com/record/display.url?origin=inward&amp;eid=2-s2.0-85173716036</realUrl>
          <published>false</published>
          <snippet>true</snippet>
        </identifier>
        <identifier>
          <otype>PublicationIdentifier</otype>
          <mtid>24499404</mtid>
          <link>/api/publicationidentifier/24499404</link>
          <label>PubMed: 37839355</label>
          <source>
            <otype>PlainSource</otype>
            <mtid>17</mtid>
            <link>/api/publicationsource/17</link>
            <label>PubMed</label>
            <type>
              <otype>PublicationSourceType</otype>
              <mtid>10003</mtid>
              <link>/api/publicationsourcetype/10003</link>
              <label>Indexelő adatbázis</label>
              <mayHaveOa>false</mayHaveOa>
              <published>true</published>
              <snippet>true</snippet>
            </type>
            <name>PubMed</name>
            <nameEng>PubMed</nameEng>
            <linkPattern>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=@@@&amp;dopt=Abstract</linkPattern>
            <publiclyVisible>true</publiclyVisible>
            <published>true</published>
            <oldId>17</oldId>
            <snippet>true</snippet>
          </source>
          <validState>IDENTICAL</validState>
          <idValue>37839355</idValue>
          <realUrl>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=37839355&amp;dopt=Abstract</realUrl>
          <published>false</published>
          <snippet>true</snippet>
        </identifier>
      </identifiers>
      <keywords>
        <keyword>
          <otype>Keyword</otype>
          <mtid>10021</mtid>
          <link>/api/keyword/10021</link>
          <label>Reperfusion</label>
          <published>true</published>
          <oldId>10021</oldId>
          <snippet>true</snippet>
        </keyword>
        <keyword>
          <otype>Keyword</otype>
          <mtid>15417</mtid>
          <link>/api/keyword/15417</link>
          <label>myocardial infarction</label>
          <published>true</published>
          <oldId>15417</oldId>
          <snippet>true</snippet>
        </keyword>
        <keyword>
          <otype>Keyword</otype>
          <mtid>17777</mtid>
          <link>/api/keyword/17777</link>
          <label>mitochondrion</label>
          <published>true</published>
          <oldId>17777</oldId>
          <snippet>true</snippet>
        </keyword>
        <keyword>
          <otype>Keyword</otype>
          <mtid>1001905</mtid>
          <link>/api/keyword/1001905</link>
          <label>MYOCARDIAL ISCHEMIA</label>
          <published>true</published>
          <oldId>1001905</oldId>
          <snippet>true</snippet>
        </keyword>
        <keyword>
          <otype>Keyword</otype>
          <mtid>1037339</mtid>
          <link>/api/keyword/1037339</link>
          <label>cardioprotection</label>
          <published>true</published>
          <oldId>1037339</oldId>
          <snippet>true</snippet>
        </keyword>
        <keyword>
          <otype>Keyword</otype>
          <mtid>1078006</mtid>
          <link>/api/keyword/1078006</link>
          <label>INFARCT SIZE</label>
          <published>true</published>
          <oldId>1078006</oldId>
          <snippet>true</snippet>
        </keyword>
        <keyword>
          <otype>Keyword</otype>
          <mtid>1560811</mtid>
          <link>/api/keyword/1560811</link>
          <label>ischemic conditioning</label>
          <published>true</published>
          <snippet>true</snippet>
        </keyword>
      </keywords>
      <ratings>
        <rating>
          <otype>SjrRating</otype>
          <mtid>11357697</mtid>
          <link>/api/sjrrating/11357697</link>
          <label>sjr:D1 (2023) Scopus - Biochemistry REDOX BIOLOGY 2213-2317 2213-2317</label>
          <listPos>23</listPos>
          <rankValue>0.1</rankValue>
          <type>journal</type>
          <ratingType>
            <otype>RatingType</otype>
            <mtid>10002</mtid>
            <link>/api/ratingtype/10002</link>
            <label>sjr</label>
            <code>sjr</code>
            <published>true</published>
            <snippet>true</snippet>
          </ratingType>
          <subject>
            <otype>ClassificationExternal</otype>
            <mtid>1303</mtid>
            <link>/api/classificationexternal/1303</link>
            <label>Scopus - Biochemistry</label>
            <published>true</published>
            <oldId>1303</oldId>
            <snippet>true</snippet>
          </subject>
          <ranking>D1</ranking>
          <calculation>DIRECT</calculation>
          <published>true</published>
          <snippet>true</snippet>
        </rating>
      </ratings>
      <references>
        <reference>
          <otype>Reference</otype>
          <mtid>45916444</mtid>
          <link>/api/reference/45916444</link>
          <label>1. Kübler 1996: Cardioprotection: definition, classification, and fundamental principles., Heart, 75, p. 330, DOI: 10.1136/hrt.75.4.330</label>
          <listPosition>1</listPosition>
          <doi>10.1136/hrt.75.4.330</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916445</mtid>
          <link>/api/reference/45916445</link>
          <label>2. Heusch 2020: Myocardial ischaemia-reperfusion injury and cardioprotection in perspective., Nat. Rev. Cardiol., 17, p. 773, DOI: 10.1038/s41569-020-0403-y</label>
          <listPosition>2</listPosition>
          <doi>10.1038/s41569-020-0403-y</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916446</mtid>
          <link>/api/reference/45916446</link>
          <label>3. Del Valle 2020: An inflammatory cytokine signature predicts COVID-19 severity and survival., Nat. Med., 26, p. 1636, DOI: 10.1038/s41591-020-1051-9</label>
          <listPosition>3</listPosition>
          <doi>10.1038/s41591-020-1051-9</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916447</mtid>
          <link>/api/reference/45916447</link>
          <label>4. Murry 2006: Regeneration gaps: observations on stem cells and cardiac repair., J. Am. Coll. Cardiol., 47, p. 1777, DOI: 10.1016/j.jacc.2006.02.002</label>
          <listPosition>4</listPosition>
          <doi>10.1016/j.jacc.2006.02.002</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916448</mtid>
          <link>/api/reference/45916448</link>
          <label>5. Gonzalez 2003: Cardiomyocyte apoptosis in hypertensive cardiomyopathy., Cardiovasc. Res., 59, p. 549, DOI: 10.1016/S0008-6363(03)00498-X</label>
          <listPosition>5</listPosition>
          <doi>10.1016/S0008-6363(03)00498-X</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916449</mtid>
          <link>/api/reference/45916449</link>
          <label>6. Hein 2003: Progression from compensated hypertrophy to failure in the pressure-overloaded human heart: structural deterioration and compensatory mechanisms., Circulation, 107, p. 984, DOI: 10.1161/01.CIR.0000051865.66123.B7</label>
          <listPosition>6</listPosition>
          <doi>10.1161/01.CIR.0000051865.66123.B7</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916450</mtid>
          <link>/api/reference/45916450</link>
          <label>7. Kyto 2004: Apoptotic cardiomyocyte death in fatal myocarditis., Am. J. Cardiol., 94, p. 746, DOI: 10.1016/j.amjcard.2004.05.056</label>
          <listPosition>7</listPosition>
          <doi>10.1016/j.amjcard.2004.05.056</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916451</mtid>
          <link>/api/reference/45916451</link>
          <label>8. Nef 2009: Activated cell survival cascade protects cardiomyocytes from cell death in Tako-Tsubo cardiomyopathy., Eur. J. Heart Fail., 11, p. 758, DOI: 10.1093/eurjhf/hfp076</label>
          <listPosition>8</listPosition>
          <doi>10.1093/eurjhf/hfp076</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916452</mtid>
          <link>/api/reference/45916452</link>
          <label>9. Stapel 2017: Low STAT3 expression sensitizes to toxic effects of beta-adrenergic receptor stimulation in peripartum cardiomyopathy., Eur. Heart J., 38, p. 349</label>
          <listPosition>9</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916453</mtid>
          <link>/api/reference/45916453</link>
          <label>10. Townsend 2011: Distinct pathophysiological mechanisms of cardiomyopathy in hearts lacking dystrophin or the sarcoglycan complex., Faseb. J., 25, p. 3106, DOI: 10.1096/fj.10-178913</label>
          <listPosition>10</listPosition>
          <doi>10.1096/fj.10-178913</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916454</mtid>
          <link>/api/reference/45916454</link>
          <label>11. Hashem 2015: Brief Report: oxidative stress mediates cardiomyocyte apoptosis in a human model of Danon disease and heart failure., Stem Cell., 33, p. 2343, DOI: 10.1002/stem.2015</label>
          <listPosition>11</listPosition>
          <doi>10.1002/stem.2015</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916455</mtid>
          <link>/api/reference/45916455</link>
          <label>12. Maloyan 2005: Mitochondrial dysfunction and apoptosis underlie the pathogenic process in alpha-B-crystallin desmin-related cardiomyopathy., Circulation, 112, p. 3451, DOI: 10.1161/CIRCULATIONAHA.105.572552</label>
          <listPosition>12</listPosition>
          <doi>10.1161/CIRCULATIONAHA.105.572552</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916456</mtid>
          <link>/api/reference/45916456</link>
          <label>13. Dorn 2009: 2nd, Apoptotic and non-apoptotic programmed cardiomyocyte death in ventricular remodelling., Cardiovasc. Res., 81, p. 465, DOI: 10.1093/cvr/cvn243</label>
          <listPosition>13</listPosition>
          <doi>10.1093/cvr/cvn243</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916457</mtid>
          <link>/api/reference/45916457</link>
          <label>14. Yamaji 2005: Apoptotic myocardial cell death in the setting of arrhythmogenic right ventricular cardiomyopathy., Acta Cardiol., 60, p. 465, DOI: 10.2143/AC.60.5.2004965</label>
          <listPosition>14</listPosition>
          <doi>10.2143/AC.60.5.2004965</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916458</mtid>
          <link>/api/reference/45916458</link>
          <label>15. Shernan 2003: Perioperative myocardial ischemia reperfusion injury., Anesthesiol. Clin. N. Am., 21, p. 465, DOI: 10.1016/S0889-8537(03)00038-5</label>
          <listPosition>15</listPosition>
          <doi>10.1016/S0889-8537(03)00038-5</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916459</mtid>
          <link>/api/reference/45916459</link>
          <label>16. Octavia 2012: Doxorubicin-induced cardiomyopathy: from molecular mechanisms to therapeutic strategies., J. Mol. Cell. Cardiol., 52, p. 1213, DOI: 10.1016/j.yjmcc.2012.03.006</label>
          <listPosition>16</listPosition>
          <doi>10.1016/j.yjmcc.2012.03.006</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916460</mtid>
          <link>/api/reference/45916460</link>
          <label>17. Diseases Injuries Collaborators 2020: Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019., Lancet, 396, p. 1204, DOI: 10.1016/S0140-6736(20)30925-9</label>
          <listPosition>17</listPosition>
          <doi>10.1016/S0140-6736(20)30925-9</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916461</mtid>
          <link>/api/reference/45916461</link>
          <label>18. Szummer 2017: Improved outcomes in patients with ST-elevation myocardial infarction during the last 20 years are related to implementation of evidence-based treatments: experiences from the SWEDEHEART registry 1995-2014., Eur. Heart J., 38, p. 3056, DOI: 10.1093/eurheartj/ehx515</label>
          <listPosition>18</listPosition>
          <doi>10.1093/eurheartj/ehx515</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916462</mtid>
          <link>/api/reference/45916462</link>
          <label>19. Blöndal 2022: Comparison of management and outcomes of ST-segment elevation myocardial infarction patients in Estonia, Hungary, Norway, and Sweden according to national ongoing registries., Eur. Heart J. Qual. Care Clin. Outcomes, 8, p. 307, DOI: 10.1093/ehjqcco/qcaa098</label>
          <listPosition>19</listPosition>
          <doi>10.1093/ehjqcco/qcaa098</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916463</mtid>
          <link>/api/reference/45916463</link>
          <label>20. Maroko 1972: Coronary artery reperfusion. I. Early effects on local myocardial function and the extent of myocardial necrosis., J. Clin. Invest., 51, p. 2710, DOI: 10.1172/JCI107090</label>
          <listPosition>20</listPosition>
          <doi>10.1172/JCI107090</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916464</mtid>
          <link>/api/reference/45916464</link>
          <label>21. Ginks 1972: Coronary artery reperfusion. II. Reduction of myocardial infarct size at 1 week after the coronary occlusion., J. Clin. Invest., 51, p. 2717, DOI: 10.1172/JCI107091</label>
          <listPosition>21</listPosition>
          <doi>10.1172/JCI107091</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916465</mtid>
          <link>/api/reference/45916465</link>
          <label>22. Reimer 1977: The wavefront phenomenon of ischemic cell death. 1. Myocardial infarct size vs duration of coronary occlusion in dogs., Circulation, 56, p. 786, DOI: 10.1161/01.CIR.56.5.786</label>
          <listPosition>22</listPosition>
          <doi>10.1161/01.CIR.56.5.786</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916466</mtid>
          <link>/api/reference/45916466</link>
          <label>23. Reimer 1979: The "wavefront phenomenon" of myocardial ischemic cell death. II. Transmural progression of necrosis within the framework of ischemic bed size (myocardium at risk) and collateral flow., Lab. Invest., 40, p. 633</label>
          <listPosition>23</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916467</mtid>
          <link>/api/reference/45916467</link>
          <label>24. Heusch 2014: Cardiovascular remodeling in coronary artery disease and heart failure., Lancet, 383, p. 1933, DOI: 10.1016/S0140-6736(14)60107-0</label>
          <listPosition>24</listPosition>
          <doi>10.1016/S0140-6736(14)60107-0</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916468</mtid>
          <link>/api/reference/45916468</link>
          <label>25. Gersh 2005: Pharmacological facilitation of primary percutaneous coronary intervention for acute myocardial infarction: is the slope of the curve the shape of the future?., JAMA, 293, p. 979, DOI: 10.1001/jama.293.8.979</label>
          <listPosition>25</listPosition>
          <doi>10.1001/jama.293.8.979</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916469</mtid>
          <link>/api/reference/45916469</link>
          <label>26. Stone 2016: Relationship between infarct size and outcomes following primary PCI: patient-level analysis from 10 randomized trials., J. Am. Coll. Cardiol., 67, p. 1674, DOI: 10.1016/j.jacc.2016.01.069</label>
          <listPosition>26</listPosition>
          <doi>10.1016/j.jacc.2016.01.069</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916470</mtid>
          <link>/api/reference/45916470</link>
          <label>27. Ibanez 2017: Eur. Heart J., 39, p. 119</label>
          <listPosition>27</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916471</mtid>
          <link>/api/reference/45916471</link>
          <label>28. Heusch 2020: Is cardioprotection salvageable?., Circulation, 141, p. 415, DOI: 10.1161/CIRCULATIONAHA.119.044176</label>
          <listPosition>28</listPosition>
          <doi>10.1161/CIRCULATIONAHA.119.044176</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916472</mtid>
          <link>/api/reference/45916472</link>
          <label>29. Jollis 2022: Treatment time and in-hospital mortality among patients with ST-segment elevation myocardial infarction, 2018-2021., JAMA, 328, p. 2033, DOI: 10.1001/jama.2022.20149</label>
          <listPosition>29</listPosition>
          <doi>10.1001/jama.2022.20149</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916473</mtid>
          <link>/api/reference/45916473</link>
          <label>30. Vora 2015: Fibrinolysis use among patients requiring interhospital transfer for ST-segment elevation myocardial infarction care: a report from the US National Cardiovascular Data Registry., JAMA Intern. Med., 175, p. 207, DOI: 10.1001/jamainternmed.2014.6573</label>
          <listPosition>30</listPosition>
          <doi>10.1001/jamainternmed.2014.6573</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916474</mtid>
          <link>/api/reference/45916474</link>
          <label>31. Redfors 2021: Time delay, infarct size, and microvascular obstruction after primary percutaneous coronary intervention for ST-segment-elevation myocardial infarction., Circ. Cardiovasc. Interv., 14, DOI: 10.1161/CIRCINTERVENTIONS.120.009879</label>
          <listPosition>31</listPosition>
          <doi>10.1161/CIRCINTERVENTIONS.120.009879</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916475</mtid>
          <link>/api/reference/45916475</link>
          <label>32. Lukhna 2021: Remote ischaemic conditioning in STEMI patients in sub-Saharan AFRICA: rationale and study design for the RIC-AFRICA trial., Cardiovasc. Drugs Ther., 37, p. 299, DOI: 10.1007/s10557-021-07283-y</label>
          <listPosition>32</listPosition>
          <doi>10.1007/s10557-021-07283-y</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916476</mtid>
          <link>/api/reference/45916476</link>
          <label>33. Kite 2021: International prospective registry of acute coronary syndromes in patients with COVID-19., J. Am. Coll. Cardiol., 77, p. 2466, DOI: 10.1016/j.jacc.2021.03.309</label>
          <listPosition>33</listPosition>
          <doi>10.1016/j.jacc.2021.03.309</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916477</mtid>
          <link>/api/reference/45916477</link>
          <label>34. Heusch 2017: Critical issues for the translation of cardioprotection., Circ. Res., 120, p. 1477, DOI: 10.1161/CIRCRESAHA.117.310820</label>
          <listPosition>34</listPosition>
          <doi>10.1161/CIRCRESAHA.117.310820</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916478</mtid>
          <link>/api/reference/45916478</link>
          <label>35. Heusch 2023: Cardioprotection and its translation: a need for new paradigms? Or for new pragmatism? An opinionated retro- and perspective., J. Cardiovasc. Pharmacol. Therapeut., DOI: 10.1177/10742484231179613</label>
          <listPosition>35</listPosition>
          <doi>10.1177/10742484231179613</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916479</mtid>
          <link>/api/reference/45916479</link>
          <label>36. Heusch 2017: The pathophysiology of acute myocardial infarction and strategies of protection beyond reperfusion: a continual challenge., Eur. Heart J., 38, p. 774</label>
          <listPosition>36</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916480</mtid>
          <link>/api/reference/45916480</link>
          <label>37. Gaspar 2018: Randomized controlled trial of remote ischemic conditioning in ST-elevation myocardial infarction as adjuvant to primary angioplasty (RIC-STEMI)., Basic Res. Cardiol., 113, p. 14, DOI: 10.1007/s00395-018-0672-3</label>
          <listPosition>37</listPosition>
          <doi>10.1007/s00395-018-0672-3</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916481</mtid>
          <link>/api/reference/45916481</link>
          <label>38. Kharbanda 2009: Translation of remote ischaemic preconditioning into clinical practice., Lancet, 374, p. 1557, DOI: 10.1016/S0140-6736(09)61421-5</label>
          <listPosition>38</listPosition>
          <doi>10.1016/S0140-6736(09)61421-5</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916482</mtid>
          <link>/api/reference/45916482</link>
          <label>39. Lieder 2019: Plasma from remotely conditioned pigs reduces infarct size when given before or after ischemia to isolated perfused rat hearts., Pflügers Arch. - Eur. J. Physiol., 471, p. 1371, DOI: 10.1007/s00424-019-02314-y</label>
          <listPosition>39</listPosition>
          <doi>10.1007/s00424-019-02314-y</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916483</mtid>
          <link>/api/reference/45916483</link>
          <label>40. Bell 2022: Remote ischaemic conditioning: defining critical criteria for success-report from the 11th Hatter Cardiovascular Workshop., Basic Res. Cardiol., 117, p. 39, DOI: 10.1007/s00395-022-00947-2</label>
          <listPosition>40</listPosition>
          <doi>10.1007/s00395-022-00947-2</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916484</mtid>
          <link>/api/reference/45916484</link>
          <label>41. Hausenloy 2019: Effect of remote ischemic conditioning on clinical outcomes at 12 months in acute myocardial infarction patients: the CONDI-2/ERIC-PPCI trial., Lancet, 394, p. 1415, DOI: 10.1016/S0140-6736(19)32039-2</label>
          <listPosition>41</listPosition>
          <doi>10.1016/S0140-6736(19)32039-2</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916485</mtid>
          <link>/api/reference/45916485</link>
          <label>42. Lukhna 2023: Remote ischaemic conditioning in STEMI patients in sub-Saharan AFRICA: rationale and study design for the RIC-AFRICA trial., Cardiovasc. Drugs Ther., 37, p. 299, DOI: 10.1007/s10557-021-07283-y</label>
          <listPosition>42</listPosition>
          <doi>10.1007/s10557-021-07283-y</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916486</mtid>
          <link>/api/reference/45916486</link>
          <label>43. Heusch 2023: Primordial non-responsiveness – a neglected obstacle to cardioprotection., Eur. Heart J., 44, p. 1687, DOI: 10.1093/eurheartj/ehad160</label>
          <listPosition>43</listPosition>
          <doi>10.1093/eurheartj/ehad160</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916487</mtid>
          <link>/api/reference/45916487</link>
          <label>44. Hausenloy 2017: Targeting reperfusion injury in patients with ST-segment elevation myocardial infarction: trials and tribulations., Eur. Heart J., 38, p. 935</label>
          <listPosition>44</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916488</mtid>
          <link>/api/reference/45916488</link>
          <label>45. Hausenloy 2013: Myocardial ischemia-reperfusion injury: a neglected therapeutic target., J. Clin. Invest., 123, p. 92, DOI: 10.1172/JCI62874</label>
          <listPosition>45</listPosition>
          <doi>10.1172/JCI62874</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916489</mtid>
          <link>/api/reference/45916489</link>
          <label>46. Ong 2014: HIF-1 reduces ischaemia-reperfusion injury in the heart by targeting the mitochondrial permeability transition pore., Cardiovasc. Res., 104, p. 24, DOI: 10.1093/cvr/cvu172</label>
          <listPosition>46</listPosition>
          <doi>10.1093/cvr/cvu172</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916490</mtid>
          <link>/api/reference/45916490</link>
          <label>47. Sousa Fialho 2019: Hypoxia-inducible factor 1 signalling, metabolism and its therapeutic potential in cardiovascular disease., Biochim. Biophys. Acta, Mol. Basis Dis., 1865, p. 831, DOI: 10.1016/j.bbadis.2018.09.024</label>
          <listPosition>47</listPosition>
          <doi>10.1016/j.bbadis.2018.09.024</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916491</mtid>
          <link>/api/reference/45916491</link>
          <label>48. Dengler 2020: Activation of AMPK under hypoxia: many roads leading to Rome., Int. J. Mol. Sci., 21, p. 2428, DOI: 10.3390/ijms21072428</label>
          <listPosition>48</listPosition>
          <doi>10.3390/ijms21072428</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916492</mtid>
          <link>/api/reference/45916492</link>
          <label>49. Webster 2010: AMP kinase activation and glut4 translocation in isolated cardiomyocytes., Cardiovasc. J. Afr., 21, p. 72</label>
          <listPosition>49</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916493</mtid>
          <link>/api/reference/45916493</link>
          <label>50. Banerjee 2010: SGLT1, a novel cardiac glucose transporter, mediates increased glucose uptake in PRKAG2 cardiomyopathy., J. Mol. Cell. Cardiol., 49, p. 683, DOI: 10.1016/j.yjmcc.2010.06.003</label>
          <listPosition>50</listPosition>
          <doi>10.1016/j.yjmcc.2010.06.003</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916494</mtid>
          <link>/api/reference/45916494</link>
          <label>51. Matsushima 2014: Physiological and pathological functions of NADPH oxidases during myocardial ischemia-reperfusion., Trends Cardiovasc. Med., 24, p. 202, DOI: 10.1016/j.tcm.2014.03.003</label>
          <listPosition>51</listPosition>
          <doi>10.1016/j.tcm.2014.03.003</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916495</mtid>
          <link>/api/reference/45916495</link>
          <label>52. Chouchani 2014: Ischaemic accumulation of succinate controls reperfusion injury through mitochondrial ROS., Nature, 515, p. 431, DOI: 10.1038/nature13909</label>
          <listPosition>52</listPosition>
          <doi>10.1038/nature13909</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916496</mtid>
          <link>/api/reference/45916496</link>
          <label>53. Scott 2010: Mitochondrial fission and fusion., Essays Biochem., 47, p. 85, DOI: 10.1042/bse0470085</label>
          <listPosition>53</listPosition>
          <doi>10.1042/bse0470085</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916497</mtid>
          <link>/api/reference/45916497</link>
          <label>54. Paiva 2010: Transitory activation of AMPK at reperfusion protects the ischaemic-reperfused rat myocardium against infarction., Cardiovasc. Drugs Ther., 24, p. 25, DOI: 10.1007/s10557-010-6222-3</label>
          <listPosition>54</listPosition>
          <doi>10.1007/s10557-010-6222-3</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916498</mtid>
          <link>/api/reference/45916498</link>
          <label>55. Cadenas 2018: ROS and redox signaling in myocardial ischemia-reperfusion injury and cardioprotection., Free Radic. Biol. Med., 117, p. 76, DOI: 10.1016/j.freeradbiomed.2018.01.024</label>
          <listPosition>55</listPosition>
          <doi>10.1016/j.freeradbiomed.2018.01.024</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916499</mtid>
          <link>/api/reference/45916499</link>
          <label>56. Lim 2007: Preconditioning and postconditioning: the essential role of the mitochondrial permeability transition pore., Cardiovasc. Res., 75, p. 530, DOI: 10.1016/j.cardiores.2007.04.022</label>
          <listPosition>56</listPosition>
          <doi>10.1016/j.cardiores.2007.04.022</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916500</mtid>
          <link>/api/reference/45916500</link>
          <label>57. Davidson 2019: Multitarget strategies to reduce myocardial ischemia/reperfusion injury: JACC Review Topic of the Week., J. Am. Coll. Cardiol., 73, p. 89, DOI: 10.1016/j.jacc.2018.09.086</label>
          <listPosition>57</listPosition>
          <doi>10.1016/j.jacc.2018.09.086</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916501</mtid>
          <link>/api/reference/45916501</link>
          <label>58. Sciarretta 2018: New insights into the role of mTOR signaling in the cardiovascular system., Circ. Res., 122, p. 489, DOI: 10.1161/CIRCRESAHA.117.311147</label>
          <listPosition>58</listPosition>
          <doi>10.1161/CIRCRESAHA.117.311147</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916502</mtid>
          <link>/api/reference/45916502</link>
          <label>59. Mishra 2019: Guidelines for evaluating myocardial cell death., Am. J. Physiol. Heart Circ. Physiol., 317, p. H891, DOI: 10.1152/ajpheart.00259.2019</label>
          <listPosition>59</listPosition>
          <doi>10.1152/ajpheart.00259.2019</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916503</mtid>
          <link>/api/reference/45916503</link>
          <label>60. Sciarretta 2011: Is autophagy in response to ischemia and reperfusion protective or detrimental for the heart?., Pediatr. Cardiol., 32, p. 275, DOI: 10.1007/s00246-010-9855-x</label>
          <listPosition>60</listPosition>
          <doi>10.1007/s00246-010-9855-x</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916504</mtid>
          <link>/api/reference/45916504</link>
          <label>61. Xing 2022: Blunting TRPML1 channels protects myocardial ischemia/reperfusion injury by restoring impaired cardiomyocyte autophagy., Basic Res. Cardiol., 117, p. 20, DOI: 10.1007/s00395-022-00930-x</label>
          <listPosition>61</listPosition>
          <doi>10.1007/s00395-022-00930-x</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916505</mtid>
          <link>/api/reference/45916505</link>
          <label>62. Nah 2020: Upregulation of Rubicon promotes autosis during myocardial ischemia/reperfusion injury., J. Clin. Invest., 130, p. 2978, DOI: 10.1172/JCI132366</label>
          <listPosition>62</listPosition>
          <doi>10.1172/JCI132366</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916506</mtid>
          <link>/api/reference/45916506</link>
          <label>63. Kale 2018: BCL-2 family proteins: changing partners in the dance towards death., Cell Death Differ., 25, p. 65, DOI: 10.1038/cdd.2017.186</label>
          <listPosition>63</listPosition>
          <doi>10.1038/cdd.2017.186</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916507</mtid>
          <link>/api/reference/45916507</link>
          <label>64. Meng 2017: Role of the PI3K/AKT signalling pathway in apoptotic cell death in the cerebral cortex of streptozotocin-induced diabetic rats., Exp. Ther. Med., 13, p. 2417, DOI: 10.3892/etm.2017.4259</label>
          <listPosition>64</listPosition>
          <doi>10.3892/etm.2017.4259</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916508</mtid>
          <link>/api/reference/45916508</link>
          <label>65. Yue 2020: Understanding MAPK signaling pathways in apoptosis., Int. J. Mol. Sci., 21, DOI: 10.3390/ijms21072346</label>
          <listPosition>65</listPosition>
          <doi>10.3390/ijms21072346</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916509</mtid>
          <link>/api/reference/45916509</link>
          <label>66. Gordon 2018: Macrophage clearance of apoptotic cells: a critical assessment., Front. Immunol., 9, p. 127, DOI: 10.3389/fimmu.2018.00127</label>
          <listPosition>66</listPosition>
          <doi>10.3389/fimmu.2018.00127</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916510</mtid>
          <link>/api/reference/45916510</link>
          <label>67. Mocanu 2000: Caspase inhibition and limitation of myocardial infarct size: protection against lethal reperfusion injury., Br. J. Pharmacol., 130, p. 197, DOI: 10.1038/sj.bjp.0703336</label>
          <listPosition>67</listPosition>
          <doi>10.1038/sj.bjp.0703336</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916511</mtid>
          <link>/api/reference/45916511</link>
          <label>68. Park 2019: Quantitative proteomic analyses reveal that GPX4 downregulation during myocardial infarction contributes to ferroptosis in cardiomyocytes., Cell Death Dis., 10, p. 835, DOI: 10.1038/s41419-019-2061-8</label>
          <listPosition>68</listPosition>
          <doi>10.1038/s41419-019-2061-8</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916512</mtid>
          <link>/api/reference/45916512</link>
          <label>69. DeBoer 1992: Iron chelation in myocardial preservation after ischemia-reperfusion injury: the importance of pretreatment and toxicity., Ann. Thorac. Surg., 53, p. 412, DOI: 10.1016/0003-4975(92)90260-B</label>
          <listPosition>69</listPosition>
          <doi>10.1016/0003-4975(92)90260-B</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916513</mtid>
          <link>/api/reference/45916513</link>
          <label>70. Ravingerova 2020: The molecular mechanisms of iron metabolism and its role in cardiac dysfunction and cardioprotection., Int. J. Mol. Sci., 21, DOI: 10.3390/ijms21217889</label>
          <listPosition>70</listPosition>
          <doi>10.3390/ijms21217889</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916514</mtid>
          <link>/api/reference/45916514</link>
          <label>71. Guo 2022: Necroptosis in heart disease: molecular mechanisms and therapeutic implications., J. Mol. Cell. Cardiol., 169, p. 74, DOI: 10.1016/j.yjmcc.2022.05.006</label>
          <listPosition>71</listPosition>
          <doi>10.1016/j.yjmcc.2022.05.006</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916515</mtid>
          <link>/api/reference/45916515</link>
          <label>72. Hu 2020: PI3K mediates tumor necrosis factor induced-necroptosis through initiating RIP1-RIP3-MLKL signaling pathway activation., Cytokine, 129, DOI: 10.1016/j.cyto.2020.155046</label>
          <listPosition>72</listPosition>
          <doi>10.1016/j.cyto.2020.155046</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916516</mtid>
          <link>/api/reference/45916516</link>
          <label>73. Zhang 2016: CaMKII is a RIP3 substrate mediating ischemia- and oxidative stress-induced myocardial necroptosis., Nat. Med., 22, p. 175, DOI: 10.1038/nm.4017</label>
          <listPosition>73</listPosition>
          <doi>10.1038/nm.4017</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916517</mtid>
          <link>/api/reference/45916517</link>
          <label>74. Smith 2007: Necrostatin: a potentially novel cardioprotective agent?., Cardiovasc. Drugs Ther., 21, p. 227, DOI: 10.1007/s10557-007-6035-1</label>
          <listPosition>74</listPosition>
          <doi>10.1007/s10557-007-6035-1</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916518</mtid>
          <link>/api/reference/45916518</link>
          <label>75. Weisel 2021: A randomised, placebo-controlled study of RIPK1 inhibitor GSK2982772 in patients with active ulcerative colitis., BMJ Open Gastroenterol., 8, DOI: 10.1136/bmjgast-2021-000680</label>
          <listPosition>75</listPosition>
          <doi>10.1136/bmjgast-2021-000680</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916519</mtid>
          <link>/api/reference/45916519</link>
          <label>76. Rao 2022: Pyroptosis in inflammatory diseases and cancer., Theranostics, 12, p. 4310, DOI: 10.7150/thno.71086</label>
          <listPosition>76</listPosition>
          <doi>10.7150/thno.71086</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916520</mtid>
          <link>/api/reference/45916520</link>
          <label>77. Shi 2021: GSDMD-mediated cardiomyocyte pyroptosis promotes myocardial I/R injury., Circ. Res., 129, p. 383, DOI: 10.1161/CIRCRESAHA.120.318629</label>
          <listPosition>77</listPosition>
          <doi>10.1161/CIRCRESAHA.120.318629</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916521</mtid>
          <link>/api/reference/45916521</link>
          <label>78. Yellon 2023: The RISK pathway leading to mitochondria and cardioprotection: how everything started., Basic Res. Cardiol., 118, p. 22, DOI: 10.1007/s00395-023-00992-5</label>
          <listPosition>78</listPosition>
          <doi>10.1007/s00395-023-00992-5</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916522</mtid>
          <link>/api/reference/45916522</link>
          <label>79. Hadebe 2018: The SAFE pathway for cardioprotection: is this a promising target?., Basic Res. Cardiol., 113, p. 9, DOI: 10.1007/s00395-018-0670-5</label>
          <listPosition>79</listPosition>
          <doi>10.1007/s00395-018-0670-5</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916523</mtid>
          <link>/api/reference/45916523</link>
          <label>80. Heusch 2011: Mitochondrial STAT3 activation and cardioprotection by ischemic postconditioning in pigs with regional myocardial ischemia/reperfusion., Circ. Res., 109, p. 1302, DOI: 10.1161/CIRCRESAHA.111.255604</label>
          <listPosition>80</listPosition>
          <doi>10.1161/CIRCRESAHA.111.255604</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916524</mtid>
          <link>/api/reference/45916524</link>
          <label>81. Boengler 2010: Inhibition of permeability transition pore opening by mitochondrial STAT3 and its role in myocardial ischemia/reperfusion., Basic Res. Cardiol., 105, p. 771, DOI: 10.1007/s00395-010-0124-1</label>
          <listPosition>81</listPosition>
          <doi>10.1007/s00395-010-0124-1</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916525</mtid>
          <link>/api/reference/45916525</link>
          <label>82. Skyschally 2015: Across-species transfer of protection by remote ischemic preconditioning with species-specific myocardial signal transduction by reperfusion injury salvage kinase and survival activating factor enhancement pathways., Circ. Res., 117, p. 279, DOI: 10.1161/CIRCRESAHA.117.306878</label>
          <listPosition>82</listPosition>
          <doi>10.1161/CIRCRESAHA.117.306878</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916526</mtid>
          <link>/api/reference/45916526</link>
          <label>83. Gent 2017: Ischemic preconditioning in pigs: a causal role for signal transducer and activator of transcription 3., Am. J. Physiol. Heart Circ. Physiol., 312, p. H478, DOI: 10.1152/ajpheart.00749.2016</label>
          <listPosition>83</listPosition>
          <doi>10.1152/ajpheart.00749.2016</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916527</mtid>
          <link>/api/reference/45916527</link>
          <label>84. Kleinbongard 2018: Reflection of cardioprotection by remote ischemic perconditioning in attenuated ST-segment elevation during ongoing coronary occlusion in pigs: evidence for cardioprotection from ischemic injury., Circ. Res., 122, p. 1102, DOI: 10.1161/CIRCRESAHA.118.312784</label>
          <listPosition>84</listPosition>
          <doi>10.1161/CIRCRESAHA.118.312784</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916528</mtid>
          <link>/api/reference/45916528</link>
          <label>85. Kleinbongard 2023: Perspective: mitochondrial STAT3 in cardioprotection., Basic Res. Cardiol., 118, p. 32, DOI: 10.1007/s00395-023-01003-3</label>
          <listPosition>85</listPosition>
          <doi>10.1007/s00395-023-01003-3</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916529</mtid>
          <link>/api/reference/45916529</link>
          <label>86. Hausenloy 2012: Investigating the signal transduction pathways underlying remote ischemic conditioning in the porcine heart., Cardiovasc. Drugs Ther., 26, p. 87, DOI: 10.1007/s10557-011-6364-y</label>
          <listPosition>86</listPosition>
          <doi>10.1007/s10557-011-6364-y</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916530</mtid>
          <link>/api/reference/45916530</link>
          <label>87. Heusch 2015: Remote ischemic conditioning., J. Am. Coll. Cardiol., 65, p. 177, DOI: 10.1016/j.jacc.2014.10.031</label>
          <listPosition>87</listPosition>
          <doi>10.1016/j.jacc.2014.10.031</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916531</mtid>
          <link>/api/reference/45916531</link>
          <label>88. Rohailla 2014: Acute, delayed and chronic remote ischemic conditioning is associated with downregulation of mTOR and enhanced autophagy signaling., PLoS One, 9, DOI: 10.1371/journal.pone.0111291</label>
          <listPosition>88</listPosition>
          <doi>10.1371/journal.pone.0111291</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916532</mtid>
          <link>/api/reference/45916532</link>
          <label>89. Li 2021: Plasma exosomes at the late phase of remote ischemic pre-conditioning attenuate myocardial ischemia-reperfusion injury through transferring miR-126a-3p., Front. Cardiovasc. Med., 8, DOI: 10.3389/fcvm.2021.736226</label>
          <listPosition>89</listPosition>
          <doi>10.3389/fcvm.2021.736226</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916533</mtid>
          <link>/api/reference/45916533</link>
          <label>90. Wei 2011: Repeated remote ischemic postconditioning protects against adverse left ventricular remodeling and improves survival in a rat model of myocardial infarction., Circ. Res., 108, p. 1220, DOI: 10.1161/CIRCRESAHA.110.236190</label>
          <listPosition>90</listPosition>
          <doi>10.1161/CIRCRESAHA.110.236190</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916534</mtid>
          <link>/api/reference/45916534</link>
          <label>91. Yamaguchi 2015: Repeated remote ischemic conditioning attenuates left ventricular remodeling via exosome-mediated intercellular communication on chronic heart failure after myocardial infarction., Int. J. Cardiol., 178, p. 239, DOI: 10.1016/j.ijcard.2014.10.144</label>
          <listPosition>91</listPosition>
          <doi>10.1016/j.ijcard.2014.10.144</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916535</mtid>
          <link>/api/reference/45916535</link>
          <label>92. Rossello 2017: The role of PI3Kalpha isoform in cardioprotection., Basic Res. Cardiol., 112, p. 66, DOI: 10.1007/s00395-017-0657-7</label>
          <listPosition>92</listPosition>
          <doi>10.1007/s00395-017-0657-7</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916536</mtid>
          <link>/api/reference/45916536</link>
          <label>93. Gong 2023: A small-molecule PI3Kalpha activator for cardioprotection and neuroregeneration., Nature, 618, p. 159, DOI: 10.1038/s41586-023-05972-2</label>
          <listPosition>93</listPosition>
          <doi>10.1038/s41586-023-05972-2</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916537</mtid>
          <link>/api/reference/45916537</link>
          <label>94. Rossello 2018: The RISK pathway and beyond., Basic Res. Cardiol., 113, p. 2, DOI: 10.1007/s00395-017-0662-x</label>
          <listPosition>94</listPosition>
          <doi>10.1007/s00395-017-0662-x</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916538</mtid>
          <link>/api/reference/45916538</link>
          <label>95. Ferdinandy 2023: Interaction of cardiovascular nonmodifiable risk factors, comorbidities and comedications with ischemia/reperfusion injury and cardioprotection by pharmacological treatments and ischemic conditioning., Pharmacol. Rev., 75, p. 159, DOI: 10.1124/pharmrev.121.000348</label>
          <listPosition>95</listPosition>
          <doi>10.1124/pharmrev.121.000348</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916539</mtid>
          <link>/api/reference/45916539</link>
          <label>96. Boengler 2009: Loss of cardioprotection with ageing., Cardiovasc. Res., 83, p. 247, DOI: 10.1093/cvr/cvp033</label>
          <listPosition>96</listPosition>
          <doi>10.1093/cvr/cvp033</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916540</mtid>
          <link>/api/reference/45916540</link>
          <label>97. Pagliaro 2017: Hypertension, hypertrophy, and reperfusion injury., J. Cardiovasc. Med., 18, p. 131, DOI: 10.2459/JCM.0000000000000435</label>
          <listPosition>97</listPosition>
          <doi>10.2459/JCM.0000000000000435</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916541</mtid>
          <link>/api/reference/45916541</link>
          <label>98. Andreadou 2020: Hyperlipidaemia and cardioprotection: animal models for translational studies., Br. J. Pharmacol., 177, p. 5287, DOI: 10.1111/bph.14931</label>
          <listPosition>98</listPosition>
          <doi>10.1111/bph.14931</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916542</mtid>
          <link>/api/reference/45916542</link>
          <label>99. Penna 2020: Effect of hyperglycaemia and diabetes on acute myocardial ischaemia-reperfusion injury and cardioprotection by ischaemic conditioning protocols., Br. J. Pharmacol., 177, p. 5312, DOI: 10.1111/bph.14993</label>
          <listPosition>99</listPosition>
          <doi>10.1111/bph.14993</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916543</mtid>
          <link>/api/reference/45916543</link>
          <label>100. Perrino 2021: Improving translational research in sex-specific effects of comorbidities and risk factors in ischaemic heart disease and cardioprotection: position paper and recommendations of the ESC Working Group on Cellular Biology of the Heart., Cardiovasc. Res., 117, p. 367, DOI: 10.1093/cvr/cvaa155</label>
          <listPosition>100</listPosition>
          <doi>10.1093/cvr/cvaa155</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916544</mtid>
          <link>/api/reference/45916544</link>
          <label>101. Kleinbongard 2023: No sex-related differences in infarct size, no-reflow and protection by ischaemic preconditioning in Göttingen minipigs., Cardiovasc. Res., 119, p. 561, DOI: 10.1093/cvr/cvac062</label>
          <listPosition>101</listPosition>
          <doi>10.1093/cvr/cvac062</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916545</mtid>
          <link>/api/reference/45916545</link>
          <label>102. Kleinbongard 2021: The platelet paradox of injury versus protection in myocardial infarction-has it been overlooked?., Basic Res. Cardiol., 116, p. 37, DOI: 10.1007/s00395-021-00876-6</label>
          <listPosition>102</listPosition>
          <doi>10.1007/s00395-021-00876-6</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916546</mtid>
          <link>/api/reference/45916546</link>
          <label>103. Kottenberg 2014: Myocardial protection by remote ischaemic pre-conditioning is abolished in sulphonylurea-treated diabetics undergoing coronary revascularisation., Acta Anaesthesiol. Scand., 58, p. 453, DOI: 10.1111/aas.12278</label>
          <listPosition>103</listPosition>
          <doi>10.1111/aas.12278</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916547</mtid>
          <link>/api/reference/45916547</link>
          <label>104. Kleinbongard 2020: Co-morbidities and co-medications as confounders of cardioprotection - does it matter in the clinical setting?., Br. J. Pharmacol., 177, p. 5252, DOI: 10.1111/bph.14839</label>
          <listPosition>104</listPosition>
          <doi>10.1111/bph.14839</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916548</mtid>
          <link>/api/reference/45916548</link>
          <label>105. Heusch 2019: Myocardial ischemia: lack of coronary blood flow, myocardial oxygen supply-demand imbalance, or what?., Am. J. Physiol. Heart Circ. Physiol., 316, p. H1439, DOI: 10.1152/ajpheart.00139.2019</label>
          <listPosition>105</listPosition>
          <doi>10.1152/ajpheart.00139.2019</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916549</mtid>
          <link>/api/reference/45916549</link>
          <label>106. Falk 1983: Plaque rupture with severe pre-existing stenosis precipitating coronary thrombosis. Characteristics of coronary atherosclerotic plaques underlying fatal occlusive thrombi., Br. Heart J., 50, p. 127, DOI: 10.1136/hrt.50.2.127</label>
          <listPosition>106</listPosition>
          <doi>10.1136/hrt.50.2.127</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916550</mtid>
          <link>/api/reference/45916550</link>
          <label>107. Libby 2021: The changing landscape of atherosclerosis., Nature, 592, p. 524, DOI: 10.1038/s41586-021-03392-8</label>
          <listPosition>107</listPosition>
          <doi>10.1038/s41586-021-03392-8</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916551</mtid>
          <link>/api/reference/45916551</link>
          <label>108. Kleinbongard 2022: A fresh look at coronary microembolization., Nat. Rev. Cardiol., 19, p. 265, DOI: 10.1038/s41569-021-00632-2</label>
          <listPosition>108</listPosition>
          <doi>10.1038/s41569-021-00632-2</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916552</mtid>
          <link>/api/reference/45916552</link>
          <label>109. Puymirat 2017: Acute myocardial infarction: changes in patient characteristics, management, and 6-month outcomes over a period of 20 years in the FAST-MI program (French registry of acute ST-elevation or non-ST-elevation myocardial infarction) 1995 to 2015., Circulation, 14, p. 1908, DOI: 10.1161/CIRCULATIONAHA.117.030798</label>
          <listPosition>109</listPosition>
          <doi>10.1161/CIRCULATIONAHA.117.030798</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916553</mtid>
          <link>/api/reference/45916553</link>
          <label>110. Bairey Merz 2017: Ischemia and no obstructive coronary artery disease (INOCA): developing evidence-based therapies and research agenda for the next decade., Circulation, 135, p. 1075, DOI: 10.1161/CIRCULATIONAHA.116.024534</label>
          <listPosition>110</listPosition>
          <doi>10.1161/CIRCULATIONAHA.116.024534</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916554</mtid>
          <link>/api/reference/45916554</link>
          <label>111. Reynolds 2021: Coronary optical coherence tomography and cardiac magnetic resonance imaging to determine underlying causes of myocardial infarction with nonobstructive coronary arteries in women., Circulation, 143, p. 624, DOI: 10.1161/CIRCULATIONAHA.120.052008</label>
          <listPosition>111</listPosition>
          <doi>10.1161/CIRCULATIONAHA.120.052008</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916555</mtid>
          <link>/api/reference/45916555</link>
          <label>112. Parwani 2023: Contemporary diagnosis and management of patients with MINOCA., Curr. Cardiol. Rep., 25, p. 561, DOI: 10.1007/s11886-023-01874-x</label>
          <listPosition>112</listPosition>
          <doi>10.1007/s11886-023-01874-x</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916556</mtid>
          <link>/api/reference/45916556</link>
          <label>113. Heusch 2016: The coronary circulation as a target of cardioprotection., Circ. Res., 118, p. 1643, DOI: 10.1161/CIRCRESAHA.116.308640</label>
          <listPosition>113</listPosition>
          <doi>10.1161/CIRCRESAHA.116.308640</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916557</mtid>
          <link>/api/reference/45916557</link>
          <label>114. Heusch 2019: Coronary microvascular obstruction: the new frontier in cardioprotection., Basic Res. Cardiol., 114, p. 45, DOI: 10.1007/s00395-019-0756-8</label>
          <listPosition>114</listPosition>
          <doi>10.1007/s00395-019-0756-8</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916558</mtid>
          <link>/api/reference/45916558</link>
          <label>115. Fernandez-Jimenez 2015: Pathophysiology underlying the bimodal edema phenomenon after myocardial ischemia/reperfusion., J. Am. Coll. Cardiol., 66, p. 816, DOI: 10.1016/j.jacc.2015.06.023</label>
          <listPosition>115</listPosition>
          <doi>10.1016/j.jacc.2015.06.023</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916559</mtid>
          <link>/api/reference/45916559</link>
          <label>116. Ehring 1995: Cholinergic and a-adrenergic coronary vasomotion with increasing ischemia-reperfusion injury., Am. J. Physiol. Heart Circ. Physiol., 268, p. H886, DOI: 10.1152/ajpheart.1995.268.2.H886</label>
          <listPosition>116</listPosition>
          <doi>10.1152/ajpheart.1995.268.2.H886</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916560</mtid>
          <link>/api/reference/45916560</link>
          <label>117. Kleinbongard 2011: Vasoconstrictor potential of coronary aspirate from patients undergoing stenting of saphenous vein aortocoronary bypass grafts and its pharmacological attenuation., Circ. Res., 108, p. 344, DOI: 10.1161/CIRCRESAHA.110.235713</label>
          <listPosition>117</listPosition>
          <doi>10.1161/CIRCRESAHA.110.235713</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916561</mtid>
          <link>/api/reference/45916561</link>
          <label>118. Kupatt 2002: Molecular mechanisms of platelet-mediated leukocyte recruitment during myocardial reperfusion., J. Leukoc. Biol., 72, p. 455, DOI: 10.1189/jlb.72.3.455</label>
          <listPosition>118</listPosition>
          <doi>10.1189/jlb.72.3.455</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916562</mtid>
          <link>/api/reference/45916562</link>
          <label>119. Folts 1999: Deleterious hemodynamic effects of thrombotic/embolic materials on the distal myocardial vasculature., Cardiovasc. Res., 42, p. 6</label>
          <listPosition>119</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916563</mtid>
          <link>/api/reference/45916563</link>
          <label>120. Driesen 2012: Histological correlate of a cardiac magnetic resonance imaged microvascular obstruction in a porcine model of ischemia-reperfusion., Cardiovasc. Pathol., 21, p. 129, DOI: 10.1016/j.carpath.2011.07.008</label>
          <listPosition>120</listPosition>
          <doi>10.1016/j.carpath.2011.07.008</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916564</mtid>
          <link>/api/reference/45916564</link>
          <label>121. Kloner 1974: The "no-reflow" phenomenon after temporary coronary occlusion in the dog., J. Clin. Invest., 54, p. 1496, DOI: 10.1172/JCI107898</label>
          <listPosition>121</listPosition>
          <doi>10.1172/JCI107898</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916565</mtid>
          <link>/api/reference/45916565</link>
          <label>122. Higginson 1982: Determinants of myocardial hemorrhage after coronary reperfusion in the anesthetized dog., Circulation, 65, p. 62, DOI: 10.1161/01.CIR.65.1.62</label>
          <listPosition>122</listPosition>
          <doi>10.1161/01.CIR.65.1.62</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916566</mtid>
          <link>/api/reference/45916566</link>
          <label>123. Baumgart 1998: Improved assessment of coronary stenosis severity using the relative flow velocity reserve., Circulation, 98, p. 40, DOI: 10.1161/01.CIR.98.1.40</label>
          <listPosition>123</listPosition>
          <doi>10.1161/01.CIR.98.1.40</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916567</mtid>
          <link>/api/reference/45916567</link>
          <label>124. Herrmann 2001: Abnormal coronary flow velocity reserve following coronary intervention is associated with cardiac marker elevation., Circulation, 103, p. 2339, DOI: 10.1161/01.CIR.103.19.2339</label>
          <listPosition>124</listPosition>
          <doi>10.1161/01.CIR.103.19.2339</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916568</mtid>
          <link>/api/reference/45916568</link>
          <label>125. Ibanez 2019: Cardiac MRI endpoints in myocardial infarction experimental and clinical trials. JACC scientific expert panel JACC scientific expert panel., J. Am. Coll. Cardiol., 74, p. 238, DOI: 10.1016/j.jacc.2019.05.024</label>
          <listPosition>125</listPosition>
          <doi>10.1016/j.jacc.2019.05.024</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916569</mtid>
          <link>/api/reference/45916569</link>
          <label>126. de Waha 2017: Relationship between microvascular obstruction and adverse events following primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: an individual patient data pooled analysis from seven randomized trials., Eur. Heart J., 38, p. 3502, DOI: 10.1093/eurheartj/ehx414</label>
          <listPosition>126</listPosition>
          <doi>10.1093/eurheartj/ehx414</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916570</mtid>
          <link>/api/reference/45916570</link>
          <label>127. Reinstadler 2019: Intramyocardial haemorrhage and prognosis after ST-elevation myocardial infarction., Eur. Heart J. Cardiovasc. Imag., 20, p. 138, DOI: 10.1093/ehjci/jey101</label>
          <listPosition>127</listPosition>
          <doi>10.1093/ehjci/jey101</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916571</mtid>
          <link>/api/reference/45916571</link>
          <label>128. Sies 2020: Findings in redox biology: from H2O2 to oxidative stress., J. Biol. Chem., 295, p. 13458, DOI: 10.1074/jbc.X120.015651</label>
          <listPosition>128</listPosition>
          <doi>10.1074/jbc.X120.015651</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916572</mtid>
          <link>/api/reference/45916572</link>
          <label>129. Sies 2022: Defining roles of specific reactive oxygen species (ROS) in cell biology and physiology., Nat. Rev. Mol. Cell Biol., 23, p. 499, DOI: 10.1038/s41580-022-00456-z</label>
          <listPosition>129</listPosition>
          <doi>10.1038/s41580-022-00456-z</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916573</mtid>
          <link>/api/reference/45916573</link>
          <label>130. Liu 2011: H2O2 is the transferrable factor mediating flow-induced dilation in human coronary arterioles., Circ. Res., 108, p. 566, DOI: 10.1161/CIRCRESAHA.110.237636</label>
          <listPosition>130</listPosition>
          <doi>10.1161/CIRCRESAHA.110.237636</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916574</mtid>
          <link>/api/reference/45916574</link>
          <label>131. Larsen 2009: Bradykinin-induced dilation of human coronary arterioles requires NADPH oxidase-derived reactive oxygen species., Arterioscler. Thromb. Vasc. Biol., 29, p. 739, DOI: 10.1161/ATVBAHA.108.169367</label>
          <listPosition>131</listPosition>
          <doi>10.1161/ATVBAHA.108.169367</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916575</mtid>
          <link>/api/reference/45916575</link>
          <label>132. Bubolz 2012: Activation of endothelial TRPV4 channels mediates flow-induced dilation in human coronary arterioles: role of Ca2+ entry and mitochondrial ROS signaling., Am. J. Physiol. Heart Circ. Physiol., 302, p. H634, DOI: 10.1152/ajpheart.00717.2011</label>
          <listPosition>132</listPosition>
          <doi>10.1152/ajpheart.00717.2011</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916576</mtid>
          <link>/api/reference/45916576</link>
          <label>133. Hori 1991: Role of oxygen-derived free radicals in myocardial edema and ischemia in coronary microvascular embolization., Circulation, 84, p. 828, DOI: 10.1161/01.CIR.84.2.828</label>
          <listPosition>133</listPosition>
          <doi>10.1161/01.CIR.84.2.828</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916577</mtid>
          <link>/api/reference/45916577</link>
          <label>134. Teixeira 2023: Reduction in mitochondrial ROS improves oxidative phosphorylation and provides resilience to coronary endothelium in non-reperfused myocardial infarction., Basic Res. Cardiol., 118, p. 3, DOI: 10.1007/s00395-022-00976-x</label>
          <listPosition>134</listPosition>
          <doi>10.1007/s00395-022-00976-x</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916578</mtid>
          <link>/api/reference/45916578</link>
          <label>135. Hausenloy 2019: The coronary circulation in acute myocardial ischaemia/reperfusion injury - a target for cardioprotection., Cardiovasc. Res., 115, p. 1143, DOI: 10.1093/cvr/cvy286</label>
          <listPosition>135</listPosition>
          <doi>10.1093/cvr/cvy286</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916579</mtid>
          <link>/api/reference/45916579</link>
          <label>136. Galaup 2012: Protection against myocardial infarction and no-reflow through preservation of vascular integrity by angiopoietin-like 4., Circulation, 125, p. 140, DOI: 10.1161/CIRCULATIONAHA.111.049072</label>
          <listPosition>136</listPosition>
          <doi>10.1161/CIRCULATIONAHA.111.049072</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916580</mtid>
          <link>/api/reference/45916580</link>
          <label>137. Thuny 2012: Post-conditioning reduces infarct size and edema in patients with ST-segment elevation myocardial infarction., J. Am. Coll. Cardiol., 59, p. 2175, DOI: 10.1016/j.jacc.2012.03.026</label>
          <listPosition>137</listPosition>
          <doi>10.1016/j.jacc.2012.03.026</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916581</mtid>
          <link>/api/reference/45916581</link>
          <label>138. Mewton 2013: Postconditioning attenuates no-reflow in STEMI patients., Basic Res. Cardiol., 108, p. 383, DOI: 10.1007/s00395-013-0383-8</label>
          <listPosition>138</listPosition>
          <doi>10.1007/s00395-013-0383-8</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916582</mtid>
          <link>/api/reference/45916582</link>
          <label>139. Traverse 2019: NHLBI-sponsored randomized trial of postconditioning during primary percutaneous coronary Iintervention for ST-elevation myocardial infarction., Circ. Res., 124, p. 769, DOI: 10.1161/CIRCRESAHA.118.314060</label>
          <listPosition>139</listPosition>
          <doi>10.1161/CIRCRESAHA.118.314060</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916583</mtid>
          <link>/api/reference/45916583</link>
          <label>140. Crimi 2013: Remote ischemic post-conditioning of the lower limb during primary percutaneous coronary intervention safely reduces enzymatic infarct size in anterior myocardial infarction: a randomized controlled trial., J. Am. Coll. Cardiol. Cardiovasc. Interv., 6, p. 1055, DOI: 10.1016/j.jcin.2013.05.011</label>
          <listPosition>140</listPosition>
          <doi>10.1016/j.jcin.2013.05.011</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916584</mtid>
          <link>/api/reference/45916584</link>
          <label>141. White 2015: Remote ischemic conditioning reduces myocardial infarct size and edema in patients with ST-segment elevation myocardial infarction., J. Am. Coll. Cardiol. Cardiovasc. Interv., 8, p. 178, DOI: 10.1016/j.jcin.2014.05.015</label>
          <listPosition>141</listPosition>
          <doi>10.1016/j.jcin.2014.05.015</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916585</mtid>
          <link>/api/reference/45916585</link>
          <label>142. Garcia-Prieto 2017: Neutrophil stunning by metoprolol reduces infarct size., Nat. Commun., 8, DOI: 10.1038/ncomms14780</label>
          <listPosition>142</listPosition>
          <doi>10.1038/ncomms14780</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916586</mtid>
          <link>/api/reference/45916586</link>
          <label>143. Niccoli 2019: Optimized treatment of ST-elevation myocardial infarction: the unmet need to target coronary microvascular obstruction as primary treatment goal to further improve prognosis., Circ. Res., 125, p. 245, DOI: 10.1161/CIRCRESAHA.119.315344</label>
          <listPosition>143</listPosition>
          <doi>10.1161/CIRCRESAHA.119.315344</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916587</mtid>
          <link>/api/reference/45916587</link>
          <label>144. van der Laan 2009: Targeting angiogenesis to restore the microcirculation after reperfused MI., Nat. Rev. Cardiol., 6, p. 515, DOI: 10.1038/nrcardio.2009.103</label>
          <listPosition>144</listPosition>
          <doi>10.1038/nrcardio.2009.103</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916588</mtid>
          <link>/api/reference/45916588</link>
          <label>145. Heusch 2022: Coronary blood flow in heart failure: cause, consequence and bystander., Basic Res. Cardiol., 117, p. 1, DOI: 10.1007/s00395-022-00909-8</label>
          <listPosition>145</listPosition>
          <doi>10.1007/s00395-022-00909-8</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916589</mtid>
          <link>/api/reference/45916589</link>
          <label>146. Faxon 2018: Circulation: cardiovascular interventions: the first 10 years., Circ. Cardiovasc. Interv., 11, DOI: 10.1161/CIRCINTERVENTIONS.118.006901</label>
          <listPosition>146</listPosition>
          <doi>10.1161/CIRCINTERVENTIONS.118.006901</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916590</mtid>
          <link>/api/reference/45916590</link>
          <label>147. Bulluck 2021: Eur. Heart J., 42, p. 2630, DOI: 10.1093/eurheartj/ehab271</label>
          <listPosition>147</listPosition>
          <doi>10.1093/eurheartj/ehab271</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916591</mtid>
          <link>/api/reference/45916591</link>
          <label>148. Silvain 2021: Procedural myocardial injury, infarction and mortality in patients undergoing elective PCI: a pooled analysis of patient-level data., Eur. Heart J., 42, p. 323, DOI: 10.1093/eurheartj/ehaa885</label>
          <listPosition>148</listPosition>
          <doi>10.1093/eurheartj/ehaa885</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916592</mtid>
          <link>/api/reference/45916592</link>
          <label>149. Thygesen 2019: Fourth universal definition of myocardial infarction (2018)., Eur. Heart J., 40, p. 237, DOI: 10.1093/eurheartj/ehy462</label>
          <listPosition>149</listPosition>
          <doi>10.1093/eurheartj/ehy462</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916593</mtid>
          <link>/api/reference/45916593</link>
          <label>150. Cavender 2016: Consistent reduction in periprocedural myocardial infarction with cangrelor as assessed by multiple definitions: findings from CHAMPION PHOENIX (cangrelor versus standard therapy to achieve optimal management of platelet inhibition)., Circulation, 134, p. 723, DOI: 10.1161/CIRCULATIONAHA.115.020829</label>
          <listPosition>150</listPosition>
          <doi>10.1161/CIRCULATIONAHA.115.020829</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916594</mtid>
          <link>/api/reference/45916594</link>
          <label>151. Wang 2014: The effect of intravenous vitamin C infusion on periprocedural myocardial injury for patients undergoing elective percutaneous coronary intervention., Can. J. Cardiol., 30, p. 96, DOI: 10.1016/j.cjca.2013.08.018</label>
          <listPosition>151</listPosition>
          <doi>10.1016/j.cjca.2013.08.018</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916595</mtid>
          <link>/api/reference/45916595</link>
          <label>152. Basili 2010: Intravenous ascorbic acid infusion improves myocardial perfusion grade during elective percutaneous coronary intervention: relationship with oxidative stress markers., JACC Cardiovasc. Interv., 3, p. 221, DOI: 10.1016/j.jcin.2009.10.025</label>
          <listPosition>152</listPosition>
          <doi>10.1016/j.jcin.2009.10.025</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916596</mtid>
          <link>/api/reference/45916596</link>
          <label>153. Mangiacapra 2013: Intracoronary enalaprilat to reduce microvascular damage during percutaneous coronary intervention (ProMicro) study., J. Am. Coll. Cardiol., 61, p. 615, DOI: 10.1016/j.jacc.2012.11.025</label>
          <listPosition>153</listPosition>
          <doi>10.1016/j.jacc.2012.11.025</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916597</mtid>
          <link>/api/reference/45916597</link>
          <label>154. Mulukutla 2004: Effect of statin therapy prior to elective percutaneous coronary intervention on frequency of periprocedural myocardial injury., Am. J. Cardiol., 94, p. 1363, DOI: 10.1016/j.amjcard.2004.07.140</label>
          <listPosition>154</listPosition>
          <doi>10.1016/j.amjcard.2004.07.140</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916598</mtid>
          <link>/api/reference/45916598</link>
          <label>155. Pasceri 2004: Randomized trial of atorvastatin for reduction of myocardial damage during coronary intervention. Results from the ARMYDA (Atorvastatin for Reduction of MYocardial Damage during Angioplasty) Study., Circulation, 110, p. 674, DOI: 10.1161/01.CIR.0000137828.06205.87</label>
          <listPosition>155</listPosition>
          <doi>10.1161/01.CIR.0000137828.06205.87</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916599</mtid>
          <link>/api/reference/45916599</link>
          <label>156. Briguori 2009: Novel approaches for preventing or limiting events (Naples) II trial impact of a single high loading dose of atorvastatin on periprocedural myocardial infarction., J. Am. Coll. Cardiol., 54, p. 2157, DOI: 10.1016/j.jacc.2009.07.005</label>
          <listPosition>156</listPosition>
          <doi>10.1016/j.jacc.2009.07.005</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916600</mtid>
          <link>/api/reference/45916600</link>
          <label>157. Sardella 2013: Comparison of high reloading ROsuvastatin and Atorvastatin pretreatment in patients undergoing elective PCI to reduce the incidence of MyocArdial periprocedural necrosis. The ROMA II trial., Int. J. Cardiol., 168, p. 3715, DOI: 10.1016/j.ijcard.2013.06.017</label>
          <listPosition>157</listPosition>
          <doi>10.1016/j.ijcard.2013.06.017</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916601</mtid>
          <link>/api/reference/45916601</link>
          <label>158. Pan 2015: Efficacy of high-dose rosuvastatin preloading in patients undergoing percutaneous coronary intervention: a meta-analysis of fourteen randomized controlled trials., Lipids Health Dis., 14, p. 97, DOI: 10.1186/s12944-015-0095-1</label>
          <listPosition>158</listPosition>
          <doi>10.1186/s12944-015-0095-1</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916602</mtid>
          <link>/api/reference/45916602</link>
          <label>159. Veselka 2014: Effect of rosuvastatin therapy on troponin I release following percutaneous coronary intervention in nonemergency patients (from the TIP 3 study)., Am. J. Cardiol., 113, p. 446, DOI: 10.1016/j.amjcard.2013.10.026</label>
          <listPosition>159</listPosition>
          <doi>10.1016/j.amjcard.2013.10.026</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916603</mtid>
          <link>/api/reference/45916603</link>
          <label>160. Zemanek 2013: Effect of seven-day atorvastatin pretreatment on the incidence of periprocedural myocardial infarction following percutaneous coronary intervention in patients receiving long-term statin therapy. A randomized study., Int. J. Cardiol., 168, p. 2494, DOI: 10.1016/j.ijcard.2013.03.002</label>
          <listPosition>160</listPosition>
          <doi>10.1016/j.ijcard.2013.03.002</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916604</mtid>
          <link>/api/reference/45916604</link>
          <label>161. Patti 2006: J. Am. Coll. Cardiol., 48, p. 1560, DOI: 10.1016/j.jacc.2006.06.061</label>
          <listPosition>161</listPosition>
          <doi>10.1016/j.jacc.2006.06.061</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916605</mtid>
          <link>/api/reference/45916605</link>
          <label>162. Ye 2014: High-dose atorvastatin reloading before percutaneous coronary intervention increased circulating endothelial progenitor cells and reduced inflammatory cytokine expression during the perioperative period., J. Cardiovasc. Pharmacol. Therapeut., 19, p. 290, DOI: 10.1177/1074248413513500</label>
          <listPosition>162</listPosition>
          <doi>10.1177/1074248413513500</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916606</mtid>
          <link>/api/reference/45916606</link>
          <label>163. Hoole 2009: Cardiac remote ischemic preconditioning in coronary stenting (CRISP Stent) study: a prospective, randomized control trial., Circulation, 119, p. 820, DOI: 10.1161/CIRCULATIONAHA.108.809723</label>
          <listPosition>163</listPosition>
          <doi>10.1161/CIRCULATIONAHA.108.809723</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916607</mtid>
          <link>/api/reference/45916607</link>
          <label>164. Luo 2013: Remote ischemic preconditioning reduces myocardial injury in patients undergoing coronary stent implantation., Can. J. Cardiol., 29, p. 1084, DOI: 10.1016/j.cjca.2012.11.022</label>
          <listPosition>164</listPosition>
          <doi>10.1016/j.cjca.2012.11.022</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916608</mtid>
          <link>/api/reference/45916608</link>
          <label>165. Pei 2014: Remote ischemic preconditioning reduces perioperative cardiac and renal events in patients undergoing elective coronary intervention: a meta-analysis of 11 randomized trials., PLoS One, 9, DOI: 10.1371/journal.pone.0115500</label>
          <listPosition>165</listPosition>
          <doi>10.1371/journal.pone.0115500</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916609</mtid>
          <link>/api/reference/45916609</link>
          <label>166. Prasad 2013: Remote ischemic preconditioning immediately before percutaneous coronary intervention does not impact myocardial necrosis, inflammatory response, and circulating endothelial progenitor cell counts: a single center randomized sham controlled trial., Cathet. Cardiovasc. Interv., 81, p. 930, DOI: 10.1002/ccd.24443</label>
          <listPosition>166</listPosition>
          <doi>10.1002/ccd.24443</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916610</mtid>
          <link>/api/reference/45916610</link>
          <label>167. Davies 2013: Remote ischemic preconditioning improves outcome at 6 years after elective percutaneous coronary intervention: the CRISP stent trial long-term follow-up., Circ. Cardiovasc. Interv., 6, p. 246, DOI: 10.1161/CIRCINTERVENTIONS.112.000184</label>
          <listPosition>167</listPosition>
          <doi>10.1161/CIRCINTERVENTIONS.112.000184</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916611</mtid>
          <link>/api/reference/45916611</link>
          <label>168. Haller 2020: Remote ischaemic conditioning for myocardial infarction or elective PCI: systematic review and meta-analyses of randomised trials., Eur. Heart J. Acute Cardiovasc. Care, 9, p. 82, DOI: 10.1177/2048872618784150</label>
          <listPosition>168</listPosition>
          <doi>10.1177/2048872618784150</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916612</mtid>
          <link>/api/reference/45916612</link>
          <label>169. El Desoky 2016: Cardioprotective effect of atorvastatin alone or in combination with remote ischemic preconditioning on the biochemical changes induced by ischemic/reperfusion injury in a mutual prospective study with a clinical and experimental animal arm., Int. J. Cardiol., 222, p. 866, DOI: 10.1016/j.ijcard.2016.07.178</label>
          <listPosition>169</listPosition>
          <doi>10.1016/j.ijcard.2016.07.178</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916613</mtid>
          <link>/api/reference/45916613</link>
          <label>170. Zhao 2022: Remote ischemic preconditioning can extend the tolerance to extended drug-coated balloon inflation time by reducing myocardial damage during percutaneous coronary intervention., Int. J. Cardiol., 353, p. 3, DOI: 10.1016/j.ijcard.2022.01.049</label>
          <listPosition>170</listPosition>
          <doi>10.1016/j.ijcard.2022.01.049</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916614</mtid>
          <link>/api/reference/45916614</link>
          <label>171. Nidorf 2020: Colchicine in patients with chronic coronary disease., N. Engl. J. Med., 383, p. 1838, DOI: 10.1056/NEJMoa2021372</label>
          <listPosition>171</listPosition>
          <doi>10.1056/NEJMoa2021372</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916615</mtid>
          <link>/api/reference/45916615</link>
          <label>172. Shah 2020: Effects of ccute colchicine administration prior to percutaneous coronary intervention: COLCHICINE-PCI Randomized Trial., Circ. Cardiovasc. Interv., 13, DOI: 10.1161/CIRCINTERVENTIONS.119.008717</label>
          <listPosition>172</listPosition>
          <doi>10.1161/CIRCINTERVENTIONS.119.008717</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916616</mtid>
          <link>/api/reference/45916616</link>
          <label>173. DeWall 2011: The origins of open heart surgery at the University of Minnesota 1951 to 1956., J. Thorac. Cardiovasc. Surg., 142, p. 267, DOI: 10.1016/j.jtcvs.2011.04.021</label>
          <listPosition>173</listPosition>
          <doi>10.1016/j.jtcvs.2011.04.021</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916617</mtid>
          <link>/api/reference/45916617</link>
          <label>174. Sellke 1993: Coronary endothelial injury after cardiopulmonary bypass and ischemic cardioplegia is mediated by oxygen-derived free radicals., Circulation, 88, p. II395</label>
          <listPosition>174</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916618</mtid>
          <link>/api/reference/45916618</link>
          <label>175. Sabe 2022: Mechanisms and clinical implications of endothelium-dependent vasomotor dysfunction in coronary microvasculature., Am. J. Physiol. Heart Circ. Physiol., 322, p. H819, DOI: 10.1152/ajpheart.00603.2021</label>
          <listPosition>175</listPosition>
          <doi>10.1152/ajpheart.00603.2021</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916619</mtid>
          <link>/api/reference/45916619</link>
          <label>176. Sabe 2023: Poorly controlled hypertension is associated with increased coronary myogenic tone in patients undergoing cardiac surgery with cardiopulmonary bypass., J. Thorac. Cardiovasc. Surg., 165, p. e256, DOI: 10.1016/j.jtcvs.2022.07.022</label>
          <listPosition>176</listPosition>
          <doi>10.1016/j.jtcvs.2022.07.022</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916620</mtid>
          <link>/api/reference/45916620</link>
          <label>177. Hearse 1975: Hypothermic arrest and potassium arrest.Metabolic and myocardial protection during elective cardiac arrest., Circ. Res., 36, p. 481, DOI: 10.1161/01.RES.36.4.481</label>
          <listPosition>177</listPosition>
          <doi>10.1161/01.RES.36.4.481</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916621</mtid>
          <link>/api/reference/45916621</link>
          <label>178. Mankad 1991: Role of potassium concentration in cardioplegic solutions in mediating endothelial damage., Ann. Thorac. Surg., 51, p. 89, DOI: 10.1016/0003-4975(91)90457-2</label>
          <listPosition>178</listPosition>
          <doi>10.1016/0003-4975(91)90457-2</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916622</mtid>
          <link>/api/reference/45916622</link>
          <label>179. Dobson 2013: Hyperkalemic cardioplegia for adult and pediatric surgery: end of an era?., Front. Physiol., 4, p. 228, DOI: 10.3389/fphys.2013.00228</label>
          <listPosition>179</listPosition>
          <doi>10.3389/fphys.2013.00228</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916623</mtid>
          <link>/api/reference/45916623</link>
          <label>180. Diao 2023: Hyperkalemic or low potassium cardioplegia protects against reduction of energy metabolism by oxidative stress., Antioxidants (Basel), DOI: 10.3390/antiox12020452</label>
          <listPosition>180</listPosition>
          <doi>10.3390/antiox12020452</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916624</mtid>
          <link>/api/reference/45916624</link>
          <label>181. Lena 2022: John H. Gibbon and the development of the heart-lung machine: the beginnings of open cardiac surgery., J. Card. Surg., 37, p. 4199, DOI: 10.1111/jocs.17067</label>
          <listPosition>181</listPosition>
          <doi>10.1111/jocs.17067</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916625</mtid>
          <link>/api/reference/45916625</link>
          <label>182. Heusch 2021: Myocardial stunning and hibernation revisited., Nat. Rev. Cardiol., 18, p. 522, DOI: 10.1038/s41569-021-00506-7</label>
          <listPosition>182</listPosition>
          <doi>10.1038/s41569-021-00506-7</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916626</mtid>
          <link>/api/reference/45916626</link>
          <label>183. Baikoussis 2015: Mechanisms of oxidative stress and myocardial protection during open-heart surgery., Ann. Card Anaesth., 18, p. 555, DOI: 10.4103/0971-9784.166465</label>
          <listPosition>183</listPosition>
          <doi>10.4103/0971-9784.166465</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916627</mtid>
          <link>/api/reference/45916627</link>
          <label>184. Kant 2023: Microvascular dysfunction following cardiopulmonary bypass plays a central role in postoperative organ dysfunction., Front. Med., 10, DOI: 10.3389/fmed.2023.1110532</label>
          <listPosition>184</listPosition>
          <doi>10.3389/fmed.2023.1110532</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916628</mtid>
          <link>/api/reference/45916628</link>
          <label>185. Suleiman 2008: Inflammatory response and cardioprotection during open-heart surgery: the importance of anaesthetics., Br. J. Pharmacol., 153, p. 21, DOI: 10.1038/sj.bjp.0707526</label>
          <listPosition>185</listPosition>
          <doi>10.1038/sj.bjp.0707526</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916629</mtid>
          <link>/api/reference/45916629</link>
          <label>186. Zakkar 2015: Cardiopulmonary bypass and oxidative stress., Oxid. Med. Cell Longev. 2015, DOI: 10.1155/2015/189863</label>
          <listPosition>186</listPosition>
          <doi>10.1155/2015/189863</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916630</mtid>
          <link>/api/reference/45916630</link>
          <label>187. Jacob 2008: Is blood cardioplegia superior to crystalloid cardioplegia?., Interact. Cardiovasc. Thorac. Surg., 7, p. 491, DOI: 10.1510/icvts.2008.178343</label>
          <listPosition>187</listPosition>
          <doi>10.1510/icvts.2008.178343</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916631</mtid>
          <link>/api/reference/45916631</link>
          <label>188. Sanetra 2018: Del Nido cardioplegia - what is the current evidence?., Kardiochir Torakochirurgia Pol., 15, p. 114</label>
          <listPosition>188</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916632</mtid>
          <link>/api/reference/45916632</link>
          <label>189. Abd-Elfattah 1995: Intermittend aortic crossclamping prevents cumulative adenosine triphosphate depletion, ventricular fibrillation, and dysfunction (stunning): is it preconditioning?., J. Thorac. Cardiovasc. Surg., 110, p. 328, DOI: 10.1016/S0022-5223(95)70228-8</label>
          <listPosition>189</listPosition>
          <doi>10.1016/S0022-5223(95)70228-8</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916633</mtid>
          <link>/api/reference/45916633</link>
          <label>190. Yellon 1993: Preconditioning the human myocardium., Lancet, 342, p. 276, DOI: 10.1016/0140-6736(93)91819-8</label>
          <listPosition>190</listPosition>
          <doi>10.1016/0140-6736(93)91819-8</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916634</mtid>
          <link>/api/reference/45916634</link>
          <label>191. Alkhulaifi 1994: Preconditioning the human heart during aorto-coronary bypass surgery., Eur. J. Cardio. Thorac. Surg., 8, p. 270, DOI: 10.1016/1010-7940(94)90159-7</label>
          <listPosition>191</listPosition>
          <doi>10.1016/1010-7940(94)90159-7</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916635</mtid>
          <link>/api/reference/45916635</link>
          <label>192. Kurapeev 2015: New technique of local ischemic preconditioning induction without repetitive aortic cross-clamping in cardiac surgery., J. Cardiothorac. Surg., 10, p. 9, DOI: 10.1186/s13019-015-0206-0</label>
          <listPosition>192</listPosition>
          <doi>10.1186/s13019-015-0206-0</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916636</mtid>
          <link>/api/reference/45916636</link>
          <label>193. Hausenloy 2007: Effect of remote ischaemic preconditioning on myocardial injury in patients undergoing coronary artery bypass graft surgery: a randomized controlled trial., Lancet, 370, p. 575, DOI: 10.1016/S0140-6736(07)61296-3</label>
          <listPosition>193</listPosition>
          <doi>10.1016/S0140-6736(07)61296-3</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916637</mtid>
          <link>/api/reference/45916637</link>
          <label>194. Xie 2012: Remote ischaemic preconditioning reduces myocardial injury in patients undergoing heart valve surgery: randomised controlled trial., Heart, 98, p. 384, DOI: 10.1136/heartjnl-2011-300860</label>
          <listPosition>194</listPosition>
          <doi>10.1136/heartjnl-2011-300860</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916638</mtid>
          <link>/api/reference/45916638</link>
          <label>195. Hong 2014: Does remote ischaemic preconditioning with postconditioning improve clinical outcomes of patients undergoing cardiac surgery? Remote Ischaemic Preconditioning with Postconditioning Outcome Trial., Eur. Heart J., 35, p. 176, DOI: 10.1093/eurheartj/eht346</label>
          <listPosition>195</listPosition>
          <doi>10.1093/eurheartj/eht346</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916639</mtid>
          <link>/api/reference/45916639</link>
          <label>196. Zhang 2014: Remote ischemic preconditioning does not improve the clinical outcomes in patients undergoing coronary artery bypass grafting: a meta-analysis of randomized controlled trials., Int. J. Cardiol., 172, p. e36, DOI: 10.1016/j.ijcard.2013.12.086</label>
          <listPosition>196</listPosition>
          <doi>10.1016/j.ijcard.2013.12.086</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916640</mtid>
          <link>/api/reference/45916640</link>
          <label>197. Hausenloy 2015: Remote ischemic preconditioning and outcomes of cardiac surgery., N. Engl. J. Med., 373, p. 1408, DOI: 10.1056/NEJMoa1413534</label>
          <listPosition>197</listPosition>
          <doi>10.1056/NEJMoa1413534</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916641</mtid>
          <link>/api/reference/45916641</link>
          <label>198. Meybohm 2015: A multicenter trial of remote ischemic preconditioning for heart surgery., N. Engl. J. Med., 373, p. 1397, DOI: 10.1056/NEJMoa1413579</label>
          <listPosition>198</listPosition>
          <doi>10.1056/NEJMoa1413579</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916642</mtid>
          <link>/api/reference/45916642</link>
          <label>199. Kleinbongard 2018: Persistent survival benefit from remote ischemic preconditioning in patients undergoing coronary artery bypass surgery., J. Am. Coll. Cardiol., 71, p. 251, DOI: 10.1016/j.jacc.2017.10.083</label>
          <listPosition>199</listPosition>
          <doi>10.1016/j.jacc.2017.10.083</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916643</mtid>
          <link>/api/reference/45916643</link>
          <label>200. Moscarelli 2019: Remote ischaemic preconditioning in isolated aortic valve and coronary artery bypass surgery: a randomized trial., Eur. J. Cardio. Thorac. Surg., 55, p. 905, DOI: 10.1093/ejcts/ezy404</label>
          <listPosition>200</listPosition>
          <doi>10.1093/ejcts/ezy404</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916644</mtid>
          <link>/api/reference/45916644</link>
          <label>201. Thielmann 2013: Cardioprotective and prognostic effects of remote ischaemic preconditioning in patients undergoing coronary artery bypass surgery: a single-centre randomised, double-blind, controlled trial., Lancet, 382, p. 597, DOI: 10.1016/S0140-6736(13)61450-6</label>
          <listPosition>201</listPosition>
          <doi>10.1016/S0140-6736(13)61450-6</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916645</mtid>
          <link>/api/reference/45916645</link>
          <label>202. Heusch 2016: Time to give up on cardioprotection? A critical appraisal of clinical studies on ischemic pre-, post-, and remote conditioning., Circ. Res., 119, p. 676, DOI: 10.1161/CIRCRESAHA.116.308736</label>
          <listPosition>202</listPosition>
          <doi>10.1161/CIRCRESAHA.116.308736</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916646</mtid>
          <link>/api/reference/45916646</link>
          <label>203. Kottenberg 2012: Protection by remote ischaemic preconditioning during coronary artery bypass grafting with isoflurane but not with propofol anesthesia - a clinical trial., Acta Anaesthesiol. Scand., 56, p. 30, DOI: 10.1111/j.1399-6576.2011.02585.x</label>
          <listPosition>203</listPosition>
          <doi>10.1111/j.1399-6576.2011.02585.x</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916647</mtid>
          <link>/api/reference/45916647</link>
          <label>204. Zangrillo 2015: Additive effect on survival of anaesthetic cardiac protection and remote ischemic preconditioning in cardiac surgery: a Bayesian network meta-analysis of randomized trials., PLoS One, 10, DOI: 10.1371/journal.pone.0134264</label>
          <listPosition>204</listPosition>
          <doi>10.1371/journal.pone.0134264</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916648</mtid>
          <link>/api/reference/45916648</link>
          <label>205. Zhou 2013: Beta-blockers and volatile anesthetics may attenuate cardioprotection by remote preconditioning in adult cardiac surgery: a meta-analysis of 15 randomized trials., J. Cardiothorac. Vasc. Anesth., 27, p. 305, DOI: 10.1053/j.jvca.2012.09.028</label>
          <listPosition>205</listPosition>
          <doi>10.1053/j.jvca.2012.09.028</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916649</mtid>
          <link>/api/reference/45916649</link>
          <label>206. Tofukuji 1998: Effects of ischemic preconditioning on myocardial perfusion, function, and microvascular regulation., Circulation, 98, p. II</label>
          <listPosition>206</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916650</mtid>
          <link>/api/reference/45916650</link>
          <label>207. Emani 2009: Increased vascular permeability after cardiopulmonary bypass in patients with diabetes is associated with increased expression of vascular endothelial growth factor and hepatocyte growth factor., J. Thorac. Cardiovasc. Surg., 138, p. 185, DOI: 10.1016/j.jtcvs.2008.12.024</label>
          <listPosition>207</listPosition>
          <doi>10.1016/j.jtcvs.2008.12.024</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916651</mtid>
          <link>/api/reference/45916651</link>
          <label>208. Feng 2012: Changes in microvascular reactivity after cardiopulmonary bypass in patients with poorly controlled versus controlled diabetes., Circulation, 126, p. S73, DOI: 10.1161/CIRCULATIONAHA.111.084590</label>
          <listPosition>208</listPosition>
          <doi>10.1161/CIRCULATIONAHA.111.084590</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916652</mtid>
          <link>/api/reference/45916652</link>
          <label>209. Sellke 2018: Enhanced coronary arteriolar contraction to vasopressin in patients with diabetes after cardiac surgery., J. Thorac. Cardiovasc. Surg., 156, p. 2098, DOI: 10.1016/j.jtcvs.2018.05.090</label>
          <listPosition>209</listPosition>
          <doi>10.1016/j.jtcvs.2018.05.090</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916653</mtid>
          <link>/api/reference/45916653</link>
          <label>210. Osipov 2009: Effect of hypercholesterolemia on myocardial necrosis and apoptosis in the setting of ischemia-reperfusion., Circulation, 120, p. S22, DOI: 10.1161/CIRCULATIONAHA.108.842724</label>
          <listPosition>210</listPosition>
          <doi>10.1161/CIRCULATIONAHA.108.842724</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916654</mtid>
          <link>/api/reference/45916654</link>
          <label>211. Heusch 2012: STAT5 activation and cardioprotection by remote ischemic preconditioning in humans., Circ. Res., 110, p. 111, DOI: 10.1161/CIRCRESAHA.111.259556</label>
          <listPosition>211</listPosition>
          <doi>10.1161/CIRCRESAHA.111.259556</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916655</mtid>
          <link>/api/reference/45916655</link>
          <label>212. Ale-Agha 2021: Mitochondrial telomerase reverse transcriptase protects from myocardial ischemia/reperfusion injury by improving complex I composition and function., Circulation, 144, p. 1876, DOI: 10.1161/CIRCULATIONAHA.120.051923</label>
          <listPosition>212</listPosition>
          <doi>10.1161/CIRCULATIONAHA.120.051923</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916656</mtid>
          <link>/api/reference/45916656</link>
          <label>213. Jernberg 2011: Association between adoption of evidence-based treatment and survival for patients with ST-elevation myocardial infarction., JAMA, 305, p. 1677, DOI: 10.1001/jama.2011.522</label>
          <listPosition>213</listPosition>
          <doi>10.1001/jama.2011.522</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916657</mtid>
          <link>/api/reference/45916657</link>
          <label>214. Puymirat 2012: Association of changes in clinical characteristics and management with improvement in survival among patients with ST-elevation myocardial infarction., JAMA, 308, p. 998, DOI: 10.1001/2012.jama.11348</label>
          <listPosition>214</listPosition>
          <doi>10.1001/2012.jama.11348</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916658</mtid>
          <link>/api/reference/45916658</link>
          <label>215. Kristensen 2014: Reperfusion therapy for ST elevation acute myocardial infarction 2010/2011: current status in 37 ESC countries., Eur. Heart J., 35, p. 1957, DOI: 10.1093/eurheartj/eht529</label>
          <listPosition>215</listPosition>
          <doi>10.1093/eurheartj/eht529</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916659</mtid>
          <link>/api/reference/45916659</link>
          <label>216. Rentoukas 2010: Cardioprotective role of remote ischemic periconditioning in primary percutaneous coronary intervention: enhancement by opioid action., J. Am. Coll. Cardiol. Cardiovasc. Interv., 3, p. 49, DOI: 10.1016/j.jcin.2009.10.015</label>
          <listPosition>216</listPosition>
          <doi>10.1016/j.jcin.2009.10.015</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916660</mtid>
          <link>/api/reference/45916660</link>
          <label>217. Prunier 2014: The RIPOST-MI study, assessing remote ischemic perconditioning alone or in combination with local ischemic postconditioning in ST-segment elevation myocardial infarction., Basic Res. Cardiol., 109, p. 400, DOI: 10.1007/s00395-013-0400-y</label>
          <listPosition>217</listPosition>
          <doi>10.1007/s00395-013-0400-y</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916661</mtid>
          <link>/api/reference/45916661</link>
          <label>218. Yellon 2015: Remote ischemic conditioning reduces myocardial infarct size in STEMI patients treated by thrombolysis., J. Am. Coll. Cardiol., 65, p. 2764, DOI: 10.1016/j.jacc.2015.02.082</label>
          <listPosition>218</listPosition>
          <doi>10.1016/j.jacc.2015.02.082</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916662</mtid>
          <link>/api/reference/45916662</link>
          <label>219. Bøtker 2010: Remote ischaemic conditioning before hospital admission, as a complement to angioplasty, and effect on myocardial salvage in patients with acute myocardial infarction: a randomised trial., Lancet, 375, p. 727, DOI: 10.1016/S0140-6736(09)62001-8</label>
          <listPosition>219</listPosition>
          <doi>10.1016/S0140-6736(09)62001-8</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916663</mtid>
          <link>/api/reference/45916663</link>
          <label>220. Verouhis 2016: Effect of remote ischemic conditioning on infarct size in patients with anterior ST-elevation myocardial infarction., Am. Heart J., 181, p. 66, DOI: 10.1016/j.ahj.2016.08.004</label>
          <listPosition>220</listPosition>
          <doi>10.1016/j.ahj.2016.08.004</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916664</mtid>
          <link>/api/reference/45916664</link>
          <label>221. Staat 2005: Postconditioning the human heart., Circulation, 112, p. 2143, DOI: 10.1161/CIRCULATIONAHA.105.558122</label>
          <listPosition>221</listPosition>
          <doi>10.1161/CIRCULATIONAHA.105.558122</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916665</mtid>
          <link>/api/reference/45916665</link>
          <label>222. Eitel 2015: Cardioprotection by combined intrahospital remote ischaemic perconditioning and postconditioning in ST-elevation myocardial infarction: the randomized LIPSIA CONDITIONING trial., Eur. Heart J., 36, p. 3049, DOI: 10.1093/eurheartj/ehv463</label>
          <listPosition>222</listPosition>
          <doi>10.1093/eurheartj/ehv463</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916666</mtid>
          <link>/api/reference/45916666</link>
          <label>223. Stiermaier 2019: Combined intrahospital remote ischemic perconditioning and postconditioning improves clinical outcome in ST-elevation myocardial infarction., Circ. Res., 124, p. 1482, DOI: 10.1161/CIRCRESAHA.118.314500</label>
          <listPosition>223</listPosition>
          <doi>10.1161/CIRCRESAHA.118.314500</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916667</mtid>
          <link>/api/reference/45916667</link>
          <label>224. Sloth 2014: Improved long-term clinical outcomes in patients with ST-elevation myocardial infarction undergoing remote ischaemic conditioning as an adjunct to primary percutaneous coronary intervention., Eur. Heart J., 35, p. 168, DOI: 10.1093/eurheartj/eht369</label>
          <listPosition>224</listPosition>
          <doi>10.1093/eurheartj/eht369</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916668</mtid>
          <link>/api/reference/45916668</link>
          <label>225. Terkelsen 2010: System delay and mortality among patients with STEMI treated with primary percutaneous coronary intervention., JAMA, 304, p. 763, DOI: 10.1001/jama.2010.1139</label>
          <listPosition>225</listPosition>
          <doi>10.1001/jama.2010.1139</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916669</mtid>
          <link>/api/reference/45916669</link>
          <label>226. Huber 2014: The organization, function, and outcomes of ST-elevation myocardial infarction networks worldwide: current state, unmet needs and future directions., Eur. Heart J., 35, p. 1526, DOI: 10.1093/eurheartj/ehu125</label>
          <listPosition>226</listPosition>
          <doi>10.1093/eurheartj/ehu125</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916670</mtid>
          <link>/api/reference/45916670</link>
          <label>227. Morrow 2000: TIMI risk score for ST-elevation myocardial infarction: a convenient, bedside, clinical score for risk assessment at presentation: an intravenous nPA for treatment of infarcting myocardium early II trial substudy., Circulation, 102, p. 2031, DOI: 10.1161/01.CIR.102.17.2031</label>
          <listPosition>227</listPosition>
          <doi>10.1161/01.CIR.102.17.2031</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916671</mtid>
          <link>/api/reference/45916671</link>
          <label>228. Pryds 2016: Remote ischaemic conditioning and healthcare system delay in patients with ST-segment elevation myocardial infarction., Heart, 102, p. 1023, DOI: 10.1136/heartjnl-2015-308980</label>
          <listPosition>228</listPosition>
          <doi>10.1136/heartjnl-2015-308980</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916672</mtid>
          <link>/api/reference/45916672</link>
          <label>229. Cheskes 2020: Field implementation of remote ischemic conditioning in ST-segment-elevation myocardial infarction: the FIRST Study., Can. J. Cardiol., 36, p. 1278, DOI: 10.1016/j.cjca.2019.11.029</label>
          <listPosition>229</listPosition>
          <doi>10.1016/j.cjca.2019.11.029</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916673</mtid>
          <link>/api/reference/45916673</link>
          <label>230. Hausenloy 2020: A future for remote ischaemic conditioning in high-risk patients., Basic Res. Cardiol., 115, p. 35, DOI: 10.1007/s00395-020-0794-2</label>
          <listPosition>230</listPosition>
          <doi>10.1007/s00395-020-0794-2</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916674</mtid>
          <link>/api/reference/45916674</link>
          <label>231. Piot 2008: Effect of cyclosporine on reperfusion injury in acute myocardial infarction., N. Engl. J. Med., 359, p. 473, DOI: 10.1056/NEJMoa071142</label>
          <listPosition>231</listPosition>
          <doi>10.1056/NEJMoa071142</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916675</mtid>
          <link>/api/reference/45916675</link>
          <label>232. Cung 2015: Cyclosporine before PCI in patients with acute myocardial infarction., N. Engl. J. Med., 373, p. 1021, DOI: 10.1056/NEJMoa1505489</label>
          <listPosition>232</listPosition>
          <doi>10.1056/NEJMoa1505489</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916676</mtid>
          <link>/api/reference/45916676</link>
          <label>233. Ottani 2016: Cyclosporine A in reperfused myocardial infarction. Themulticenter, contolled, open-label CYCLE Trial., J. Am. Coll. Cardiol., 67, p. 365, DOI: 10.1016/j.jacc.2015.10.081</label>
          <listPosition>233</listPosition>
          <doi>10.1016/j.jacc.2015.10.081</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916677</mtid>
          <link>/api/reference/45916677</link>
          <label>234. Gibson 2016: EMBRACE STEMI study: a phase 2a trial to evaluate the safety, tolerability, and efficacy of intravenous MTP-131 on reperfusion injury in patients undergoing primary percutaneous coronary intervention., Eur. Heart J., 37, p. 1296, DOI: 10.1093/eurheartj/ehv597</label>
          <listPosition>234</listPosition>
          <doi>10.1093/eurheartj/ehv597</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916678</mtid>
          <link>/api/reference/45916678</link>
          <label>235. Atar 2015: Effect of intravenous TRO40303 as an adjunct to primary percutaneous coronary intervention for acute ST-elevation myocardial infarction: MITOCARE study results., Eur. Heart J., 36, p. 112, DOI: 10.1093/eurheartj/ehu331</label>
          <listPosition>235</listPosition>
          <doi>10.1093/eurheartj/ehu331</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916679</mtid>
          <link>/api/reference/45916679</link>
          <label>236. Siddiqi 2014: Intravenous sodium nitrite in acute ST-elevation myocardial infarction: a randomized controlled trial (NIAMI)., Eur. Heart J., 35, p. 1255, DOI: 10.1093/eurheartj/ehu096</label>
          <listPosition>236</listPosition>
          <doi>10.1093/eurheartj/ehu096</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916680</mtid>
          <link>/api/reference/45916680</link>
          <label>237. Jones 2015: Randomized phase 2 trial of intracoronary nitrite during acute myocardial infarction., Circ. Res., 116, p. 437, DOI: 10.1161/CIRCRESAHA.116.305082</label>
          <listPosition>237</listPosition>
          <doi>10.1161/CIRCRESAHA.116.305082</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916681</mtid>
          <link>/api/reference/45916681</link>
          <label>238. Janssens 2018: Nitric oxide for inhalation in ST-elevation myocardial infarction (NOMI): a multicentre, double-blind, randomized controlled trial., Eur. Heart J., 39, p. 2717, DOI: 10.1093/eurheartj/ehy232</label>
          <listPosition>238</listPosition>
          <doi>10.1093/eurheartj/ehy232</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916682</mtid>
          <link>/api/reference/45916682</link>
          <label>239. Thiele 2010: J. Am. Coll. Cardiol., 55, p. 2201, DOI: 10.1016/j.jacc.2009.08.091</label>
          <listPosition>239</listPosition>
          <doi>10.1016/j.jacc.2009.08.091</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916683</mtid>
          <link>/api/reference/45916683</link>
          <label>240. Pasupathy 2017: Circulation, 136, p. 894, DOI: 10.1161/CIRCULATIONAHA.117.027575</label>
          <listPosition>240</listPosition>
          <doi>10.1161/CIRCULATIONAHA.117.027575</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916684</mtid>
          <link>/api/reference/45916684</link>
          <label>241. Kleveland 2016: Effect of a single dose of the interleukin-6 receptor antagonist tocilizumab on inflammation and troponin T release in patients with non-ST-elevation myocardial infarction: a double-blind, randomized, placebo-controlled phase 2 trial., Eur. Heart J., 37, p. 2406, DOI: 10.1093/eurheartj/ehw171</label>
          <listPosition>241</listPosition>
          <doi>10.1093/eurheartj/ehw171</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916685</mtid>
          <link>/api/reference/45916685</link>
          <label>242. Broch 2021: Randomized trial of interleukin-6 receptor Inhibition in patients with acute ST-segment elevation myocardial infarction., J. Am. Coll. Cardiol., 77, p. 1845, DOI: 10.1016/j.jacc.2021.02.049</label>
          <listPosition>242</listPosition>
          <doi>10.1016/j.jacc.2021.02.049</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916686</mtid>
          <link>/api/reference/45916686</link>
          <label>243. Lincoff 2014: Inhibition of delta-protein kinase C by delcasertib as an adjunct to primary percutaneous coronary intervention for acute anterior ST-segment elevation myocardial infarction: results of the PROTECTION AMI Randomized Controlled Trial., Eur. Heart J., 35, p. 2516, DOI: 10.1093/eurheartj/ehu177</label>
          <listPosition>243</listPosition>
          <doi>10.1093/eurheartj/ehu177</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916687</mtid>
          <link>/api/reference/45916687</link>
          <label>244. Ibanez 2013: Circulation, 128, p. 1495, DOI: 10.1161/CIRCULATIONAHA.113.003653</label>
          <listPosition>244</listPosition>
          <doi>10.1161/CIRCULATIONAHA.113.003653</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916688</mtid>
          <link>/api/reference/45916688</link>
          <label>245. Roolvink 2016: Early administration of intravenous beta blockers in patients with ST-elevation myocardial infarction before primary PCI., J. Am. Coll. Cardiol., 67, p. 2705, DOI: 10.1016/j.jacc.2016.03.522</label>
          <listPosition>245</listPosition>
          <doi>10.1016/j.jacc.2016.03.522</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916689</mtid>
          <link>/api/reference/45916689</link>
          <label>246. Bøtker 2020: Translational issues for mitoprotective agents as adjunct to reperfusion therapy in patients with ST-segment elevation myocardial infarction., J. Cell Mol. Med., 24, p. 2717, DOI: 10.1111/jcmm.14953</label>
          <listPosition>246</listPosition>
          <doi>10.1111/jcmm.14953</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916690</mtid>
          <link>/api/reference/45916690</link>
          <label>247. Kleinbongard 2023: No robust reduction of infarct size and no-reflow by metoprolol pretreatment in adult Göttingen minipigs., Basic Res. Cardiol., 118, p. 23, DOI: 10.1007/s00395-023-00993-4</label>
          <listPosition>247</listPosition>
          <doi>10.1007/s00395-023-00993-4</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916691</mtid>
          <link>/api/reference/45916691</link>
          <label>248. Bulluck 2016: Clinical benefit of adenosine as an adjunct to reperfusion in ST-elevation myocardial infarction patients: an updated meta-analysis of randomized controlled trials., Int. J. Cardiol., 202, p. 228, DOI: 10.1016/j.ijcard.2015.09.005</label>
          <listPosition>248</listPosition>
          <doi>10.1016/j.ijcard.2015.09.005</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916692</mtid>
          <link>/api/reference/45916692</link>
          <label>249. Kitakaze 2007: Human atrial natriuretic peptide and nicorandil as adjuncts to reperfusion treatment for acute myocardial infarction (J-WIND): two randomised trials., Lancet, 370, p. 1483, DOI: 10.1016/S0140-6736(07)61634-1</label>
          <listPosition>249</listPosition>
          <doi>10.1016/S0140-6736(07)61634-1</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916693</mtid>
          <link>/api/reference/45916693</link>
          <label>250. Garcia Del Blanco 2021: Effect of COMBinAtion therapy with remote ischemic conditioning and exenatide on the myocardial infarct size: a two-by-two factorial randomized trial (COMBAT-MI)., Basic Res. Cardiol., 116, p. 4, DOI: 10.1007/s00395-021-00842-2</label>
          <listPosition>250</listPosition>
          <doi>10.1007/s00395-021-00842-2</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916694</mtid>
          <link>/api/reference/45916694</link>
          <label>251. Ndrepepa 2016: Mechanical strategies to enhance myocardial salvage during primary percutaneous coronary intervention in patients with STEMI., EuroIntervention, 12, p. 319, DOI: 10.4244/EIJV12I3A52</label>
          <listPosition>251</listPosition>
          <doi>10.4244/EIJV12I3A52</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916695</mtid>
          <link>/api/reference/45916695</link>
          <label>252. Swain 2020: Transvalvular ventricular unloading before reperfusion in acute myocardial infarction., J. Am. Coll. Cardiol., 76, p. 684, DOI: 10.1016/j.jacc.2020.06.031</label>
          <listPosition>252</listPosition>
          <doi>10.1016/j.jacc.2020.06.031</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916696</mtid>
          <link>/api/reference/45916696</link>
          <label>253. Heusch 2020: Left ventricular unloading in myocardial infarction: gentle reperfusion through the backdoor?., J. Am. Coll. Cardiol., 76, p. 700, DOI: 10.1016/j.jacc.2020.06.032</label>
          <listPosition>253</listPosition>
          <doi>10.1016/j.jacc.2020.06.032</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916697</mtid>
          <link>/api/reference/45916697</link>
          <label>254. Tissier 2012: Myocardial protection with mild hypothermia., Cardiovasc. Res., 94, p. 217, DOI: 10.1093/cvr/cvr315</label>
          <listPosition>254</listPosition>
          <doi>10.1093/cvr/cvr315</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916698</mtid>
          <link>/api/reference/45916698</link>
          <label>255. Dixon 2002: Induction of mild systemic hypothermia with endovascular cooling during primary percutaneous coronary intervention for acute myocardial infarction., J. Am. Coll. Cardiol., 40, p. 1928, DOI: 10.1016/S0735-1097(02)02567-6</label>
          <listPosition>255</listPosition>
          <doi>10.1016/S0735-1097(02)02567-6</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916699</mtid>
          <link>/api/reference/45916699</link>
          <label>256. Götberg 2010: A pilot study of rapid cooling by cold saline and endovascular cooling before reperfusion in patients with ST-elevation myocardial infarction., Circ. Cardiovasc. Interv., 3, p. 400, DOI: 10.1161/CIRCINTERVENTIONS.110.957902</label>
          <listPosition>256</listPosition>
          <doi>10.1161/CIRCINTERVENTIONS.110.957902</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916700</mtid>
          <link>/api/reference/45916700</link>
          <label>257. Erlinge 2014: Rapid endovascular catheter core cooling combined with cold saline as an adjunct to percutaneous coronary intervention for the treatment of acute myocardial infarction (The CHILL-MI trial)., J. Am. Coll. Cardiol., 63, p. 1857, DOI: 10.1016/j.jacc.2013.12.027</label>
          <listPosition>257</listPosition>
          <doi>10.1016/j.jacc.2013.12.027</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916701</mtid>
          <link>/api/reference/45916701</link>
          <label>258. Erlinge 2015: Therapeutic hypothermia for the treatment of acute myocardial infarction-combined analysis of the RAPID MI-ICE and the CHILL-MI trials., Ther. Hypothermia Temp. Manag., 5, p. 77, DOI: 10.1089/ther.2015.0009</label>
          <listPosition>258</listPosition>
          <doi>10.1089/ther.2015.0009</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916702</mtid>
          <link>/api/reference/45916702</link>
          <label>259. Noc 2017: COOL AMI EU pilot trial: a multicentre, prospective, randomised controlled trial to assess cooling as an adjunctive therapy to percutaneous intervention in patients with acute myocardial infarction., EuroIntervention, 13, p. e531, DOI: 10.4244/EIJ-D-17-00279</label>
          <listPosition>259</listPosition>
          <doi>10.4244/EIJ-D-17-00279</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916703</mtid>
          <link>/api/reference/45916703</link>
          <label>260. Noc 2021: A multicentre, prospective, randomised controlled trial to assess the safety and effectiveness of cooling as an adjunctive therapy to percutaneous intervention in patients with acute myocardial infarction: the COOL AMI EU Pivotal Trial., EuroIntervention, 17, p. 466, DOI: 10.4244/EIJ-D-21-00348</label>
          <listPosition>260</listPosition>
          <doi>10.4244/EIJ-D-21-00348</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916704</mtid>
          <link>/api/reference/45916704</link>
          <label>261. Fuernau 2018: Mild hypothermia in cardiogenic shock complicating myocardial infarction: the randomized SHOCK-COOL Trial., Circulation, 139, p. 448, DOI: 10.1161/CIRCULATIONAHA.117.032722</label>
          <listPosition>261</listPosition>
          <doi>10.1161/CIRCULATIONAHA.117.032722</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916705</mtid>
          <link>/api/reference/45916705</link>
          <label>262. Kloner 2021: Update on cardioprotective strategies for STEMI: focus on supersaturated oxygen delivery., JACC Basic Transl. Sci., 6, p. 1021, DOI: 10.1016/j.jacbts.2021.07.011</label>
          <listPosition>262</listPosition>
          <doi>10.1016/j.jacbts.2021.07.011</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916706</mtid>
          <link>/api/reference/45916706</link>
          <label>263. O'Neill 2007: Acute myocardial infarction with hyperoxemic therapy (AMIHOT): a prospective, randomized trial of intracoronary hyperoxemic reperfusion after percutaneous coronary intervention., J. Am. Coll. Cardiol., 50, p. 397, DOI: 10.1016/j.jacc.2007.01.099</label>
          <listPosition>263</listPosition>
          <doi>10.1016/j.jacc.2007.01.099</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916707</mtid>
          <link>/api/reference/45916707</link>
          <label>264. Stone 2009: Effect of supersaturated oxygen delivery on infarct size after percutaneous coronary intervention in acute myocardial infarction., Circ. Cardiovasc. Interv., 2, p. 366, DOI: 10.1161/CIRCINTERVENTIONS.108.840066</label>
          <listPosition>264</listPosition>
          <doi>10.1161/CIRCINTERVENTIONS.108.840066</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916708</mtid>
          <link>/api/reference/45916708</link>
          <label>265. Desta 2015: JACC Heart Fail, 3, p. 234, DOI: 10.1016/j.jchf.2014.10.007</label>
          <listPosition>265</listPosition>
          <doi>10.1016/j.jchf.2014.10.007</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916709</mtid>
          <link>/api/reference/45916709</link>
          <label>266. De Filippo 2023: IncidenCe and predictOrs of heaRt fAiLure after acute coronarY Syndrome: the CORALYS registry., Int. J. Cardiol., 370, p. 35, DOI: 10.1016/j.ijcard.2022.10.146</label>
          <listPosition>266</listPosition>
          <doi>10.1016/j.ijcard.2022.10.146</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916710</mtid>
          <link>/api/reference/45916710</link>
          <label>267. Hamilton 2023: Prevalence and prognostic impact of left ventricular systolic dysfunction or pulmonary congestion after acute myocardial infarction., ESC Heart Fail, 10, p. 1347, DOI: 10.1002/ehf2.14301</label>
          <listPosition>267</listPosition>
          <doi>10.1002/ehf2.14301</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916711</mtid>
          <link>/api/reference/45916711</link>
          <label>268. Pryds 2017: Effect of long-term remote ischemic conditioning in patients with chronic ischemic heart failure., Basic Res. Cardiol., 112, p. 67, DOI: 10.1007/s00395-017-0658-6</label>
          <listPosition>268</listPosition>
          <doi>10.1007/s00395-017-0658-6</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916712</mtid>
          <link>/api/reference/45916712</link>
          <label>269. Chen 2017: Effects of remote ischaemic conditioning on heart rate variability and cardiac function in patients with mild ischaemic heart failure., Heart Lung Circ., 4, p. 477</label>
          <listPosition>269</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916713</mtid>
          <link>/api/reference/45916713</link>
          <label>270. Kuzuya 1993: Delayed effects of sublethal ischemia on the acquisition of tolerance to ischemia., Circ. Res., 72, p. 1293, DOI: 10.1161/01.RES.72.6.1293</label>
          <listPosition>270</listPosition>
          <doi>10.1161/01.RES.72.6.1293</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916714</mtid>
          <link>/api/reference/45916714</link>
          <label>271. Marber 1993: Cardiac stress protein elevation 24 hours after brief ischemia or heat stress is associated with resistance to myocardial infarction., Circulation, 88, p. 1264, DOI: 10.1161/01.CIR.88.3.1264</label>
          <listPosition>271</listPosition>
          <doi>10.1161/01.CIR.88.3.1264</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916715</mtid>
          <link>/api/reference/45916715</link>
          <label>272. Loubani 2004: Delayed preconditioning of the human myocardium: signal transduction and clinical implications., Cardiovasc. Res., 61, p. 600, DOI: 10.1016/j.cardiores.2003.10.013</label>
          <listPosition>272</listPosition>
          <doi>10.1016/j.cardiores.2003.10.013</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916716</mtid>
          <link>/api/reference/45916716</link>
          <label>273. Davidson 2023: Methods for the identification and characterization of extracellular vesicles in cardiovascular studies: from exosomes to microvesicles., Cardiovasc. Res., 119, p. 45, DOI: 10.1093/cvr/cvac031</label>
          <listPosition>273</listPosition>
          <doi>10.1093/cvr/cvac031</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916717</mtid>
          <link>/api/reference/45916717</link>
          <label>274. Giricz 2014: Cardioprotection by remote ischemic preconditioning of the rat heart is mediated by extracellular vesicles., J. Mol. Cell. Cardiol., 68, p. 75, DOI: 10.1016/j.yjmcc.2014.01.004</label>
          <listPosition>274</listPosition>
          <doi>10.1016/j.yjmcc.2014.01.004</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916718</mtid>
          <link>/api/reference/45916718</link>
          <label>275. Vicencio 2015: Plasma exosomes protect the myocardium from ischemia-reperfusion injury., J. Am. Coll. Cardiol., 65, p. 1525, DOI: 10.1016/j.jacc.2015.02.026</label>
          <listPosition>275</listPosition>
          <doi>10.1016/j.jacc.2015.02.026</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916719</mtid>
          <link>/api/reference/45916719</link>
          <label>276. Lassen 2021: Cardioprotection by remote ischemic conditioning is transferable by plasma and mediated by extracellular vesicles., Basic Res. Cardiol., 116, p. 16, DOI: 10.1007/s00395-021-00856-w</label>
          <listPosition>276</listPosition>
          <doi>10.1007/s00395-021-00856-w</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916720</mtid>
          <link>/api/reference/45916720</link>
          <label>277. Homme 2021: Remote hind-limb ischemia mechanism of preserved ejection fraction during heart failure., Front. Physiol., 12, DOI: 10.3389/fphys.2021.745328</label>
          <listPosition>277</listPosition>
          <doi>10.3389/fphys.2021.745328</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916721</mtid>
          <link>/api/reference/45916721</link>
          <label>278. Vanezis 2018: Daily remote ischaemic conditioning following acute myocardial infarction: a randomised controlled trial., Heart, 104, p. 1955, DOI: 10.1136/heartjnl-2018-313091</label>
          <listPosition>278</listPosition>
          <doi>10.1136/heartjnl-2018-313091</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916722</mtid>
          <link>/api/reference/45916722</link>
          <label>279. Munk 2010: Remote ischemic conditioning in patients with myocardial infarction treated with primary angioplasty: impact on left ventricular function assessed by comprehensive echocardiography and gated single-photon emission CT., Circ. Cardiovasc. Imag., 3, p. 656, DOI: 10.1161/CIRCIMAGING.110.957340</label>
          <listPosition>279</listPosition>
          <doi>10.1161/CIRCIMAGING.110.957340</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916723</mtid>
          <link>/api/reference/45916723</link>
          <label>280. Arnold 2022: Effects of late, repetitive remote ischaemic conditioning on myocardial strain in patients with acute myocardial infarction., Basic Res. Cardiol., 117, p. 23, DOI: 10.1007/s00395-022-00926-7</label>
          <listPosition>280</listPosition>
          <doi>10.1007/s00395-022-00926-7</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916724</mtid>
          <link>/api/reference/45916724</link>
          <label>281. Kono 2014: Remote ischemic conditioning improves coronary microcirculation in healthy subjects and patients with heart failure., Drug Des. Dev. Ther., 8, p. 1175</label>
          <listPosition>281</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916725</mtid>
          <link>/api/reference/45916725</link>
          <label>282. Pryds 2019: Effect of long-term remote ischemic conditioning on inflammation and cardiac remodeling., Scand. Cardiovasc. J., p. 1</label>
          <listPosition>282</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916726</mtid>
          <link>/api/reference/45916726</link>
          <label>283. Shimizu 2010: Remote ischemic preconditioning decreases adhesion and selectively modifies functional responses of human neutrophils., J. Surg. Res., 158, p. 155, DOI: 10.1016/j.jss.2008.08.010</label>
          <listPosition>283</listPosition>
          <doi>10.1016/j.jss.2008.08.010</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916727</mtid>
          <link>/api/reference/45916727</link>
          <label>284. Ikonomidis 2021: Vascular conditioning prevents adverse left ventricular remodelling after acute myocardial infarction: a randomised remote conditioning study., Basic Res. Cardiol., 116, p. 9, DOI: 10.1007/s00395-021-00851-1</label>
          <listPosition>284</listPosition>
          <doi>10.1007/s00395-021-00851-1</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916728</mtid>
          <link>/api/reference/45916728</link>
          <label>285. Jean-St-Michel 2011: Remote preconditioning improves maximal performance in highly trained athletes., Med. Sci. Sports Exerc., 43, p. 1280, DOI: 10.1249/MSS.0b013e318206845d</label>
          <listPosition>285</listPosition>
          <doi>10.1249/MSS.0b013e318206845d</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916729</mtid>
          <link>/api/reference/45916729</link>
          <label>286. Groennebaek 2019: Effect of blood flow restricted resistance exercise and remote ischemic conditioning on functional capacity and myocellular adaptations in patients with heart failure., Circ. Heart Fail, 12, DOI: 10.1161/CIRCHEARTFAILURE.119.006427</label>
          <listPosition>286</listPosition>
          <doi>10.1161/CIRCHEARTFAILURE.119.006427</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916730</mtid>
          <link>/api/reference/45916730</link>
          <label>287. Pearson 2015: A review on the mechanisms of blood-flow restriction resistance training-induced muscle hypertrophy., Sports Med., 45, p. 187, DOI: 10.1007/s40279-014-0264-9</label>
          <listPosition>287</listPosition>
          <doi>10.1007/s40279-014-0264-9</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916731</mtid>
          <link>/api/reference/45916731</link>
          <label>288. Cornish 2020: A focused review of myokines as a potential contributor to muscle hypertrophy from resistance-based exercise., Eur. J. Appl. Physiol., 120, p. 941, DOI: 10.1007/s00421-020-04337-1</label>
          <listPosition>288</listPosition>
          <doi>10.1007/s00421-020-04337-1</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916732</mtid>
          <link>/api/reference/45916732</link>
          <label>289. Nielsen 2012: Proliferation of myogenic stem cells in human skeletal muscle in response to low-load resistance training with blood flow restriction., J. Physiol., 590, p. 4351, DOI: 10.1113/jphysiol.2012.237008</label>
          <listPosition>289</listPosition>
          <doi>10.1113/jphysiol.2012.237008</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916733</mtid>
          <link>/api/reference/45916733</link>
          <label>290. Aguayo 2016: One bout of vibration exercise with vascular occlusion activates satellite cells., Exp. Physiol., 101, p. 295, DOI: 10.1113/EP085330</label>
          <listPosition>290</listPosition>
          <doi>10.1113/EP085330</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916734</mtid>
          <link>/api/reference/45916734</link>
          <label>291. Gu 2022: The role of plasma extracellular vesicles in remote ischemic conditioning and exercise-induced ischemic tolerance., Int. J. Mol. Sci., 23, p. 3334, DOI: 10.3390/ijms23063334</label>
          <listPosition>291</listPosition>
          <doi>10.3390/ijms23063334</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916735</mtid>
          <link>/api/reference/45916735</link>
          <label>292. Barac 2015: Cardiovascular health of patients with cancer and cancer survivors: a roadmap to the next level., J. Am. Coll. Cardiol., 65, p. 2739, DOI: 10.1016/j.jacc.2015.04.059</label>
          <listPosition>292</listPosition>
          <doi>10.1016/j.jacc.2015.04.059</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916736</mtid>
          <link>/api/reference/45916736</link>
          <label>293. Lyon 2022: ESC guidelines on cardio-oncology developed in collaboration with the European hematology association (EHA), the European society for therapeutic radiology and oncology (ESTRO) and the international cardio-oncology society (IC-OS)., Eur. Heart J., 43, p. 4229, DOI: 10.1093/eurheartj/ehac244</label>
          <listPosition>293</listPosition>
          <doi>10.1093/eurheartj/ehac244</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916737</mtid>
          <link>/api/reference/45916737</link>
          <label>294. Omland 2022: The role of cardioprotection in cancer therapy cardiotoxicity: JACC: CardioOncology State-of-the-Art Review., JACC CardioOncol., 4, p. 19, DOI: 10.1016/j.jaccao.2022.01.101</label>
          <listPosition>294</listPosition>
          <doi>10.1016/j.jaccao.2022.01.101</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916738</mtid>
          <link>/api/reference/45916738</link>
          <label>295. Lopez-Sendon 2020: Classification, prevalence, and outcomes of anticancer therapy-induced cardiotoxicity: the CARDIOTOX registry., Eur. Heart J., 41, p. 1720, DOI: 10.1093/eurheartj/ehaa006</label>
          <listPosition>295</listPosition>
          <doi>10.1093/eurheartj/ehaa006</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916739</mtid>
          <link>/api/reference/45916739</link>
          <label>296. Hahn 2021: Heart failure with targeted cancer therapies: mechanisms and cardioprotection., Circ. Res., 128, p. 1576, DOI: 10.1161/CIRCRESAHA.121.318223</label>
          <listPosition>296</listPosition>
          <doi>10.1161/CIRCRESAHA.121.318223</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916740</mtid>
          <link>/api/reference/45916740</link>
          <label>297. Totzeck 2019: Cardio-oncology - strategies for management of cancer-therapy related cardiovascular disease., Int. J. Cardiol., 280, p. 163, DOI: 10.1016/j.ijcard.2019.01.038</label>
          <listPosition>297</listPosition>
          <doi>10.1016/j.ijcard.2019.01.038</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916741</mtid>
          <link>/api/reference/45916741</link>
          <label>298. Zamorano 2016: ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: the Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC)., Eur. Heart J., 37, p. 2768, DOI: 10.1093/eurheartj/ehw211</label>
          <listPosition>298</listPosition>
          <doi>10.1093/eurheartj/ehw211</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916742</mtid>
          <link>/api/reference/45916742</link>
          <label>299. Galan-Arriola 2021: Remote ischaemic preconditioning ameliorates anthracycline-induced cardiotoxicity and preserves mitochondrial integrity., Cardiovasc. Res., 117, p. 1132, DOI: 10.1093/cvr/cvaa181</label>
          <listPosition>299</listPosition>
          <doi>10.1093/cvr/cvaa181</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916743</mtid>
          <link>/api/reference/45916743</link>
          <label>300. Galan-Arriola 2021: Coronary microcirculation damage in anthracycline cardiotoxicity., Cardiovasc. Res., 118, p. 531, DOI: 10.1093/cvr/cvab053</label>
          <listPosition>300</listPosition>
          <doi>10.1093/cvr/cvab053</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916744</mtid>
          <link>/api/reference/45916744</link>
          <label>301. Galan-Arriola 2019: Serial magnetic resonance imaging to identify early stages of anthracycline-induced cardiotoxicity., J. Am. Coll. Cardiol., 73, p. 779, DOI: 10.1016/j.jacc.2018.11.046</label>
          <listPosition>301</listPosition>
          <doi>10.1016/j.jacc.2018.11.046</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916745</mtid>
          <link>/api/reference/45916745</link>
          <label>302. Bosch 2013: J. Am. Coll. Cardiol., 61, p. 2355, DOI: 10.1016/j.jacc.2013.02.072</label>
          <listPosition>302</listPosition>
          <doi>10.1016/j.jacc.2013.02.072</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916746</mtid>
          <link>/api/reference/45916746</link>
          <label>303. Avila 2018: Carvedilol for prevention of chemotherapy-related cardiotoxicity: the CECCY Trial., J. Am. Coll. Cardiol., 71, p. 2281, DOI: 10.1016/j.jacc.2018.02.049</label>
          <listPosition>303</listPosition>
          <doi>10.1016/j.jacc.2018.02.049</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916747</mtid>
          <link>/api/reference/45916747</link>
          <label>304. Huang 2019: Protective role of beta-blockers in chemotherapy-induced cardiotoxicity-a systematic review and meta-analysis of carvedilol., Heart Fail. Rev., 24, p. 325, DOI: 10.1007/s10741-018-9755-3</label>
          <listPosition>304</listPosition>
          <doi>10.1007/s10741-018-9755-3</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916748</mtid>
          <link>/api/reference/45916748</link>
          <label>305. Akpek 2015: Protective effects of spironolactone against anthracycline-induced cardiomyopathy., Eur. J. Heart Fail., 17, p. 81, DOI: 10.1002/ejhf.196</label>
          <listPosition>305</listPosition>
          <doi>10.1002/ejhf.196</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916749</mtid>
          <link>/api/reference/45916749</link>
          <label>306. Gulati 2016: Prevention of cardiac dysfunction during adjuvant breast cancer therapy (PRADA): a 2 x 2 factorial, randomized, placebo-controlled, double-blind clinical trial of candesartan and metoprolol., Eur. Heart J., 37, p. 1671, DOI: 10.1093/eurheartj/ehw022</label>
          <listPosition>306</listPosition>
          <doi>10.1093/eurheartj/ehw022</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916750</mtid>
          <link>/api/reference/45916750</link>
          <label>307. Cardinale 2018: Anthracycline-induced cardiotoxicity: a multicenter randomised trial comparing two strategies for guiding prevention with enalapril: the International CardioOncology Society-one trial., Eur. J. Cancer, 94, p. 126, DOI: 10.1016/j.ejca.2018.02.005</label>
          <listPosition>307</listPosition>
          <doi>10.1016/j.ejca.2018.02.005</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916751</mtid>
          <link>/api/reference/45916751</link>
          <label>308. Acar 2011: Efficiency of atorvastatin in the protection of anthracycline-induced cardiomyopathy., J. Am. Coll. Cardiol., 58, p. 988, DOI: 10.1016/j.jacc.2011.05.025</label>
          <listPosition>308</listPosition>
          <doi>10.1016/j.jacc.2011.05.025</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916752</mtid>
          <link>/api/reference/45916752</link>
          <label>309. Nabati 2019: Effect of rosuvastatin in preventing chemotherapy-induced cardiotoxicity in women with breast cancer: a randomized, single-blind, placebo-controlled trial., J. Cardiovasc. Pharmacol. Therapeut., 24, p. 233, DOI: 10.1177/1074248418821721</label>
          <listPosition>309</listPosition>
          <doi>10.1177/1074248418821721</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916753</mtid>
          <link>/api/reference/45916753</link>
          <label>310. Hundley 2023: Statins and left ventricular ejection fraction following doxorubicin treatment., NEJM Evid., 1</label>
          <listPosition>310</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916754</mtid>
          <link>/api/reference/45916754</link>
          <label>311. Thavendiranathan 2023: Statins to prevent early cardiac dysfunction in cancer patients at increased cardiotoxicity risk receiving anthracyclines., Eur. Heart J. Cardiovasc. Pharmacother., DOI: 10.1093/ehjcvp/pvad031</label>
          <listPosition>311</listPosition>
          <doi>10.1093/ehjcvp/pvad031</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916755</mtid>
          <link>/api/reference/45916755</link>
          <label>312. Neilan 2023: Atorvastatin for anthracycline-associated cardiac dysfunction: the STOP-CA randomized clinical trial., JAMA, 330, p. 528, DOI: 10.1001/jama.2023.11887</label>
          <listPosition>312</listPosition>
          <doi>10.1001/jama.2023.11887</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916756</mtid>
          <link>/api/reference/45916756</link>
          <label>313. Mallouppas 2023: Anthracyclines and biomarkers of myocardial injury: the effect of remote ischemic conditioning (RIC)., JACC CardioOncol., 5, p. 343, DOI: 10.1016/j.jaccao.2023.03.008</label>
          <listPosition>313</listPosition>
          <doi>10.1016/j.jaccao.2023.03.008</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916757</mtid>
          <link>/api/reference/45916757</link>
          <label>314. Cheung 2023: Remote ischemic conditioning in pediatric cancer patients receiving anthracycline chemotherapy: a sham-controlled single-blind randomized trial., JACC CardioOncol., 5, p. 332, DOI: 10.1016/j.jaccao.2022.11.020</label>
          <listPosition>314</listPosition>
          <doi>10.1016/j.jaccao.2022.11.020</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916758</mtid>
          <link>/api/reference/45916758</link>
          <label>315. Heusch 2023: Cardioprotection in cardio-oncology – a case for concern?., Cardiovasc. Res., 10</label>
          <listPosition>315</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916759</mtid>
          <link>/api/reference/45916759</link>
          <label>316. Ibanez 2023: Remote ischemic conditioning for anthracycline cardiotoxicity: the need to protect the most vulnerable., JACC CardioOncol., 5, p. 356, DOI: 10.1016/j.jaccao.2023.05.002</label>
          <listPosition>316</listPosition>
          <doi>10.1016/j.jaccao.2023.05.002</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916760</mtid>
          <link>/api/reference/45916760</link>
          <label>317. Rywalsch 1907: Über die Katalyse des H202 durch Bakterien., Zentralbl Bakt und Parasit, 44, p. 295</label>
          <listPosition>317</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916761</mtid>
          <link>/api/reference/45916761</link>
          <label>318. McCord 1968: The reduction of cytochrome c by milk xanthine oxidase., J. Biol. Chem., 243, p. 5753, DOI: 10.1016/S0021-9258(18)91929-0</label>
          <listPosition>318</listPosition>
          <doi>10.1016/S0021-9258(18)91929-0</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916762</mtid>
          <link>/api/reference/45916762</link>
          <label>319. McCord 1969: The utility of superoxide dismutase in studying free radical reactions. I. Radicals generated by the interaction of sulfite, dimethyl sulfoxide, and oxygen., J. Biol. Chem., 244, p. 6056, DOI: 10.1016/S0021-9258(18)63505-7</label>
          <listPosition>319</listPosition>
          <doi>10.1016/S0021-9258(18)63505-7</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916763</mtid>
          <link>/api/reference/45916763</link>
          <label>320. Hearse 1973: Abrupt reoxygenation of the anoxic potassium-arrested perfused rat heart: a study of myocardial enzyme release., J. Mol. Cell. Cardiol., 5, p. 395, DOI: 10.1016/0022-2828(73)90030-8</label>
          <listPosition>320</listPosition>
          <doi>10.1016/0022-2828(73)90030-8</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916764</mtid>
          <link>/api/reference/45916764</link>
          <label>321. Jolly 1984: Canine myocardial reperfusion injury its reduction by the combined administration of superoxide dismutase and catalase., Circ. Res., 54, p. 277, DOI: 10.1161/01.RES.54.3.277</label>
          <listPosition>321</listPosition>
          <doi>10.1161/01.RES.54.3.277</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916765</mtid>
          <link>/api/reference/45916765</link>
          <label>322. Werns 1988: The role of the polymorphonuclear leukocyte in mediating myocardial reperfusion injury.Oxygen Radicals in the Pathophysiology of Heart Disease, p. 123</label>
          <listPosition>322</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916766</mtid>
          <link>/api/reference/45916766</link>
          <label>323. Chambers 1985: Xanthine oxidase as a source of free radical damage in myocardial ischemia., J. Mol. Cell. Cardiol., 17, p. 145, DOI: 10.1016/S0022-2828(85)80017-1</label>
          <listPosition>323</listPosition>
          <doi>10.1016/S0022-2828(85)80017-1</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916767</mtid>
          <link>/api/reference/45916767</link>
          <label>324. Miura 1988: Effect of superoxide dismutase plus catalase on myocardial infarct size in rabbits., Can. J. Cardiol., 4, p. 407</label>
          <listPosition>324</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916768</mtid>
          <link>/api/reference/45916768</link>
          <label>325. Ooiwa 1991: Superoxide dismutase conjugated to polyethylene glycol fails to limit myocardial infarct size after 30 min ischemia followed by 72 h of reperfusion in the rabbit., J. Mol. Cell. Cardiol., 23, p. 119, DOI: 10.1016/0022-2828(91)90099-8</label>
          <listPosition>325</listPosition>
          <doi>10.1016/0022-2828(91)90099-8</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916769</mtid>
          <link>/api/reference/45916769</link>
          <label>326. Reimer 1989: The role of neutrophils and free radicals in the ischemic-reperfused heart: why the confusion and controversy?., J. Mol. Cell. Cardiol., 21, p. 1225, DOI: 10.1016/0022-2828(89)90669-X</label>
          <listPosition>326</listPosition>
          <doi>10.1016/0022-2828(89)90669-X</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916770</mtid>
          <link>/api/reference/45916770</link>
          <label>327. Kloner 1989: Deleterious effects of oxygen radicals in ischemia/reperfusion., Circulation, 80, p. 1115, DOI: 10.1161/01.CIR.80.5.1115</label>
          <listPosition>327</listPosition>
          <doi>10.1161/01.CIR.80.5.1115</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916771</mtid>
          <link>/api/reference/45916771</link>
          <label>328. Ytrehus 1994: Rat and rabbit heart infarction: effects of aneasthesia, perfusate, risk zone, and method of infarct sizing., Am. J. Physiol. Heart Circ. Physiol., 267, p. H2383, DOI: 10.1152/ajpheart.1994.267.6.H2383</label>
          <listPosition>328</listPosition>
          <doi>10.1152/ajpheart.1994.267.6.H2383</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916772</mtid>
          <link>/api/reference/45916772</link>
          <label>329. Miura 1987: Determinants of infarct size during permanent occlusion of a coronary artery in the closed chest dog., J. Am. Coll. Cardiol., 9, p. 647, DOI: 10.1016/S0735-1097(87)80060-8</label>
          <listPosition>329</listPosition>
          <doi>10.1016/S0735-1097(87)80060-8</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916773</mtid>
          <link>/api/reference/45916773</link>
          <label>330. Chien 1994: "Normothermic range" temperature affects myocardial infarct size., Cardiovasc. Res., 28, p. 1014, DOI: 10.1093/cvr/28.7.1014</label>
          <listPosition>330</listPosition>
          <doi>10.1093/cvr/28.7.1014</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916774</mtid>
          <link>/api/reference/45916774</link>
          <label>331. Grisham 1986: Xanthine oxidase and neutrophil infiltration in intestinal ischemia., Am. J. Physiol., 251, p. G567</label>
          <listPosition>331</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916775</mtid>
          <link>/api/reference/45916775</link>
          <label>332. Eddy 1987: Free radical-producing enzyme, xanthine oxidase, is undetectable in human hearts., Am. J. Physiol., 253, p. H709</label>
          <listPosition>332</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916776</mtid>
          <link>/api/reference/45916776</link>
          <label>333. Pain 2000: Opening of mitochondrial K(ATP) channels triggers the preconditioned state by generating free radicals., Circ. Res., 87, p. 460, DOI: 10.1161/01.RES.87.6.460</label>
          <listPosition>333</listPosition>
          <doi>10.1161/01.RES.87.6.460</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916777</mtid>
          <link>/api/reference/45916777</link>
          <label>334. Nakamura 2019: Iron homeostasis and iron-regulated ROS in cell death, senescence and human diseases., Biochim. Biophys. Acta Gen. Subj., 1863, p. 1398, DOI: 10.1016/j.bbagen.2019.06.010</label>
          <listPosition>334</listPosition>
          <doi>10.1016/j.bbagen.2019.06.010</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916778</mtid>
          <link>/api/reference/45916778</link>
          <label>335. Murphy 2016: Mitochondrial function, biology, and role in disease: a scientific statement from the American heart association., Circ. Res., 118, p. 1960, DOI: 10.1161/RES.0000000000000104</label>
          <listPosition>335</listPosition>
          <doi>10.1161/RES.0000000000000104</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916779</mtid>
          <link>/api/reference/45916779</link>
          <label>336. Shen 1972: Myocardial calcium and magnesium in acute ischemic injury., Am. J. Pathol., 67, p. 417</label>
          <listPosition>336</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916780</mtid>
          <link>/api/reference/45916780</link>
          <label>337. Ganote 1976: Oxygen-induced enzyme release after irreversible myocardial injury. Effects of cyanide in perfused rat hearts., Am. J. Pathol., 84, p. 327</label>
          <listPosition>337</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916781</mtid>
          <link>/api/reference/45916781</link>
          <label>338. Elz 1988: Calcium gain during postischemic reperfusion. The effect of 2,4-dinitrophenol., Am. J. Pathol., 131, p. 137</label>
          <listPosition>338</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916782</mtid>
          <link>/api/reference/45916782</link>
          <label>339. Zamzami 1995: Reduction in mitochondrial potential constitutes an early irreversible step of programmed lymphocyte death in vivo., J. Exp. Med., 181, p. 1661, DOI: 10.1084/jem.181.5.1661</label>
          <listPosition>339</listPosition>
          <doi>10.1084/jem.181.5.1661</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916783</mtid>
          <link>/api/reference/45916783</link>
          <label>340. Hearse 1978: The oxygen paradox and the calcium paradox: two facts of the same problem?., J. Mol. Cell. Cardiol., 10, p. 641, DOI: 10.1016/S0022-2828(78)80004-2</label>
          <listPosition>340</listPosition>
          <doi>10.1016/S0022-2828(78)80004-2</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916784</mtid>
          <link>/api/reference/45916784</link>
          <label>341. Bernardi 2015: The mitochondrial permeability transition pore: molecular nature and role as a target in cardioprotection., J. Mol. Cell. Cardiol., 78, p. 100, DOI: 10.1016/j.yjmcc.2014.09.023</label>
          <listPosition>341</listPosition>
          <doi>10.1016/j.yjmcc.2014.09.023</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916785</mtid>
          <link>/api/reference/45916785</link>
          <label>342. Penna 2009: Cardioprotection: a radical view free radicals in pre- and postconditioning., Biochim. Biophys. Acta, 1787, p. 781, DOI: 10.1016/j.bbabio.2009.02.008</label>
          <listPosition>342</listPosition>
          <doi>10.1016/j.bbabio.2009.02.008</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916786</mtid>
          <link>/api/reference/45916786</link>
          <label>343. Kaludercic 2014: Monoamine oxidase B prompts mitochondrial and cardiac dysfunction in pressure overloaded hearts., Antioxidants Redox Signal., 20, p. 267, DOI: 10.1089/ars.2012.4616</label>
          <listPosition>343</listPosition>
          <doi>10.1089/ars.2012.4616</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916787</mtid>
          <link>/api/reference/45916787</link>
          <label>344. Di Lisa 2017: New aspects of p66Shc in ischemia reperfusion injury and cardiovascular diseases., Br. J. Pharmacol., 174, p. 1690, DOI: 10.1111/bph.13478</label>
          <listPosition>344</listPosition>
          <doi>10.1111/bph.13478</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916788</mtid>
          <link>/api/reference/45916788</link>
          <label>345. Heger 2021: Cardiomyocytes-specific deletion of monoamine oxidase B reduces irreversible myocardial ischemia/reperfusion injury., Free Radic. Biol. Med., 165, p. 14, DOI: 10.1016/j.freeradbiomed.2021.01.020</label>
          <listPosition>345</listPosition>
          <doi>10.1016/j.freeradbiomed.2021.01.020</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916789</mtid>
          <link>/api/reference/45916789</link>
          <label>346. Carpi 2009: The cardioprotective effects elicited by p66(Shc) ablation demonstrate the crucial role of mitochondrial ROS formation in ischemia/reperfusion injury., Biochim. Biophys. Acta, 1787, p. 744</label>
          <listPosition>346</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916790</mtid>
          <link>/api/reference/45916790</link>
          <label>347. Chen 2008: Activation of aldehyde dehydrogenase-2 reduces ischemic damage to the heart., Science, 321, p. 1493, DOI: 10.1126/science.1158554</label>
          <listPosition>347</listPosition>
          <doi>10.1126/science.1158554</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916791</mtid>
          <link>/api/reference/45916791</link>
          <label>348. Asimakis 2002: Postischemic recovery of contractile function is impaired in SOD2(+/-) but not SOD1(+/-) mouse hearts., Circulation, 105, p. 981, DOI: 10.1161/hc0802.104502</label>
          <listPosition>348</listPosition>
          <doi>10.1161/hc0802.104502</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916792</mtid>
          <link>/api/reference/45916792</link>
          <label>349. Zaha 2016: AMPK is critical for mitochondrial function during reperfusion after myocardial ischemia., J. Mol. Cell. Cardiol., 91, p. 104, DOI: 10.1016/j.yjmcc.2015.12.032</label>
          <listPosition>349</listPosition>
          <doi>10.1016/j.yjmcc.2015.12.032</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916793</mtid>
          <link>/api/reference/45916793</link>
          <label>350. Schulz 2023: Importance of mitochondria in cardiac pathologies: focus on uncoupling proteins and monoamine oxidases., Int. J. Mol. Sci., 24, p. 6459, DOI: 10.3390/ijms24076459</label>
          <listPosition>350</listPosition>
          <doi>10.3390/ijms24076459</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916794</mtid>
          <link>/api/reference/45916794</link>
          <label>351. Kaludercic 2020: The energetic cost of NNT-dependent ROS removal., J. Biol. Chem., 295, p. 16217, DOI: 10.1074/jbc.H120.016368</label>
          <listPosition>351</listPosition>
          <doi>10.1074/jbc.H120.016368</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916795</mtid>
          <link>/api/reference/45916795</link>
          <label>352. Daiber 2017: Crosstalk of mitochondria with NADPH oxidase via reactive oxygen and nitrogen species signalling and its role for vascular function., Br. J. Pharmacol., 174, p. 1670, DOI: 10.1111/bph.13403</label>
          <listPosition>352</listPosition>
          <doi>10.1111/bph.13403</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916796</mtid>
          <link>/api/reference/45916796</link>
          <label>353. Murphy 2023: Mitochondrial calcium and reactive oxygen species in cardiovascular disease., Cardiovasc. Res., 119, p. 1105, DOI: 10.1093/cvr/cvac134</label>
          <listPosition>353</listPosition>
          <doi>10.1093/cvr/cvac134</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916797</mtid>
          <link>/api/reference/45916797</link>
          <label>354. Heinzel 2006: Formation of reactive oyxgen species at increased contraction frequency in rat cardiomyocytes., Cardiovasc. Res., 71, p. 374, DOI: 10.1016/j.cardiores.2006.05.014</label>
          <listPosition>354</listPosition>
          <doi>10.1016/j.cardiores.2006.05.014</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916798</mtid>
          <link>/api/reference/45916798</link>
          <label>355. Penzo 2004: Arachidonic acid released by phospholipase A(2) activation triggers Ca(2+)-dependent apoptosis through the mitochondrial pathway., J. Biol. Chem., 279, p. 25219, DOI: 10.1074/jbc.M310381200</label>
          <listPosition>355</listPosition>
          <doi>10.1074/jbc.M310381200</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916799</mtid>
          <link>/api/reference/45916799</link>
          <label>356. Chelko 2021: Exercise triggers CAPN1-mediated AIF truncation, inducing myocyte cell death in arrhythmogenic cardiomyopathy., Sci. Transl. Med., 13, DOI: 10.1126/scitranslmed.abf0891</label>
          <listPosition>356</listPosition>
          <doi>10.1126/scitranslmed.abf0891</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916800</mtid>
          <link>/api/reference/45916800</link>
          <label>357. Antonucci 2019: Selective mitochondrial superoxide generation in vivo is cardioprotective through hormesis., Free Radic. Biol. Med., 134, p. 678, DOI: 10.1016/j.freeradbiomed.2019.01.034</label>
          <listPosition>357</listPosition>
          <doi>10.1016/j.freeradbiomed.2019.01.034</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916801</mtid>
          <link>/api/reference/45916801</link>
          <label>358. Martin 2019: Succinate accumulation drives ischaemia-reperfusion injury during organ transplantation., Nat. Metab., 1, p. 966, DOI: 10.1038/s42255-019-0115-y</label>
          <listPosition>358</listPosition>
          <doi>10.1038/s42255-019-0115-y</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916802</mtid>
          <link>/api/reference/45916802</link>
          <label>359. Mottahedin 2023: Targeting succinate metabolism to decrease brain injury upon mechanical thrombectomy treatment of ischemic stroke., Redox Biol., 59, DOI: 10.1016/j.redox.2023.102600</label>
          <listPosition>359</listPosition>
          <doi>10.1016/j.redox.2023.102600</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916803</mtid>
          <link>/api/reference/45916803</link>
          <label>360. Taghavi 2022: Dimethyl malonate slows succinate accumulation and preserves cardiac function in a swine model of hemorrhagic shock., J. Trauma Acute Care Surg., 93, p. 13, DOI: 10.1097/TA.0000000000003593</label>
          <listPosition>360</listPosition>
          <doi>10.1097/TA.0000000000003593</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916804</mtid>
          <link>/api/reference/45916804</link>
          <label>361. Reddy 2020: pH-Gated succinate secretion regulates muscle remodeling in response to exercise., Cell, 183, p. 62, DOI: 10.1016/j.cell.2020.08.039</label>
          <listPosition>361</listPosition>
          <doi>10.1016/j.cell.2020.08.039</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916805</mtid>
          <link>/api/reference/45916805</link>
          <label>362. Mills 2018: Accumulation of succinate controls activation of adipose tissue thermogenesis., Nature, 560, p. 102, DOI: 10.1038/s41586-018-0353-2</label>
          <listPosition>362</listPosition>
          <doi>10.1038/s41586-018-0353-2</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916806</mtid>
          <link>/api/reference/45916806</link>
          <label>363. Mills 2016: Succinate dehydrogenase supports metabolic repurposing of mitochondria to drive inflammatory macrophages., Cell, 167, p. 457, DOI: 10.1016/j.cell.2016.08.064</label>
          <listPosition>363</listPosition>
          <doi>10.1016/j.cell.2016.08.064</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916807</mtid>
          <link>/api/reference/45916807</link>
          <label>364. Pryde 2011: Superoxide is produced by the reduced flavin in mitochondrial complex I: a single, unified mechanism that applies during both forward and reverse electron transfer., J. Biol. Chem., 286, p. 18056, DOI: 10.1074/jbc.M110.186841</label>
          <listPosition>364</listPosition>
          <doi>10.1074/jbc.M110.186841</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916808</mtid>
          <link>/api/reference/45916808</link>
          <label>365. Pell 2016: Moving forwards by blocking back-flow: the Yin and Yang of MI therapy., Circ. Res., 118, p. 898, DOI: 10.1161/CIRCRESAHA.115.306569</label>
          <listPosition>365</listPosition>
          <doi>10.1161/CIRCRESAHA.115.306569</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916809</mtid>
          <link>/api/reference/45916809</link>
          <label>366. Zhang 2018: Accumulation of succinate in cardiac ischemia primarily occurs via canonical Krebs cycle activity., Cell Rep., 23, p. 2617, DOI: 10.1016/j.celrep.2018.04.104</label>
          <listPosition>366</listPosition>
          <doi>10.1016/j.celrep.2018.04.104</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916810</mtid>
          <link>/api/reference/45916810</link>
          <label>367. Chouchani 2016: A unifying mechanism for mitochondrial superoxide production during ischemia-reperfusion injury., Cell Metabol., 23, p. 254, DOI: 10.1016/j.cmet.2015.12.009</label>
          <listPosition>367</listPosition>
          <doi>10.1016/j.cmet.2015.12.009</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916811</mtid>
          <link>/api/reference/45916811</link>
          <label>368. Vujic 2021: Mitochondrial redox and TCA cycle metabolite signaling in the heart., Free Radic. Biol. Med., 166, p. 287, DOI: 10.1016/j.freeradbiomed.2021.02.041</label>
          <listPosition>368</listPosition>
          <doi>10.1016/j.freeradbiomed.2021.02.041</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916812</mtid>
          <link>/api/reference/45916812</link>
          <label>369. Robb 2018: Control of mitochondrial superoxide production by reverse electron transport at complex I., J. Biol. Chem., 293, p. 9869, DOI: 10.1074/jbc.RA118.003647</label>
          <listPosition>369</listPosition>
          <doi>10.1074/jbc.RA118.003647</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916813</mtid>
          <link>/api/reference/45916813</link>
          <label>370. Prag 2022: Cyclophilin D knockout mice do not accumulate succinate during cardiac ischemia., J. Mol. Cell. Cardiol., 173, p. 73, DOI: 10.1016/j.yjmcc.2022.09.006</label>
          <listPosition>370</listPosition>
          <doi>10.1016/j.yjmcc.2022.09.006</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916814</mtid>
          <link>/api/reference/45916814</link>
          <label>371. Chen 2006: Reversible blockade of electron transport during ischemia protects mitochondria and decreases myocardial injury following reperfusion., J. Pharmacol. Exp. Therapeut., 319, p. 1405, DOI: 10.1124/jpet.106.110262</label>
          <listPosition>371</listPosition>
          <doi>10.1124/jpet.106.110262</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916815</mtid>
          <link>/api/reference/45916815</link>
          <label>372. Methner 2014: Mitochondria selective S-nitrosation by mitochondria-targeted S-nitrosothiol protects against post-infarct heart failure in mouse hearts., Eur. J. Heart Fail., 16, p. 712, DOI: 10.1002/ejhf.100</label>
          <listPosition>372</listPosition>
          <doi>10.1002/ejhf.100</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916816</mtid>
          <link>/api/reference/45916816</link>
          <label>373. Chouchani 2014: Complex I deficiency due to selective loss of Ndufs4 in the mouse heart results in severe hypertrophic cardiomyopathy., PLoS One, 9, DOI: 10.1371/journal.pone.0094157</label>
          <listPosition>373</listPosition>
          <doi>10.1371/journal.pone.0094157</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916817</mtid>
          <link>/api/reference/45916817</link>
          <label>374. Prag 2023: Preventing mitochondrial reverse electron transport as a strategy for cardioprotection., Basic Res. Cardiol., 118, p. 34, DOI: 10.1007/s00395-023-01002-4</label>
          <listPosition>374</listPosition>
          <doi>10.1007/s00395-023-01002-4</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916818</mtid>
          <link>/api/reference/45916818</link>
          <label>375. Kula-Alwar 2019: Targeting succinate metabolism in ischemia/reperfusion injury., Circulation, 140, p. 1968, DOI: 10.1161/CIRCULATIONAHA.119.042791</label>
          <listPosition>375</listPosition>
          <doi>10.1161/CIRCULATIONAHA.119.042791</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916819</mtid>
          <link>/api/reference/45916819</link>
          <label>376. Kohlhauer 2018: Metabolomic profiling in acute ST-segment-elevation myocardial infarction identifies succinate as an early marker of human ischemia-reperfusion injury., J. Am. Heart Assoc., 7, DOI: 10.1161/JAHA.117.007546</label>
          <listPosition>376</listPosition>
          <doi>10.1161/JAHA.117.007546</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916820</mtid>
          <link>/api/reference/45916820</link>
          <label>377. Prag 2021: Mechanism of succinate efflux upon reperfusion of the ischaemic heart., Cardiovasc. Res., 117, p. 1188, DOI: 10.1093/cvr/cvaa148</label>
          <listPosition>377</listPosition>
          <doi>10.1093/cvr/cvaa148</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916821</mtid>
          <link>/api/reference/45916821</link>
          <label>378. Prag 2022: Ischemia-selective cardioprotection by malonate for ischemia/reperfusion injury., Circ. Res., 131, p. 528, DOI: 10.1161/CIRCRESAHA.121.320717</label>
          <listPosition>378</listPosition>
          <doi>10.1161/CIRCRESAHA.121.320717</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916822</mtid>
          <link>/api/reference/45916822</link>
          <label>379. Schulz 2022: Targeted mito- and cardioprotection by malonate., Circ. Res., 131, p. 542, DOI: 10.1161/CIRCRESAHA.122.321582</label>
          <listPosition>379</listPosition>
          <doi>10.1161/CIRCRESAHA.122.321582</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916823</mtid>
          <link>/api/reference/45916823</link>
          <label>380. Valls-Lacalle 2016: Succinate dehydrogenase inhibition with malonate during reperfusion reduces infarct size by preventing mitochondrial permeability transition., Cardiovasc. Res., 109, p. 374, DOI: 10.1093/cvr/cvv279</label>
          <listPosition>380</listPosition>
          <doi>10.1093/cvr/cvv279</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916824</mtid>
          <link>/api/reference/45916824</link>
          <label>381. Valls-Lacalle 2018: Selective inhibition of succinate dehydrogenase in reperfused myocardium with intracoronary malonate reduces infarct size., Sci. Rep., 8, p. 2442, DOI: 10.1038/s41598-018-20866-4</label>
          <listPosition>381</listPosition>
          <doi>10.1038/s41598-018-20866-4</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916825</mtid>
          <link>/api/reference/45916825</link>
          <label>382. He 2004: Citric acid cycle intermediates as ligands for orphan G-protein-coupled receptors., Nature, 429, p. 188, DOI: 10.1038/nature02488</label>
          <listPosition>382</listPosition>
          <doi>10.1038/nature02488</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916826</mtid>
          <link>/api/reference/45916826</link>
          <label>383. Murphy 2018: Krebs cycle reimagined: the emerging roles of succinate and itaconate as signal transducers., Cell, 174, p. 780, DOI: 10.1016/j.cell.2018.07.030</label>
          <listPosition>383</listPosition>
          <doi>10.1016/j.cell.2018.07.030</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916827</mtid>
          <link>/api/reference/45916827</link>
          <label>384. Bertero 2018: Calcium signaling and reactive oxygen species in mitochondria., Circ. Res., 122, p. 1460, DOI: 10.1161/CIRCRESAHA.118.310082</label>
          <listPosition>384</listPosition>
          <doi>10.1161/CIRCRESAHA.118.310082</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916828</mtid>
          <link>/api/reference/45916828</link>
          <label>385. Smith 1993: Relationship between intracellular pH and metabolite concentrations during metabolic inhibition in isolated ferret heart., J. Physiol., 472, p. 11, DOI: 10.1113/jphysiol.1993.sp019932</label>
          <listPosition>385</listPosition>
          <doi>10.1113/jphysiol.1993.sp019932</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916829</mtid>
          <link>/api/reference/45916829</link>
          <label>386. Fabiato 1978: Effects of pH on the myofilaments and the sarcoplasmic reticulum of skinned cells from cardiace and skeletal muscles., J. Physiol., 276, p. 233, DOI: 10.1113/jphysiol.1978.sp012231</label>
          <listPosition>386</listPosition>
          <doi>10.1113/jphysiol.1978.sp012231</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916830</mtid>
          <link>/api/reference/45916830</link>
          <label>387. Hartmann 1999: Blocking Na+ -H+ exchange by cariporide reduces Na+ -overload in ischemia and is cardioprotective., J. Mol. Cell. Cardiol., 31, p. 1985, DOI: 10.1006/jmcc.1999.1029</label>
          <listPosition>387</listPosition>
          <doi>10.1006/jmcc.1999.1029</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916831</mtid>
          <link>/api/reference/45916831</link>
          <label>388. Pike 1990: 23Na-NMR measurements of intracellular sodium in intact perfused ferret hearts during ischemia and reperfusion., Am. J. Physiol., 259, p. H1767</label>
          <listPosition>388</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916832</mtid>
          <link>/api/reference/45916832</link>
          <label>389. Murphy 2008: Ion transport and energetics during cell death and protection., Physiology (Bethesda), 23, p. 115</label>
          <listPosition>389</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916833</mtid>
          <link>/api/reference/45916833</link>
          <label>390. Sun 2006: Hypercontractile female hearts exhibit increased S-nitrosylation of the L-type Ca2+ channel alpha1 subunit and reduced ischemia/reperfusion injury., Circ. Res., 98, p. 403, DOI: 10.1161/01.RES.0000202707.79018.0a</label>
          <listPosition>390</listPosition>
          <doi>10.1161/01.RES.0000202707.79018.0a</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916834</mtid>
          <link>/api/reference/45916834</link>
          <label>391. Imahashi 1999: Intracellular sodium accumulation during ischemia as the substrate for reperfusion injury., Circ. Res., 84, p. 1401, DOI: 10.1161/01.RES.84.12.1401</label>
          <listPosition>391</listPosition>
          <doi>10.1161/01.RES.84.12.1401</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916835</mtid>
          <link>/api/reference/45916835</link>
          <label>392. Halestrap 2006: Calcium, mitochondria and reperfusion injury: a pore way to die., Biochem. Soc. Trans., 34, p. 232, DOI: 10.1042/BST0340232</label>
          <listPosition>392</listPosition>
          <doi>10.1042/BST0340232</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916836</mtid>
          <link>/api/reference/45916836</link>
          <label>393. Finkel 2015: The ins and outs of mitochondrial calcium., Circ. Res., 116, p. 1810, DOI: 10.1161/CIRCRESAHA.116.305484</label>
          <listPosition>393</listPosition>
          <doi>10.1161/CIRCRESAHA.116.305484</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916837</mtid>
          <link>/api/reference/45916837</link>
          <label>394. Ashok 2023: Mitochondrial membrane potential instability on reperfusion after ischemia does not depend on mitochondrial Ca(2+) uptake., J. Biol. Chem., 299, DOI: 10.1016/j.jbc.2023.104708</label>
          <listPosition>394</listPosition>
          <doi>10.1016/j.jbc.2023.104708</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916838</mtid>
          <link>/api/reference/45916838</link>
          <label>395. Bernardi 2022: The mitochondrial permeability transition: recent progress and open questions., FEBS J., 289, p. 7051, DOI: 10.1111/febs.16254</label>
          <listPosition>395</listPosition>
          <doi>10.1111/febs.16254</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916839</mtid>
          <link>/api/reference/45916839</link>
          <label>396. Cohen 2007: The pH hypothesis of postconditioning: staccato reperfusion reintroduces oxygen and perpetuates myocardial acidosis., Circulation, 115, p. 1895, DOI: 10.1161/CIRCULATIONAHA.106.675710</label>
          <listPosition>396</listPosition>
          <doi>10.1161/CIRCULATIONAHA.106.675710</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916840</mtid>
          <link>/api/reference/45916840</link>
          <label>397. Bolli 1999: Molecular and cellular mechanisms of myocardial stunning., Physiol. Rev., 70, p. 609, DOI: 10.1152/physrev.1999.79.2.609</label>
          <listPosition>397</listPosition>
          <doi>10.1152/physrev.1999.79.2.609</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916841</mtid>
          <link>/api/reference/45916841</link>
          <label>398. Nickel 2014: Mitochondrial reactive oxygen species production and elimination., J. Mol. Cell. Cardiol., 73, p. 26, DOI: 10.1016/j.yjmcc.2014.03.011</label>
          <listPosition>398</listPosition>
          <doi>10.1016/j.yjmcc.2014.03.011</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916842</mtid>
          <link>/api/reference/45916842</link>
          <label>399. Balaban 2005: Mitochondria, oxidants, and aging., Cell, 120, p. 483, DOI: 10.1016/j.cell.2005.02.001</label>
          <listPosition>399</listPosition>
          <doi>10.1016/j.cell.2005.02.001</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916843</mtid>
          <link>/api/reference/45916843</link>
          <label>400. Aon 2010: Redox-optimized ROS balance: a unifying hypothesis., Biochim. Biophys. Acta, 1797, p. 865, DOI: 10.1016/j.bbabio.2010.02.016</label>
          <listPosition>400</listPosition>
          <doi>10.1016/j.bbabio.2010.02.016</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916844</mtid>
          <link>/api/reference/45916844</link>
          <label>401. Zorov 2000: Reactive oxygen species (ROS)-induced ROS release: a new phenomenon accompanying induction of the mitochondrial permeability transition in cardiac myocytes., J. Exp. Med., 192, p. 1001, DOI: 10.1084/jem.192.7.1001</label>
          <listPosition>401</listPosition>
          <doi>10.1084/jem.192.7.1001</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916845</mtid>
          <link>/api/reference/45916845</link>
          <label>402. Aon 2003: Synchronized whole cell oscillations in mitochondrial metabolism triggered by a local release of reactive oxygen species in cardiac myocytes., J. Biol. Chem., 278, p. 44735, DOI: 10.1074/jbc.M302673200</label>
          <listPosition>402</listPosition>
          <doi>10.1074/jbc.M302673200</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916846</mtid>
          <link>/api/reference/45916846</link>
          <label>403. Akar 2005: The mitochondrial origin of postischemic arrhythmias., J. Clin. Invest., 115, p. 3527, DOI: 10.1172/JCI25371</label>
          <listPosition>403</listPosition>
          <doi>10.1172/JCI25371</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916847</mtid>
          <link>/api/reference/45916847</link>
          <label>404. Dai 2011: Mitochondrial oxidative stress mediates angiotensin II-induced cardiac hypertrophy and G{alpha}q overexpression-induced heart failure., Circ. Res., 108, p. 837, DOI: 10.1161/CIRCRESAHA.110.232306</label>
          <listPosition>404</listPosition>
          <doi>10.1161/CIRCRESAHA.110.232306</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916848</mtid>
          <link>/api/reference/45916848</link>
          <label>405. Kimura 2005: Role of NAD(P)H oxidase- and mitochondria-derived reactive oxygen species in cardioprotection of ischemic reperfusion injury by angiotensin II., Hypertension, 45, p. 860, DOI: 10.1161/01.HYP.0000163462.98381.7f</label>
          <listPosition>405</listPosition>
          <doi>10.1161/01.HYP.0000163462.98381.7f</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916849</mtid>
          <link>/api/reference/45916849</link>
          <label>406. Nickel 2015: Reversal of mitochondrial transhydrogenase causes oxidative stress in heart failure., Cell Metabol., 22, p. 472, DOI: 10.1016/j.cmet.2015.07.008</label>
          <listPosition>406</listPosition>
          <doi>10.1016/j.cmet.2015.07.008</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916850</mtid>
          <link>/api/reference/45916850</link>
          <label>407. Aon 2007: Sequential opening of mitochondrial ion channels as a function of glutathione redox thiol status., J. Biol. Chem., 282, p. 21889, DOI: 10.1074/jbc.M702841200</label>
          <listPosition>407</listPosition>
          <doi>10.1074/jbc.M702841200</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916851</mtid>
          <link>/api/reference/45916851</link>
          <label>408. Maack 2011: Targeting mitochondrial oxidative stress in heart failure throttling the afterburner., J. Am. Coll. Cardiol., 58, p. 83, DOI: 10.1016/j.jacc.2011.01.032</label>
          <listPosition>408</listPosition>
          <doi>10.1016/j.jacc.2011.01.032</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916852</mtid>
          <link>/api/reference/45916852</link>
          <label>409. Dai 2011: Mitochondrial targeted antioxidant peptide ameliorates hypertensive cardiomyopathy., J. Am. Coll. Cardiol., 58, p. 73, DOI: 10.1016/j.jacc.2010.12.044</label>
          <listPosition>409</listPosition>
          <doi>10.1016/j.jacc.2010.12.044</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916853</mtid>
          <link>/api/reference/45916853</link>
          <label>410. Kröller-Schön 2014: Molecular mechanisms of the crosstalk between mitochondria and NADPH oxidase through reactive oxygen species-studies in white blood cells and in animal models., Antioxidants Redox Signal., 20, p. 247, DOI: 10.1089/ars.2012.4953</label>
          <listPosition>410</listPosition>
          <doi>10.1089/ars.2012.4953</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916854</mtid>
          <link>/api/reference/45916854</link>
          <label>411. Ardehali 2005: Mitochondrial KATP channels in cell survival and death., J. Mol. Cell. Cardiol., 39, p. 7, DOI: 10.1016/j.yjmcc.2004.12.003</label>
          <listPosition>411</listPosition>
          <doi>10.1016/j.yjmcc.2004.12.003</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916855</mtid>
          <link>/api/reference/45916855</link>
          <label>412. Cohen 2001: Acetylcholine, bradykinin, opioids, and phenylephrine, but not adenosine, trigger preconditioning by generating free radicals and opening mitochondrial KATP channels., Circ. Res., 89, p. 273, DOI: 10.1161/hh1501.094266</label>
          <listPosition>412</listPosition>
          <doi>10.1161/hh1501.094266</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916856</mtid>
          <link>/api/reference/45916856</link>
          <label>413. Heinzel 2005: Impairment of diazoxide-induced formation of reactive oxygen species and loss of cardioprotection in connexin 43 deficient mice., Circ. Res., 97, p. 583, DOI: 10.1161/01.RES.0000181171.65293.65</label>
          <listPosition>413</listPosition>
          <doi>10.1161/01.RES.0000181171.65293.65</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916857</mtid>
          <link>/api/reference/45916857</link>
          <label>414. Juhaszova 2004: Glycogen synthase kinase-3ß mediates convergence of protection signaling to inhibit the mitochondrial permeability transition pore., J. Clin. Invest., 113, p. 1535, DOI: 10.1172/JCI19906</label>
          <listPosition>414</listPosition>
          <doi>10.1172/JCI19906</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916858</mtid>
          <link>/api/reference/45916858</link>
          <label>415. Paggio 2019: Identification of an ATP-sensitive potassium channel in mitochondria., Nature, 572, p. 609, DOI: 10.1038/s41586-019-1498-3</label>
          <listPosition>415</listPosition>
          <doi>10.1038/s41586-019-1498-3</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916859</mtid>
          <link>/api/reference/45916859</link>
          <label>416. Ardehali 2005: Cardioprotective role of the mitochondrial ATP-binding cassette protein 1., Circ. Res., 97, p. 740, DOI: 10.1161/01.RES.0000186277.12336.11</label>
          <listPosition>416</listPosition>
          <doi>10.1161/01.RES.0000186277.12336.11</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916860</mtid>
          <link>/api/reference/45916860</link>
          <label>417. Juhaszova 2022: ATP Synthase K(+)- and H(+)-fluxes drive ATP synthesis and enable mitochondrial K(+)-"uniporter" function: II. Ion and ATP synthase flux regulation., Function (Oxf), 3</label>
          <listPosition>417</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916861</mtid>
          <link>/api/reference/45916861</link>
          <label>418. Bertero 2022: Rethinking Mitchell's chemiosmotic theory: potassium dominates over proton flux to drive mitochondrial F1Fo-ATP synthase., Function (Oxf), 3</label>
          <listPosition>418</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916862</mtid>
          <link>/api/reference/45916862</link>
          <label>419. Ide 1999: Mitochondrial electron transport complex I is a potential source of oxygen free radicals in the failing myocardium., Circ. Res., 85, p. 357, DOI: 10.1161/01.RES.85.4.357</label>
          <listPosition>419</listPosition>
          <doi>10.1161/01.RES.85.4.357</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916863</mtid>
          <link>/api/reference/45916863</link>
          <label>420. Ide 2000: Direct evidence for increased hydroxyl radicals originating from superoxide in the failing myocardium., Circ. Res., 86, p. 152, DOI: 10.1161/01.RES.86.2.152</label>
          <listPosition>420</listPosition>
          <doi>10.1161/01.RES.86.2.152</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916864</mtid>
          <link>/api/reference/45916864</link>
          <label>421. Dey 2018: Mitochondrial ROS drive sudden cardiac death and chronic proteome remodeling in heart failure., Circ. Res., 123, p. 356, DOI: 10.1161/CIRCRESAHA.118.312708</label>
          <listPosition>421</listPosition>
          <doi>10.1161/CIRCRESAHA.118.312708</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916865</mtid>
          <link>/api/reference/45916865</link>
          <label>422. Dai 2012: Mitochondrial proteome remodelling in pressure overload-induced heart failure: the role of mitochondrial oxidative stress., Cardiovasc. Res., 93, p. 79, DOI: 10.1093/cvr/cvr274</label>
          <listPosition>422</listPosition>
          <doi>10.1093/cvr/cvr274</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916866</mtid>
          <link>/api/reference/45916866</link>
          <label>423. Nakagawa 2005: Cyclophilin D-dependent mitochondrial permeability transition regulates some necrotic but not apoptotic cell death., Nature, 434, p. 652, DOI: 10.1038/nature03317</label>
          <listPosition>423</listPosition>
          <doi>10.1038/nature03317</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916867</mtid>
          <link>/api/reference/45916867</link>
          <label>424. Adlam 2005: Targeting an antioxidant to mitochondria decreases cardiac ischemia-reperfusion injury., Faseb. J., 19, p. 1088, DOI: 10.1096/fj.05-3718com</label>
          <listPosition>424</listPosition>
          <doi>10.1096/fj.05-3718com</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916868</mtid>
          <link>/api/reference/45916868</link>
          <label>425. Chouchani 2013: Cardioprotection by S-nitrosation of a cysteine switch on mitochondrial complex I., Nat. Med., 19, p. 753, DOI: 10.1038/nm.3212</label>
          <listPosition>425</listPosition>
          <doi>10.1038/nm.3212</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916869</mtid>
          <link>/api/reference/45916869</link>
          <label>426. Wojtovich 2013: Physiological consequences of complex II inhibition for aging, disease, and the mK(ATP) channel., Biochim. Biophys. Acta, 1827, p. 598, DOI: 10.1016/j.bbabio.2012.12.007</label>
          <listPosition>426</listPosition>
          <doi>10.1016/j.bbabio.2012.12.007</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916870</mtid>
          <link>/api/reference/45916870</link>
          <label>427. Brennan 2006: Mitochondrial uncoupling, with low concentration FCCP, induces ROS-dependent cardioprotection independent of K(ATP) channel activation., Cardiovasc. Res., 72, p. 313, DOI: 10.1016/j.cardiores.2006.07.019</label>
          <listPosition>427</listPosition>
          <doi>10.1016/j.cardiores.2006.07.019</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916871</mtid>
          <link>/api/reference/45916871</link>
          <label>428. Hebert-Chatelain 2013: Src kinases are important regulators of mitochondrial functions., Int. J. Biochem. Cell Biol., 45, p. 90, DOI: 10.1016/j.biocel.2012.08.014</label>
          <listPosition>428</listPosition>
          <doi>10.1016/j.biocel.2012.08.014</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916872</mtid>
          <link>/api/reference/45916872</link>
          <label>429. Wang 2003: Mice with a null mutation in the NHE1 Na+ -H+ exchanger are resistant to cardiac ischemia-reperfusion injury., Circ. Res., 93, p. 776, DOI: 10.1161/01.RES.0000094746.24774.DC</label>
          <listPosition>429</listPosition>
          <doi>10.1161/01.RES.0000094746.24774.DC</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916873</mtid>
          <link>/api/reference/45916873</link>
          <label>430. Theroux 2000: Inhibition of the sodium-hydrogen exchanger with cariporide to prevent myocardial infarction in high-risk ischemic situations. Main results of the GUARDIAN trial., Circulation, 102, p. 3032, DOI: 10.1161/01.CIR.102.25.3032</label>
          <listPosition>430</listPosition>
          <doi>10.1161/01.CIR.102.25.3032</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916874</mtid>
          <link>/api/reference/45916874</link>
          <label>431. Butler 2022: Effect of empagliflozin in patients with heart failure across the spectrum of left ventricular ejection fraction., Eur. Heart J., 43, p. 416, DOI: 10.1093/eurheartj/ehab798</label>
          <listPosition>431</listPosition>
          <doi>10.1093/eurheartj/ehab798</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916875</mtid>
          <link>/api/reference/45916875</link>
          <label>432. Jhund 2022: Dapagliflozin across the range of ejection fraction in patients with heart failure: a patient-level, pooled meta-analysis of DAPA-HF and DELIVER., Nat. Med., 28, p. 1956, DOI: 10.1038/s41591-022-01971-4</label>
          <listPosition>432</listPosition>
          <doi>10.1038/s41591-022-01971-4</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916876</mtid>
          <link>/api/reference/45916876</link>
          <label>433. Baartscheer 2017: Empagliflozin decreases myocardial cytoplasmic Na(+) through inhibition of the cardiac Na(+)/H(+) exchanger in rats and rabbits., Diabetologia, 60, p. 568, DOI: 10.1007/s00125-016-4134-x</label>
          <listPosition>433</listPosition>
          <doi>10.1007/s00125-016-4134-x</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916877</mtid>
          <link>/api/reference/45916877</link>
          <label>434. Uthman 2018: Class effects of SGLT2 inhibitors in mouse cardiomyocytes and hearts: inhibition of Na(+)/H(+) exchanger, lowering of cytosolic Na(+) and vasodilation., Diabetologia, 61, p. 722, DOI: 10.1007/s00125-017-4509-7</label>
          <listPosition>434</listPosition>
          <doi>10.1007/s00125-017-4509-7</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916878</mtid>
          <link>/api/reference/45916878</link>
          <label>435. Mustroph 2022: Empagliflozin inhibits cardiac late sodium current by Ca/Calmodulin-dependent kinase II., Circulation, 146, p. 1259, DOI: 10.1161/CIRCULATIONAHA.122.057364</label>
          <listPosition>435</listPosition>
          <doi>10.1161/CIRCULATIONAHA.122.057364</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916879</mtid>
          <link>/api/reference/45916879</link>
          <label>436. Hegyi 2022: Empagliflozin reverses late Na(+) current enhancement and cardiomyocyte proarrhythmia in a translational murine model of heart failure with preserved ejection fraction., Circulation, 145, p. 1029, DOI: 10.1161/CIRCULATIONAHA.121.057237</label>
          <listPosition>436</listPosition>
          <doi>10.1161/CIRCULATIONAHA.121.057237</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916880</mtid>
          <link>/api/reference/45916880</link>
          <label>437. Philippaert 2021: Cardiac late sodium channel current is a molecular target for the sodium/glucose cotransporter 2 inhibitor empagliflozin., Circulation, 143, p. 2188, DOI: 10.1161/CIRCULATIONAHA.121.053350</label>
          <listPosition>437</listPosition>
          <doi>10.1161/CIRCULATIONAHA.121.053350</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916881</mtid>
          <link>/api/reference/45916881</link>
          <label>438. Clancy 2015: Deranged sodium to sudden death., J. Physiol., 593, p. 1331, DOI: 10.1113/jphysiol.2014.281204</label>
          <listPosition>438</listPosition>
          <doi>10.1113/jphysiol.2014.281204</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916882</mtid>
          <link>/api/reference/45916882</link>
          <label>439. Chen 2023: Sodium glucose cotransporter-2 inhibitor empagliflozin reduces infarct size independently of sodium glucose cotransporter-2., Circulation, 147, p. 276, DOI: 10.1161/CIRCULATIONAHA.122.061688</label>
          <listPosition>439</listPosition>
          <doi>10.1161/CIRCULATIONAHA.122.061688</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916883</mtid>
          <link>/api/reference/45916883</link>
          <label>440. Pan 2013: The physiological role of mitochondrial calcium revealed by mice lacking the mitochondrial calcium uniporter., Nat. Cell Biol., 15, p. 1464, DOI: 10.1038/ncb2868</label>
          <listPosition>440</listPosition>
          <doi>10.1038/ncb2868</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916884</mtid>
          <link>/api/reference/45916884</link>
          <label>441. Luongo 2015: The mitochondrial calcium uniporter matches energetic supply with cardiac workload during stress and modulates permeability transition., Cell Rep., 12, p. 23, DOI: 10.1016/j.celrep.2015.06.017</label>
          <listPosition>441</listPosition>
          <doi>10.1016/j.celrep.2015.06.017</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916885</mtid>
          <link>/api/reference/45916885</link>
          <label>442. Garcia-Rivas Gde 2006: Ru360, a specific mitochondrial calcium uptake inhibitor, improves cardiac post-ischaemic functional recovery in rats in vivo., Br. J. Pharmacol., 149, p. 829, DOI: 10.1038/sj.bjp.0706932</label>
          <listPosition>442</listPosition>
          <doi>10.1038/sj.bjp.0706932</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916886</mtid>
          <link>/api/reference/45916886</link>
          <label>443. Liu 2014: Inhibiting mitochondrial Na+/Ca2+ exchange prevents sudden death in a Guinea pig model of heart failure., Circ. Res., 115, p. 44, DOI: 10.1161/CIRCRESAHA.115.303062</label>
          <listPosition>443</listPosition>
          <doi>10.1161/CIRCRESAHA.115.303062</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916887</mtid>
          <link>/api/reference/45916887</link>
          <label>444. Kalyanaraman 2012: Measuring reactive oxygen and nitrogen species with fluorescent probes: challenges and limitations., Free Radic. Biol. Med., 52, p. 1, DOI: 10.1016/j.freeradbiomed.2011.09.030</label>
          <listPosition>444</listPosition>
          <doi>10.1016/j.freeradbiomed.2011.09.030</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916888</mtid>
          <link>/api/reference/45916888</link>
          <label>445. Rezende 2018: Detection of hydrogen peroxide with fluorescent dyes., Antioxidants Redox Signal., 29, p. 585, DOI: 10.1089/ars.2017.7401</label>
          <listPosition>445</listPosition>
          <doi>10.1089/ars.2017.7401</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916889</mtid>
          <link>/api/reference/45916889</link>
          <label>446. Schiattarella 2019: Nitrosative stress drives heart failure with preserved ejection fraction., Nature, 568, p. 351, DOI: 10.1038/s41586-019-1100-z</label>
          <listPosition>446</listPosition>
          <doi>10.1038/s41586-019-1100-z</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916890</mtid>
          <link>/api/reference/45916890</link>
          <label>447. Weir 2005: Acute oxygen-sensing mechanisms., N. Engl. J. Med., 353, p. 2042, DOI: 10.1056/NEJMra050002</label>
          <listPosition>447</listPosition>
          <doi>10.1056/NEJMra050002</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916891</mtid>
          <link>/api/reference/45916891</link>
          <label>448. Fernandez-Caggiano 2020: Mitochondrial pyruvate carrier abundance mediates pathological cardiac hypertrophy., Nat. Metab., 2, p. 1223, DOI: 10.1038/s42255-020-00276-5</label>
          <listPosition>448</listPosition>
          <doi>10.1038/s42255-020-00276-5</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916892</mtid>
          <link>/api/reference/45916892</link>
          <label>449. Heusch 2011: A radical view on the contractile machinery in human heart failure., J. Am. Coll. Cardiol., 57, p. 310, DOI: 10.1016/j.jacc.2010.06.057</label>
          <listPosition>449</listPosition>
          <doi>10.1016/j.jacc.2010.06.057</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916893</mtid>
          <link>/api/reference/45916893</link>
          <label>450. Nanadikar 2023: IDH3gamma functions as a redox switch regulating mitochondrial energy metabolism and contractility in the heart., Nat. Commun., 14, p. 2123, DOI: 10.1038/s41467-023-37744-x</label>
          <listPosition>450</listPosition>
          <doi>10.1038/s41467-023-37744-x</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916894</mtid>
          <link>/api/reference/45916894</link>
          <label>451. Heusch 2010: The contribution of reactive oxygen species and p38 mitogen activated protein kinase to myofilament oxidation and progression of heart failure in rabbits., Br. J. Pharmacol., 160, p. 1408, DOI: 10.1111/j.1476-5381.2010.00793.x</label>
          <listPosition>451</listPosition>
          <doi>10.1111/j.1476-5381.2010.00793.x</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916895</mtid>
          <link>/api/reference/45916895</link>
          <label>452. Canton 2006: Oxidative modification of tropomyosin and myocardial dysfunction following coronary microembolization., Eur. Heart J., 27, p. 875, DOI: 10.1093/eurheartj/ehi751</label>
          <listPosition>452</listPosition>
          <doi>10.1093/eurheartj/ehi751</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916896</mtid>
          <link>/api/reference/45916896</link>
          <label>453. Bolli 1989: Marked reduction of free radical generation and contractile dysfunction by antioxidant therapy begun at the time of reperfusion. Evidence that myocardial "stunning" is a manifestation of reperfusion injury., Circ. Res., 65, p. 607, DOI: 10.1161/01.RES.65.3.607</label>
          <listPosition>453</listPosition>
          <doi>10.1161/01.RES.65.3.607</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916897</mtid>
          <link>/api/reference/45916897</link>
          <label>454. Bolli 1995: Recurrent ischemia in the canine heart causes recurrent bursts of free radical production that have a cumulative effect of contractile function., J. Clin. Invest., 96, p. 1066, DOI: 10.1172/JCI118093</label>
          <listPosition>454</listPosition>
          <doi>10.1172/JCI118093</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916898</mtid>
          <link>/api/reference/45916898</link>
          <label>455. Schröder 2012: Nox4 is a protective reactive oxygen species generating vascular NADPH oxidase., Circ. Res., 110, p. 1217, DOI: 10.1161/CIRCRESAHA.112.267054</label>
          <listPosition>455</listPosition>
          <doi>10.1161/CIRCRESAHA.112.267054</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916899</mtid>
          <link>/api/reference/45916899</link>
          <label>456. Xiao 2020: A quantitative tissue-specific landscape of protein redox regulation during aging., Cell, 180, p. 968, DOI: 10.1016/j.cell.2020.02.012</label>
          <listPosition>456</listPosition>
          <doi>10.1016/j.cell.2020.02.012</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916900</mtid>
          <link>/api/reference/45916900</link>
          <label>457. Semenzato 2023: Oxidization of optic atrophy 1 cysteines occurs during heart ischemia-reperfusion and amplifies cell death by oxidative stress., Redox Biol., 63, DOI: 10.1016/j.redox.2023.102755</label>
          <listPosition>457</listPosition>
          <doi>10.1016/j.redox.2023.102755</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916901</mtid>
          <link>/api/reference/45916901</link>
          <label>458. Eaton 2005: Ischemic preconditioning: a potential role for protein S-thiolation?., Antioxidants Redox Signal., 7, p. 882, DOI: 10.1089/ars.2005.7.882</label>
          <listPosition>458</listPosition>
          <doi>10.1089/ars.2005.7.882</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916902</mtid>
          <link>/api/reference/45916902</link>
          <label>459. Kohr 2011: Simultaneous measurement of protein oxidation and s-nitrosylation during preconditioning and ischemia/reperfusion injury with resin-assisted capture., Circ. Res., 108, p. 418, DOI: 10.1161/CIRCRESAHA.110.232173</label>
          <listPosition>459</listPosition>
          <doi>10.1161/CIRCRESAHA.110.232173</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916903</mtid>
          <link>/api/reference/45916903</link>
          <label>460. Cuello 2019: Cysteine-based redox sensing and its role in signaling by cyclic nucleotide-dependent kinases in the cardiovascular system., Annu. Rev. Physiol., 81, p. 63, DOI: 10.1146/annurev-physiol-020518-114417</label>
          <listPosition>460</listPosition>
          <doi>10.1146/annurev-physiol-020518-114417</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916904</mtid>
          <link>/api/reference/45916904</link>
          <label>461. Charles 2022: Redox regulation of soluble epoxide hydrolase-implications for cardiovascular health and disease., Cells, 11, DOI: 10.3390/cells11121932</label>
          <listPosition>461</listPosition>
          <doi>10.3390/cells11121932</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916905</mtid>
          <link>/api/reference/45916905</link>
          <label>462. Schaefer 2023: Recent advances in covalent drug discovery., Pharmaceuticals, 16, p. 663, DOI: 10.3390/ph16050663</label>
          <listPosition>462</listPosition>
          <doi>10.3390/ph16050663</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916906</mtid>
          <link>/api/reference/45916906</link>
          <label>463. Cohen 2005: Structural bioinformatics-based design of selective, irreversible kinase inhibitors., Science, 308, p. 1318, DOI: 10.1126/science1108367</label>
          <listPosition>463</listPosition>
          <doi>10.1126/science1108367</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916907</mtid>
          <link>/api/reference/45916907</link>
          <label>464. Burgoyne 2017: Proof of principle for a novel class of antihypertensives that target the oxidative activation of PKG Ialpha (Protein Kinase G Ialpha)., Hypertension, 70, p. 577, DOI: 10.1161/HYPERTENSIONAHA.117.09670</label>
          <listPosition>464</listPosition>
          <doi>10.1161/HYPERTENSIONAHA.117.09670</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916908</mtid>
          <link>/api/reference/45916908</link>
          <label>465. Hu 2023: 3rd, H(2)S donors with cytoprotective effects in models of MI/R injury and chemotherapy-induced cardiotoxicity., Antioxidants (Basel), 12, p. 650, DOI: 10.3390/antiox12030650</label>
          <listPosition>465</listPosition>
          <doi>10.3390/antiox12030650</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916909</mtid>
          <link>/api/reference/45916909</link>
          <label>466. Citi 2018: The role of hydrogen sulfide and H2S-donors in myocardial protection against ischemia/reperfusion injury., Curr. Med. Chem., 25, p. 4380, DOI: 10.2174/0929867325666180212120504</label>
          <listPosition>466</listPosition>
          <doi>10.2174/0929867325666180212120504</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916910</mtid>
          <link>/api/reference/45916910</link>
          <label>467. Testai 2016: The novel H(2)S-donor 4-carboxyphenyl isothiocyanate promotes cardioprotective effects against ischemia/reperfusion injury through activation of mitoK(ATP) channels and reduction of oxidative stress., Pharmacol. Res., 113, p. 290, DOI: 10.1016/j.phrs.2016.09.006</label>
          <listPosition>467</listPosition>
          <doi>10.1016/j.phrs.2016.09.006</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916911</mtid>
          <link>/api/reference/45916911</link>
          <label>468. Ellmers 2020: Hydrogen sulfide treatment improves post-Infarct remodeling and long-term cardiac function in CSE knockout and wild-type mice., Int. J. Mol. Sci., 21, p. 4284, DOI: 10.3390/ijms21124284</label>
          <listPosition>468</listPosition>
          <doi>10.3390/ijms21124284</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916912</mtid>
          <link>/api/reference/45916912</link>
          <label>469. Salloum 2015: Hydrogen sulfide and cardioprotection - mechanistic insights and clinical translatability., Pharmacol. Ther., 152, p. 11, DOI: 10.1016/j.pharmthera.2015.04.004</label>
          <listPosition>469</listPosition>
          <doi>10.1016/j.pharmthera.2015.04.004</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916913</mtid>
          <link>/api/reference/45916913</link>
          <label>470. Andreadou 2020: The role of mitochondrial reactive oxygen species, NO and H2 S in ischaemia/reperfusion injury and cardioprotection., J. Cell Mol. Med., 24, p. 6510, DOI: 10.1111/jcmm.15279</label>
          <listPosition>470</listPosition>
          <doi>10.1111/jcmm.15279</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916914</mtid>
          <link>/api/reference/45916914</link>
          <label>471. Luo 2021: Activation of the CaR-CSE/H2S pathway confers cardioprotection against ischemia-reperfusion injury., Exp. Cell Res., 398, DOI: 10.1016/j.yexcr.2020.112389</label>
          <listPosition>471</listPosition>
          <doi>10.1016/j.yexcr.2020.112389</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916915</mtid>
          <link>/api/reference/45916915</link>
          <label>472. Wu 2018: Amelioration of mitochondrial dysfunction in heart failure through S-sulfhydration of Ca(2+)/calmodulin-dependent protein kinase II., Redox Biol., 19, p. 250, DOI: 10.1016/j.redox.2018.08.008</label>
          <listPosition>472</listPosition>
          <doi>10.1016/j.redox.2018.08.008</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916916</mtid>
          <link>/api/reference/45916916</link>
          <label>473. Karwi 2017: Pre- and postconditioning the heart with hydrogen sulfide (H2S) against ischemia/reperfusion injury in vivo: a systematic review and meta-analysis., Basic Res. Cardiol., 113, p. 6, DOI: 10.1007/s00395-017-0664-8</label>
          <listPosition>473</listPosition>
          <doi>10.1007/s00395-017-0664-8</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916917</mtid>
          <link>/api/reference/45916917</link>
          <label>474. Shen 2015: The cardioprotective effects of hydrogen sulfide in heart diseases: from molecular mechanisms to therapeutic potential., Oxid. Med. Cell Longev. 2015, DOI: 10.1155/2015/925167</label>
          <listPosition>474</listPosition>
          <doi>10.1155/2015/925167</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916918</mtid>
          <link>/api/reference/45916918</link>
          <label>475. Chen 2020: Protective mechanisms of hydrogen sulfide in myocardial ischemia., J. Cell. Physiol., 235, p. 9059, DOI: 10.1002/jcp.29761</label>
          <listPosition>475</listPosition>
          <doi>10.1002/jcp.29761</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916919</mtid>
          <link>/api/reference/45916919</link>
          <label>476. Zhang 2020: Role of hydrogen sulfide in myocardial ischemia-reperfusion injury., J. Cardiovasc. Pharmacol., 77, p. 130, DOI: 10.1097/FJC.0000000000000943</label>
          <listPosition>476</listPosition>
          <doi>10.1097/FJC.0000000000000943</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916920</mtid>
          <link>/api/reference/45916920</link>
          <label>477. Sun 2016: Additive cardioprotection by pharmacological postconditioning with hydrogen sulfide and nitric oxide donors in mouse heart: S-sulfhydration vs. S-nitrosylation., Cardiovasc. Res., 110, p. 96, DOI: 10.1093/cvr/cvw037</label>
          <listPosition>477</listPosition>
          <doi>10.1093/cvr/cvw037</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916921</mtid>
          <link>/api/reference/45916921</link>
          <label>478. Mahalakshmi 2020: Mitochondrial dysfunction plays a key role in the abrogation of cardioprotection by sodium hydrosulfide post-conditioning in diabetic cardiomyopathy rat heart., Naunyn-Schmiedeberg’s Arch. Pharmacol., 393, p. 339, DOI: 10.1007/s00210-019-01733-z</label>
          <listPosition>478</listPosition>
          <doi>10.1007/s00210-019-01733-z</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916922</mtid>
          <link>/api/reference/45916922</link>
          <label>479. Powell 2018: A review of hydrogen sulfide (H(2)S) donors: chemistry and potential therapeutic applications., Biochem. Pharmacol., 149, p. 110, DOI: 10.1016/j.bcp.2017.11.014</label>
          <listPosition>479</listPosition>
          <doi>10.1016/j.bcp.2017.11.014</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916923</mtid>
          <link>/api/reference/45916923</link>
          <label>480. Chatzianastasiou 2016: Cardioprotection by H2S donors: nitric oxide-dependent and -independent mechanisms., J. Pharmacol. Exp. Therapeut., 358, p. 431, DOI: 10.1124/jpet.116.235119</label>
          <listPosition>480</listPosition>
          <doi>10.1124/jpet.116.235119</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916924</mtid>
          <link>/api/reference/45916924</link>
          <label>481. Bibli 2015: Cardioprotection by H2S engages a cGMP-dependent protein kinase G/phospholamban pathway., Cardiovasc. Res., 106, p. 432, DOI: 10.1093/cvr/cvv129</label>
          <listPosition>481</listPosition>
          <doi>10.1093/cvr/cvv129</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916925</mtid>
          <link>/api/reference/45916925</link>
          <label>482. Andreadou 2015: The role of gasotransmitters NO, H2S and CO in myocardial ischaemia/reperfusion injury and cardioprotection by preconditioning, postconditioning and remote conditioning., Br. J. Pharmacol., 172, p. 1587, DOI: 10.1111/bph.12811</label>
          <listPosition>482</listPosition>
          <doi>10.1111/bph.12811</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916926</mtid>
          <link>/api/reference/45916926</link>
          <label>483. Karwi 2017: AP39, a mitochondria-targeting hydrogen sulfide (H2 S) donor, protects against myocardial reperfusion injury independently of salvage kinase signalling., Br. J. Pharmacol., 174, p. 287, DOI: 10.1111/bph.13688</label>
          <listPosition>483</listPosition>
          <doi>10.1111/bph.13688</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916927</mtid>
          <link>/api/reference/45916927</link>
          <label>484. Yao 2019: Controllable thioester-based hydrogen sulfide slow-releasing donors as cardioprotective agents., Chem. Commun., 55, p. 6193, DOI: 10.1039/C9CC02829C</label>
          <listPosition>484</listPosition>
          <doi>10.1039/C9CC02829C</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916928</mtid>
          <link>/api/reference/45916928</link>
          <label>485. Liang 2019: Conductive hydrogen sulfide-releasing hydrogel encapsulating ADSCs for myocardial infarction treatment., ACS Appl. Mater. Interfaces, 11, p. 14619, DOI: 10.1021/acsami.9b01886</label>
          <listPosition>485</listPosition>
          <doi>10.1021/acsami.9b01886</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916929</mtid>
          <link>/api/reference/45916929</link>
          <label>486. Vass 2023: Reperfusion-induced injury and the effects of the dithioacetate type hydrogen sulfide donor ibuprofen derivative, BM-88, in isolated rat hearts., Eur. J. Pharmaceut. Sci., 185, DOI: 10.1016/j.ejps.2023.106449</label>
          <listPosition>486</listPosition>
          <doi>10.1016/j.ejps.2023.106449</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916930</mtid>
          <link>/api/reference/45916930</link>
          <label>487. Pharoah 2022: Hydropersulfides (RSSH) outperform post-conditioning and other reactive sulfur species in limiting ischemia-reperfusion injury in the isolated mouse heart., Antioxidants (Basel), 11, p. 1010, DOI: 10.3390/antiox11051010</label>
          <listPosition>487</listPosition>
          <doi>10.3390/antiox11051010</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916931</mtid>
          <link>/api/reference/45916931</link>
          <label>488. Lougiakis 2016: Synthesis and pharmacological evaluation of novel adenine-hydrogen sulfide slow release hybrids designed as multitarget cardioprotective agents., J. Med. Chem., 59, p. 1776, DOI: 10.1021/acs.jmedchem.5b01223</label>
          <listPosition>488</listPosition>
          <doi>10.1021/acs.jmedchem.5b01223</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916932</mtid>
          <link>/api/reference/45916932</link>
          <label>489. Wu 2018: An update on hydrogen sulfide and nitric oxide interactions in the cardiovascular system., Oxid. Med. Cell Longev. 2018, DOI: 10.1155/2018/4579140</label>
          <listPosition>489</listPosition>
          <doi>10.1155/2018/4579140</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916933</mtid>
          <link>/api/reference/45916933</link>
          <label>490. Chang 2019: ZYZ-803 mitigates endoplasmic reticulum stress-related necroptosis after acute myocardial infarction through downregulating the RIP3-CaMKII signaling pathway., Oxid. Med. Cell Longev. 2019, DOI: 10.1155/2019/6173685</label>
          <listPosition>490</listPosition>
          <doi>10.1155/2019/6173685</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916934</mtid>
          <link>/api/reference/45916934</link>
          <label>491. Daiber 2021: Discovery of new therapeutic redox targets for cardioprotection against ischemia/reperfusion injury and heart failure., Free Radic. Biol. Med., 163, p. 325, DOI: 10.1016/j.freeradbiomed.2020.12.026</label>
          <listPosition>491</listPosition>
          <doi>10.1016/j.freeradbiomed.2020.12.026</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916935</mtid>
          <link>/api/reference/45916935</link>
          <label>492. Corvino 2021: Trends in H(2)S-donors chemistry and their effects in cardiovascular diseases., Antioxidants (Basel), 10, p. 429, DOI: 10.3390/antiox10030429</label>
          <listPosition>492</listPosition>
          <doi>10.3390/antiox10030429</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916936</mtid>
          <link>/api/reference/45916936</link>
          <label>493. Lecour 2021: IMproving preclinical assessment of cardioprotective therapies (IMPACT) criteria: guidelines of the EU-CARDIOPROTECTION COST action., Basic Res. Cardiol., 116, p. 52, DOI: 10.1007/s00395-021-00893-5</label>
          <listPosition>493</listPosition>
          <doi>10.1007/s00395-021-00893-5</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916937</mtid>
          <link>/api/reference/45916937</link>
          <label>494. Osipov 2009: Effect of hydrogen sulfide in a porcine model of myocardial ischemia-reperfusion: comparison of different administration regimens and characterization of the cellular mechanisms of protection., J. Cardiovasc. Pharmacol., 54, p. 287, DOI: 10.1097/FJC.0b013e3181b2b72b</label>
          <listPosition>494</listPosition>
          <doi>10.1097/FJC.0b013e3181b2b72b</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916938</mtid>
          <link>/api/reference/45916938</link>
          <label>495. Sodha 2009: Hydrogen sulfide therapy attenuates the inflammatory response in a porcine model of myocardial ischemia/reperfusion injury., J. Thorac. Cardiovasc. Surg., 138, p. 977, DOI: 10.1016/j.jtcvs.2008.08.074</label>
          <listPosition>495</listPosition>
          <doi>10.1016/j.jtcvs.2008.08.074</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916939</mtid>
          <link>/api/reference/45916939</link>
          <label>496. Donnarumma 2016: Zofenopril protects against myocardial ischemia-reperfusion injury by increasing nitric oxide and hydrogen sulfide bioavailability., J. Am. Heart Assoc., 5, DOI: 10.1161/JAHA.116.003531</label>
          <listPosition>496</listPosition>
          <doi>10.1161/JAHA.116.003531</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916940</mtid>
          <link>/api/reference/45916940</link>
          <label>497. Kar 2019: Hydrogen sulfide-mediated regulation of cell death signaling ameliorates adverse cardiac remodeling and diabetic cardiomyopathy., Am. J. Physiol. Heart Circ. Physiol., 316, p. H1237, DOI: 10.1152/ajpheart.00004.2019</label>
          <listPosition>497</listPosition>
          <doi>10.1152/ajpheart.00004.2019</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916941</mtid>
          <link>/api/reference/45916941</link>
          <label>498. Ansari 2020: Mechanism of hydrogen sulfide preconditioning-associated protection against ischemia-reperfusion injury differs in diabetic heart that develops myopathy., Cardiovasc. Toxicol., 20, p. 155, DOI: 10.1007/s12012-019-09542-9</label>
          <listPosition>498</listPosition>
          <doi>10.1007/s12012-019-09542-9</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916942</mtid>
          <link>/api/reference/45916942</link>
          <label>499. Ansari 2019: Hydrogen sulfide preconditioning could ameliorate reperfusion associated injury in diabetic cardiomyopathy rat heart through preservation of mitochondria., Biochimie, 158, p. 208, DOI: 10.1016/j.biochi.2019.01.011</label>
          <listPosition>499</listPosition>
          <doi>10.1016/j.biochi.2019.01.011</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916943</mtid>
          <link>/api/reference/45916943</link>
          <label>500. Ansari 2022: Hydrogen sulfide postconditioning rendered cardioprotection against myocardial ischemia-reperfusion injury is compromised in rats with diabetic cardiomyopathy., Microvasc. Res., 141, DOI: 10.1016/j.mvr.2022.104322</label>
          <listPosition>500</listPosition>
          <doi>10.1016/j.mvr.2022.104322</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916944</mtid>
          <link>/api/reference/45916944</link>
          <label>501. Kar 2019: Exercise training promotes cardiac hydrogen sulfide biosynthesis and mitigates pyroptosis to prevent high-fat diet-induced diabetic cardiomyopathy., Antioxidants (Basel), 8, p. 638, DOI: 10.3390/antiox8120638</label>
          <listPosition>501</listPosition>
          <doi>10.3390/antiox8120638</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916945</mtid>
          <link>/api/reference/45916945</link>
          <label>502. Chen 2016: Involvement of exogenous H2S in recovery of cardioprotection from ischemic post-conditioning via increase of autophagy in the aged hearts., Int. J. Cardiol., 220, p. 681, DOI: 10.1016/j.ijcard.2016.06.200</label>
          <listPosition>502</listPosition>
          <doi>10.1016/j.ijcard.2016.06.200</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916946</mtid>
          <link>/api/reference/45916946</link>
          <label>503. Zhang 2019: H(2)S restores the cardioprotective effects of ischemic post-conditioning by upregulating HB-EGF/EGFR signaling., Aging (Albany NY), 11, p. 1745, DOI: 10.18632/aging.101866</label>
          <listPosition>503</listPosition>
          <doi>10.18632/aging.101866</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916947</mtid>
          <link>/api/reference/45916947</link>
          <label>504. Polhemus 2015: A novel hydrogen sulfide prodrug, SG1002, promotes hydrogen sulfide and nitric oxide bioavailability in heart failure patients., Cardiovasc. Ther., 33, p. 216, DOI: 10.1111/1755-5922.12128</label>
          <listPosition>504</listPosition>
          <doi>10.1111/1755-5922.12128</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916948</mtid>
          <link>/api/reference/45916948</link>
          <label>505. Zhang 2018: Hydrogen sulfide (H(2)S)-releasing compounds: therapeutic potential in cardiovascular diseases., Front. Pharmacol., 9, p. 1066, DOI: 10.3389/fphar.2018.01066</label>
          <listPosition>505</listPosition>
          <doi>10.3389/fphar.2018.01066</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916949</mtid>
          <link>/api/reference/45916949</link>
          <label>506. M.-S. L. Y. de Koning, P. van Dorp, S. Assa, G. Pundziute-Do Prado, M. Voskuil, R. L. Anthonio, et al., Sodium thiosulfate in acute myocardial infarction: A Randomized Clinical Trial, J. Am. Coll. Cardiol. Basic Trans. Sci. https://doi.org/10.1016/j.jacbts.2023.06.001., DOI: 10.1016/j.jacbts.2023.06.001</label>
          <listPosition>506</listPosition>
          <doi>10.1016/j.jacbts.2023.06.001</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916950</mtid>
          <link>/api/reference/45916950</link>
          <label>507. Lassegue 2012: Biochemistry, physiology, and pathophysiology of NADPH oxidases in the cardiovascular system., Circ. Res., 110, p. 1364, DOI: 10.1161/CIRCRESAHA.111.243972</label>
          <listPosition>507</listPosition>
          <doi>10.1161/CIRCRESAHA.111.243972</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916951</mtid>
          <link>/api/reference/45916951</link>
          <label>508. Schröder 2019: NADPH oxidase-derived reactive oxygen species: dosis facit venenum., Exp. Physiol., 104, p. 447, DOI: 10.1113/EP087125</label>
          <listPosition>508</listPosition>
          <doi>10.1113/EP087125</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916952</mtid>
          <link>/api/reference/45916952</link>
          <label>509. Cipriano 2023: NADPH oxidases: from molecular mechanisms to current inhibitors., J. Med. Chem., DOI: 10.1021/acs.jmedchem.3c00770</label>
          <listPosition>509</listPosition>
          <doi>10.1021/acs.jmedchem.3c00770</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916953</mtid>
          <link>/api/reference/45916953</link>
          <label>510. Dinauer 1987: The glycoprotein encoded by the X-linked chronic granulomatous disease locus is a component of the neutrophil cytochrome b complex., Nature, 327, p. 717, DOI: 10.1038/327717a0</label>
          <listPosition>510</listPosition>
          <doi>10.1038/327717a0</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916954</mtid>
          <link>/api/reference/45916954</link>
          <label>511. Trevelin 2020: Beyond bacterial killing: NADPH oxidase 2 is an immunomodulator., Immunol. Lett., 221, p. 39, DOI: 10.1016/j.imlet.2020.02.009</label>
          <listPosition>511</listPosition>
          <doi>10.1016/j.imlet.2020.02.009</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916955</mtid>
          <link>/api/reference/45916955</link>
          <label>512. Mortimer 2021: Beyond the extra respiration of phagocytosis: NADPH oxidase 2 in adaptive immunity and inflammation., Front. Immunol., 12, DOI: 10.3389/fimmu.2021.733918</label>
          <listPosition>512</listPosition>
          <doi>10.3389/fimmu.2021.733918</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916956</mtid>
          <link>/api/reference/45916956</link>
          <label>513. Visnagri 2023: Nicotinamide adenosine dinucleotidephosphate oxidase-mediated signaling in cardiac remodeling., Antioxidants Redox Signal., 38, p. 371</label>
          <listPosition>513</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916957</mtid>
          <link>/api/reference/45916957</link>
          <label>514. Takac 2011: The E-loop is involved in hydrogen peroxide formation by the NADPH oxidase Nox4., J. Biol. Chem., 286, p. 13304, DOI: 10.1074/jbc.M110.192138</label>
          <listPosition>514</listPosition>
          <doi>10.1074/jbc.M110.192138</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916958</mtid>
          <link>/api/reference/45916958</link>
          <label>515. Santos 2016: Targeted redox inhibition of protein phosphatase 1 by Nox4 regulates eIF2alpha-mediated stress signaling., EMBO J., 35, p. 319, DOI: 10.15252/embj.201592394</label>
          <listPosition>515</listPosition>
          <doi>10.15252/embj.201592394</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916959</mtid>
          <link>/api/reference/45916959</link>
          <label>516. Nabeebaccus 2023: The regulation of cardiac intermediary metabolism by NADPH oxidases., Cardiovasc. Res., 118, p. 3305, DOI: 10.1093/cvr/cvac030</label>
          <listPosition>516</listPosition>
          <doi>10.1093/cvr/cvac030</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916960</mtid>
          <link>/api/reference/45916960</link>
          <label>517. Prosser 2011: X-ROS signaling: rapid mechano-chemo transduction in heart., Science, 333, p. 1440, DOI: 10.1126/science.1202768</label>
          <listPosition>517</listPosition>
          <doi>10.1126/science.1202768</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916961</mtid>
          <link>/api/reference/45916961</link>
          <label>518. Zhang 2015: Contractile function during angiotensin-II activation: increased Nox2 activity modulates cardiac calcium handling via phospholamban phosphorylation., J. Am. Coll. Cardiol., 66, p. 261, DOI: 10.1016/j.jacc.2015.05.020</label>
          <listPosition>518</listPosition>
          <doi>10.1016/j.jacc.2015.05.020</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916962</mtid>
          <link>/api/reference/45916962</link>
          <label>519. Bell 2005: Pivotal role of NOX-2-containing NADPH oxidase in early ischemic preconditoning., Faseb. J., 19, p. 2037, DOI: 10.1096/fj.04-2774fje</label>
          <listPosition>519</listPosition>
          <doi>10.1096/fj.04-2774fje</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916963</mtid>
          <link>/api/reference/45916963</link>
          <label>520. Ma 2009: Antitumorigenesis of antioxidants in a transgenic Rac1 model of Kaposi's sarcoma., Proc. Natl. Acad. Sci. U.S.A., 106, p. 8683, DOI: 10.1073/pnas.0812688106</label>
          <listPosition>520</listPosition>
          <doi>10.1073/pnas.0812688106</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916964</mtid>
          <link>/api/reference/45916964</link>
          <label>521. Zhang 2010: NADPH oxidase-4 mediates protection against chronic load-induced stress in mouse hearts by enhancing angiogenesis., Proc. Natl. Acad. Sci. U.S.A., 107, p. 18121, DOI: 10.1073/pnas.1009700107</label>
          <listPosition>521</listPosition>
          <doi>10.1073/pnas.1009700107</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916965</mtid>
          <link>/api/reference/45916965</link>
          <label>522. Kuroda 2010: NADPH oxidase 4 (Nox4) is a major source of oxidative stress in the failing heart., Proc. Natl. Acad. Sci. U.S.A., 107, p. 15565, DOI: 10.1073/pnas.1002178107</label>
          <listPosition>522</listPosition>
          <doi>10.1073/pnas.1002178107</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916966</mtid>
          <link>/api/reference/45916966</link>
          <label>523. Sciarretta 2013: Circ. Res., 113, p. 1253, DOI: 10.1161/CIRCRESAHA.113.301787</label>
          <listPosition>523</listPosition>
          <doi>10.1161/CIRCRESAHA.113.301787</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916967</mtid>
          <link>/api/reference/45916967</link>
          <label>524. Hecker 2014: Reversal of persistent fibrosis in aging by targeting Nox4-Nrf2 redox imbalance., Sci. Transl. Med., 6, DOI: 10.1126/scitranslmed.3008182</label>
          <listPosition>524</listPosition>
          <doi>10.1126/scitranslmed.3008182</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916968</mtid>
          <link>/api/reference/45916968</link>
          <label>525. Zhang 2018: Both cardiomyocyte and endothelial cell Nox4 mediate protection against hemodynamic overload-induced remodelling., Cardiovasc. Res., 114, p. 401, DOI: 10.1093/cvr/cvx204</label>
          <listPosition>525</listPosition>
          <doi>10.1093/cvr/cvx204</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916969</mtid>
          <link>/api/reference/45916969</link>
          <label>526. Smyrnias 2015: Nicotinamide adenine dinucleotide phosphate oxidase-4-dependent upregulation of nuclear factor erythroid-derived 2-like 2 protects the heart during chronic pressure overload., Hypertension, 65, p. 547, DOI: 10.1161/HYPERTENSIONAHA.114.04208</label>
          <listPosition>526</listPosition>
          <doi>10.1161/HYPERTENSIONAHA.114.04208</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916970</mtid>
          <link>/api/reference/45916970</link>
          <label>527. Hancock 2018: Myocardial NADPH oxidase-4 regulates the physiological response to acute exercise., Elife, 7, DOI: 10.7554/eLife.41044</label>
          <listPosition>527</listPosition>
          <doi>10.7554/eLife.41044</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916971</mtid>
          <link>/api/reference/45916971</link>
          <label>528. Pakos-Zebrucka 2016: The integrated stress response., EMBO Rep., 17, p. 1374, DOI: 10.15252/embr.201642195</label>
          <listPosition>528</listPosition>
          <doi>10.15252/embr.201642195</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916972</mtid>
          <link>/api/reference/45916972</link>
          <label>529. Nabeebaccus 2017: Nox4 reprograms cardiac substrate metabolism via protein O-GlcNAcylation to enhance stress adaptation., JCI Insight, 2, DOI: 10.1172/jci.insight.96184</label>
          <listPosition>529</listPosition>
          <doi>10.1172/jci.insight.96184</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916973</mtid>
          <link>/api/reference/45916973</link>
          <label>530. Marchi 2018: Mitochondrial and endoplasmic reticulum calcium homeostasis and cell death., Cell Calcium, 69, p. 62, DOI: 10.1016/j.ceca.2017.05.003</label>
          <listPosition>530</listPosition>
          <doi>10.1016/j.ceca.2017.05.003</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916974</mtid>
          <link>/api/reference/45916974</link>
          <label>531. Beretta 2020: Nox4 regulates InsP(3) receptor-dependent Ca(2+) release into mitochondria to promote cell survival., EMBO J., 39, DOI: 10.15252/embj.2019103530</label>
          <listPosition>531</listPosition>
          <doi>10.15252/embj.2019103530</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916975</mtid>
          <link>/api/reference/45916975</link>
          <label>532. Daiber 2010: Redox signaling (cross-talk) from and to mitochondria involves mitochondrial pores and reactive oxygen species., Biochim. Biophys. Acta, 1797, p. 897, DOI: 10.1016/j.bbabio.2010.01.032</label>
          <listPosition>532</listPosition>
          <doi>10.1016/j.bbabio.2010.01.032</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916976</mtid>
          <link>/api/reference/45916976</link>
          <label>533. Kimura 2005: Mitochondria-derived reactive oxygen species and vascular MAP kinases. Comparison of angiotensin II and diazoxide., Hypertension, 45, p. 438, DOI: 10.1161/01.HYP.0000157169.27818.ae</label>
          <listPosition>533</listPosition>
          <doi>10.1161/01.HYP.0000157169.27818.ae</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916977</mtid>
          <link>/api/reference/45916977</link>
          <label>534. Brandes 2005: Triggering mitochondrial radical release. A new function for NADPH oxidases., Hypertension, 45, p. 847, DOI: 10.1161/01.HYP.0000165019.32059.b2</label>
          <listPosition>534</listPosition>
          <doi>10.1161/01.HYP.0000165019.32059.b2</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916978</mtid>
          <link>/api/reference/45916978</link>
          <label>535. Schulz 2014: Mitochondrial redox signaling: interaction of mitochondrial reactive oxygen species with other sources of oxidative stress., Antioxidants Redox Signal., 20, p. 308, DOI: 10.1089/ars.2012.4609</label>
          <listPosition>535</listPosition>
          <doi>10.1089/ars.2012.4609</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916979</mtid>
          <link>/api/reference/45916979</link>
          <label>536. Doughan 2008: Molecular mechanisms of angiotensin II-mediated mitochondrial dysfunction: linking mitochondrial oxidative damage and vascular endothelial dysfunction., Circ. Res., 102, p. 488, DOI: 10.1161/CIRCRESAHA.107.162800</label>
          <listPosition>536</listPosition>
          <doi>10.1161/CIRCRESAHA.107.162800</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916980</mtid>
          <link>/api/reference/45916980</link>
          <label>537. Dikalova 2010: Therapeutic targeting of mitochondrial superoxide in hypertension., Circ. Res., 107, p. 106, DOI: 10.1161/CIRCRESAHA.109.214601</label>
          <listPosition>537</listPosition>
          <doi>10.1161/CIRCRESAHA.109.214601</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916981</mtid>
          <link>/api/reference/45916981</link>
          <label>538. Wenzel 2008: First evidence for a crosstalk between mitochondrial and NADPH oxidase-derived reactive oxygen species in nitroglycerin-triggered vascular dysfunction., Antioxidants Redox Signal., 10, p. 1435, DOI: 10.1089/ars.2007.1969</label>
          <listPosition>538</listPosition>
          <doi>10.1089/ars.2007.1969</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916982</mtid>
          <link>/api/reference/45916982</link>
          <label>539. Wenzel 2008: Manganese superoxide dismutase and aldehyde dehydrogenase deficiency increase mitochondrial oxidative stress and aggravate age-dependent vascular dysfunction., Cardiovasc. Res., 80, p. 280, DOI: 10.1093/cvr/cvn182</label>
          <listPosition>539</listPosition>
          <doi>10.1093/cvr/cvn182</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916983</mtid>
          <link>/api/reference/45916983</link>
          <label>540. Oelze 2014: Glutathione peroxidase-1 deficiency potentiates dysregulatory modifications of endothelial nitric oxide synthase and vascular dysfunction in aging., Hypertension, 63, p. 390, DOI: 10.1161/HYPERTENSIONAHA.113.01602</label>
          <listPosition>540</listPosition>
          <doi>10.1161/HYPERTENSIONAHA.113.01602</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916984</mtid>
          <link>/api/reference/45916984</link>
          <label>541. Itani 2016: Mitochondrial cyclophilin D in vascular oxidative stress and hypertension., Hypertension, 67, p. 1218, DOI: 10.1161/HYPERTENSIONAHA.115.07085</label>
          <listPosition>541</listPosition>
          <doi>10.1161/HYPERTENSIONAHA.115.07085</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916985</mtid>
          <link>/api/reference/45916985</link>
          <label>542. Nguyen 2011: Cysteine 203 of cyclophilin d is critical for cyclophilin d activation of the mitochondrial permeability transition pore., J. Biol. Chem., 286, p. 40184, DOI: 10.1074/jbc.M111.243469</label>
          <listPosition>542</listPosition>
          <doi>10.1074/jbc.M111.243469</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916986</mtid>
          <link>/api/reference/45916986</link>
          <label>543. Bibli 2019: Nitroglycerine limits infarct size through S-nitrosation of cyclophilin D: a novel mechanism for an old drug., Cardiovasc. Res., 115, p. 625, DOI: 10.1093/cvr/cvy222</label>
          <listPosition>543</listPosition>
          <doi>10.1093/cvr/cvy222</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916987</mtid>
          <link>/api/reference/45916987</link>
          <label>544. Archer 2008: Mitochondrial metabolism, redox signaling, and fusion: a mitochondria-ROS-HIF-1{alpha}-Kv1.5 O2-sensing pathway at the intersection of pulmonary hypertension and cancer., Am. J. Physiol. Heart Circ. Physiol., 294, p. H570, DOI: 10.1152/ajpheart.01324.2007</label>
          <listPosition>544</listPosition>
          <doi>10.1152/ajpheart.01324.2007</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916988</mtid>
          <link>/api/reference/45916988</link>
          <label>545. Giordano 2005: Oxygen, oxidative stress, hypoxia, and heart failure., J. Clin. Invest., 115, p. 500, DOI: 10.1172/JCI200524408</label>
          <listPosition>545</listPosition>
          <doi>10.1172/JCI200524408</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916989</mtid>
          <link>/api/reference/45916989</link>
          <label>546. Powell 2003: Mitochondrial complex I, aconitase, and succinate dehydrogenase during hypoxia-reoxygenation: modulation of enzyme activities by MnSOD., Am. J. Physiol. Lung Cell Mol. Physiol., 285, p. L189, DOI: 10.1152/ajplung.00253.2002</label>
          <listPosition>546</listPosition>
          <doi>10.1152/ajplung.00253.2002</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916990</mtid>
          <link>/api/reference/45916990</link>
          <label>547. Rathore 2008: Hypoxia activates NADPH oxidase to increase [ROS]i and [Ca2+]i through the mitochondrial ROS-PKCepsilon signaling axis in pulmonary artery smooth muscle cells., Free Radic. Biol. Med., 45, p. 1223, DOI: 10.1016/j.freeradbiomed.2008.06.012</label>
          <listPosition>547</listPosition>
          <doi>10.1016/j.freeradbiomed.2008.06.012</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916991</mtid>
          <link>/api/reference/45916991</link>
          <label>548. Granger 2015: Reperfusion injury and reactive oxygen species: the evolution of a concept., Redox Biol., 6, p. 524, DOI: 10.1016/j.redox.2015.08.020</label>
          <listPosition>548</listPosition>
          <doi>10.1016/j.redox.2015.08.020</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916992</mtid>
          <link>/api/reference/45916992</link>
          <label>549. da Silva 2015: Attenuation of Ca2+ homeostasis, oxidative stress, and mitochondrial dysfunctions in diabetic rat heart: insulin therapy or aerobic exercise?., J. Appl. Physiol. (1985), 119, p. 148, DOI: 10.1152/japplphysiol.00915.2014</label>
          <listPosition>549</listPosition>
          <doi>10.1152/japplphysiol.00915.2014</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916993</mtid>
          <link>/api/reference/45916993</link>
          <label>550. Hempel 2017: Crosstalk between calcium and reactive oxygen species signaling in cancer., Cell Calcium, 63, p. 70, DOI: 10.1016/j.ceca.2017.01.007</label>
          <listPosition>550</listPosition>
          <doi>10.1016/j.ceca.2017.01.007</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916994</mtid>
          <link>/api/reference/45916994</link>
          <label>551. Gorlach 2015: Calcium and ROS: a mutual interplay., Redox Biol., 6, p. 260, DOI: 10.1016/j.redox.2015.08.010</label>
          <listPosition>551</listPosition>
          <doi>10.1016/j.redox.2015.08.010</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916995</mtid>
          <link>/api/reference/45916995</link>
          <label>552. Sluijter 2018: Extracellular vesicles in diagnostics and therapy of the ischaemic heart: position paper from the working group on cellular biology of the heart of the European society of cardiology., Cardiovasc. Res., 114, p. 19, DOI: 10.1093/cvr/cvx211</label>
          <listPosition>552</listPosition>
          <doi>10.1093/cvr/cvx211</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916996</mtid>
          <link>/api/reference/45916996</link>
          <label>553. Davidson 2018: Exosomes and cardioprotection - a critical analysis., Mol. Aspect. Med., 60, p. 104, DOI: 10.1016/j.mam.2017.11.004</label>
          <listPosition>553</listPosition>
          <doi>10.1016/j.mam.2017.11.004</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916997</mtid>
          <link>/api/reference/45916997</link>
          <label>554. Lisi 2023: Plasma-derived extracellular vesicles released after endurance exercise exert cardioprotective activity through the activation of antioxidant pathways., Redox Biol., 63, DOI: 10.1016/j.redox.2023.102737</label>
          <listPosition>554</listPosition>
          <doi>10.1016/j.redox.2023.102737</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916998</mtid>
          <link>/api/reference/45916998</link>
          <label>555. Bitirim 2022: Cardioprotective effect of extracellular vesicles derived from ticagrelor-pretreated cardiomyocyte on hyperglycemic cardiomyocytes through alleviation of oxidative and endoplasmic reticulum stress., Sci. Rep., 12, p. 5651, DOI: 10.1038/s41598-022-09627-6</label>
          <listPosition>555</listPosition>
          <doi>10.1038/s41598-022-09627-6</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45916999</mtid>
          <link>/api/reference/45916999</link>
          <label>556. Andreadou 2021: Influence of cardiometabolic comorbidities on myocardial function, infarction, and cardioprotection: role of cardiac redox signaling., Free Radic. Biol. Med., 166, p. 33, DOI: 10.1016/j.freeradbiomed.2021.02.012</label>
          <listPosition>556</listPosition>
          <doi>10.1016/j.freeradbiomed.2021.02.012</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45917000</mtid>
          <link>/api/reference/45917000</link>
          <label>557. Wider 2018: Remote ischemic preconditioning fails to reduce infarct size in the Zucker fatty rat model of type-2 diabetes: role of defective humoral communication., Basic Res. Cardiol., 113, p. 16, DOI: 10.1007/s00395-018-0674-1</label>
          <listPosition>557</listPosition>
          <doi>10.1007/s00395-018-0674-1</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45917001</mtid>
          <link>/api/reference/45917001</link>
          <label>558. Davidson 2017: Cardioprotection mediated by exosomes is impaired in the setting of type II diabetes but can be rescued by the use of non-diabetic exosomes in vitro., J. Cell Mol. Med., 22, p. 141, DOI: 10.1111/jcmm.13302</label>
          <listPosition>558</listPosition>
          <doi>10.1111/jcmm.13302</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45917002</mtid>
          <link>/api/reference/45917002</link>
          <label>559. Gambim 2007: Platelet-derived exosomes induce endothelial cell apoptosis through peroxynitrite generation: experimental evidence for a novel mechanism of septic vascular dysfunction., Crit. Care, 11, p. R107, DOI: 10.1186/cc6133</label>
          <listPosition>559</listPosition>
          <doi>10.1186/cc6133</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45917003</mtid>
          <link>/api/reference/45917003</link>
          <label>560. Azevedo 2007: Platelet-derived exosomes from septic shock patients induce myocardial dysfunction., Crit. Care, 11, p. R120, DOI: 10.1186/cc6176</label>
          <listPosition>560</listPosition>
          <doi>10.1186/cc6176</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45917004</mtid>
          <link>/api/reference/45917004</link>
          <label>561. Crewe 2021: Extracellular vesicle-based interorgan transport of mitochondria from energetically stressed adipocytes., Cell Metabol., 33, p. 1853, DOI: 10.1016/j.cmet.2021.08.002</label>
          <listPosition>561</listPosition>
          <doi>10.1016/j.cmet.2021.08.002</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45917005</mtid>
          <link>/api/reference/45917005</link>
          <label>562. Lai 2010: Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury., Stem Cell Res., 4, p. 214, DOI: 10.1016/j.scr.2009.12.003</label>
          <listPosition>562</listPosition>
          <doi>10.1016/j.scr.2009.12.003</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45917006</mtid>
          <link>/api/reference/45917006</link>
          <label>563. Wang 2018: Exosomes derived from miR-214-enriched bone marrow-derived mesenchymal stem cells regulate oxidative damage in cardiac stem cells by targeting CaMKII., Oxid. Med. Cell Longev. 2018, DOI: 10.1155/2018/4971261</label>
          <listPosition>563</listPosition>
          <doi>10.1155/2018/4971261</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45917007</mtid>
          <link>/api/reference/45917007</link>
          <label>564. Yadid 2020: Endothelial extracellular vesicles contain protective proteins and rescue ischemia-reperfusion injury in a human heart-on-chip., Sci. Transl. Med., 12, DOI: 10.1126/scitranslmed.aax8005</label>
          <listPosition>564</listPosition>
          <doi>10.1126/scitranslmed.aax8005</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45917008</mtid>
          <link>/api/reference/45917008</link>
          <label>565. Chen 2020: Cardiomyocyte-derived small extracellular vesicles can signal eNOS activation in cardiac microvascular endothelial cells to protect against Ischemia/Reperfusion injury., Theranostics, 10, p. 11754, DOI: 10.7150/thno.43163</label>
          <listPosition>565</listPosition>
          <doi>10.7150/thno.43163</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45917009</mtid>
          <link>/api/reference/45917009</link>
          <label>566. Rolski 2022: T lymphocyte-derived exosomes transport MEK1/2 and ERK1/2 and induce NOX4-dependent oxidative stress in cardiac microvascular endothelial cells., Oxid. Med. Cell. Longev., 2022, DOI: 10.1155/2022/2457687</label>
          <listPosition>566</listPosition>
          <doi>10.1155/2022/2457687</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45917010</mtid>
          <link>/api/reference/45917010</link>
          <label>567. Herrera-Zelada 2023: Endothelial activation impairs the function of small extracellular vesicles., Front. Pharmacol., 14, DOI: 10.3389/fphar.2023.1143888</label>
          <listPosition>567</listPosition>
          <doi>10.3389/fphar.2023.1143888</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45917011</mtid>
          <link>/api/reference/45917011</link>
          <label>568. Makkos 2021: Systematic review and network analysis of microRNAs involved in cardioprotection against myocardial ischemia/reperfusion injury and infarction: involvement of redox signalling., Free Radic. Biol. Med., 172, p. 237, DOI: 10.1016/j.freeradbiomed.2021.04.034</label>
          <listPosition>568</listPosition>
          <doi>10.1016/j.freeradbiomed.2021.04.034</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45917012</mtid>
          <link>/api/reference/45917012</link>
          <label>569. Bergmann 2009: Evidence for cardiomyocyte renewal in humans., Science, 324, p. 98, DOI: 10.1126/science.1164680</label>
          <listPosition>569</listPosition>
          <doi>10.1126/science.1164680</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45917013</mtid>
          <link>/api/reference/45917013</link>
          <label>570. Senyo 2013: Mammalian heart renewal by pre-existing cardiomyocytes., Nature, 493, p. 433, DOI: 10.1038/nature11682</label>
          <listPosition>570</listPosition>
          <doi>10.1038/nature11682</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45917014</mtid>
          <link>/api/reference/45917014</link>
          <label>571. Soonpaa 1997: Assessment of cardiomyocyte DNA synthesis in normal and injured adult mouse hearts., Am. J. Physiol., 272, p. H220</label>
          <listPosition>571</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45917015</mtid>
          <link>/api/reference/45917015</link>
          <label>572. Suzuki 2003: Growth factor signaling for cardioprotection against oxidative stress-induced apoptosis., Antioxidants Redox Signal., 5, p. 741, DOI: 10.1089/152308603770380043</label>
          <listPosition>572</listPosition>
          <doi>10.1089/152308603770380043</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45917016</mtid>
          <link>/api/reference/45917016</link>
          <label>573. Rassaf 2014: Macrophage migration inhibitory factor in myocardial ischaemia/reperfusion injury., Cardiovasc. Res., 102, p. 321, DOI: 10.1093/cvr/cvu071</label>
          <listPosition>573</listPosition>
          <doi>10.1093/cvr/cvu071</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45917017</mtid>
          <link>/api/reference/45917017</link>
          <label>574. Matsushita 2005: Interleukin-6/soluble interleukin-6 receptor complex reduces infarct size via inhibiting myocardial apoptosis., Lab. Invest., 85, p. 1210, DOI: 10.1038/labinvest.3700322</label>
          <listPosition>574</listPosition>
          <doi>10.1038/labinvest.3700322</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45917018</mtid>
          <link>/api/reference/45917018</link>
          <label>575. Smart 2006: IL-6 induces PI 3-kinase and nitric oxide-dependent protection and preserves mitochondrial function in cardiomyocytes., Cardiovasc. Res., 69, p. 164, DOI: 10.1016/j.cardiores.2005.08.017</label>
          <listPosition>575</listPosition>
          <doi>10.1016/j.cardiores.2005.08.017</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45917019</mtid>
          <link>/api/reference/45917019</link>
          <label>576. Wang 2017: Irisin plays a pivotal role to protect the heart against ischemia and reperfusion injury., J. Cell. Physiol., 232, p. 3775, DOI: 10.1002/jcp.25857</label>
          <listPosition>576</listPosition>
          <doi>10.1002/jcp.25857</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45917020</mtid>
          <link>/api/reference/45917020</link>
          <label>577. Wang 2018: Irisin protects heart against ischemia-reperfusion injury through a SOD2-dependent mitochondria mechanism., J. Cardiovasc. Pharmacol., 72, p. 259, DOI: 10.1097/FJC.0000000000000608</label>
          <listPosition>577</listPosition>
          <doi>10.1097/FJC.0000000000000608</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45917021</mtid>
          <link>/api/reference/45917021</link>
          <label>578. Oshima 2008: Follistatin-like 1 is an Akt-regulated cardioprotective factor that is secreted by the heart., Circulation, 117, p. 3099, DOI: 10.1161/CIRCULATIONAHA.108.767673</label>
          <listPosition>578</listPosition>
          <doi>10.1161/CIRCULATIONAHA.108.767673</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45917022</mtid>
          <link>/api/reference/45917022</link>
          <label>579. Ogura 2012: Therapeutic impact of follistatin-like 1 on myocardial ischemic injury in preclinical models., Circulation, 126, p. 1728, DOI: 10.1161/CIRCULATIONAHA.112.115089</label>
          <listPosition>579</listPosition>
          <doi>10.1161/CIRCULATIONAHA.112.115089</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45917023</mtid>
          <link>/api/reference/45917023</link>
          <label>580. Szabo 2020: Modulatory effect of myokines on reactive oxygen species in ischemia/reperfusion., Int. J. Mol. Sci., 21, p. 9382, DOI: 10.3390/ijms21249382</label>
          <listPosition>580</listPosition>
          <doi>10.3390/ijms21249382</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45917024</mtid>
          <link>/api/reference/45917024</link>
          <label>581. Korf-Klingebiel 2015: Myeloid-derived growth factor (C19orf10) mediates cardiac repair following myocardial infarction., Nat. Med., 21, p. 140, DOI: 10.1038/nm.3778</label>
          <listPosition>581</listPosition>
          <doi>10.1038/nm.3778</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45917025</mtid>
          <link>/api/reference/45917025</link>
          <label>582. Bortolotti 2017: In vivo functional selection identifies cardiotrophin-1 as a cardiac engraftment factor for mesenchymal stromal cells., Circulation, 136, p. 1509, DOI: 10.1161/CIRCULATIONAHA.117.029003</label>
          <listPosition>582</listPosition>
          <doi>10.1161/CIRCULATIONAHA.117.029003</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45917026</mtid>
          <link>/api/reference/45917026</link>
          <label>583. Ruozi 2015: AAV-mediated in vivo functional selection of tissue-protective factors against ischaemia., Nat. Commun., 6, p. 7388, DOI: 10.1038/ncomms8388</label>
          <listPosition>583</listPosition>
          <doi>10.1038/ncomms8388</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45917027</mtid>
          <link>/api/reference/45917027</link>
          <label>584. Ruozi 2022: Cardioprotective factors against myocardial infarction selected in vivo from an AAV secretome library., Sci. Transl. Med., 14, DOI: 10.1126/scitranslmed.abo0699</label>
          <listPosition>584</listPosition>
          <doi>10.1126/scitranslmed.abo0699</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45917028</mtid>
          <link>/api/reference/45917028</link>
          <label>585. Nakayama 2001: A novel chordin-like protein inhibitor for bone morphogenetic proteins expressed preferentially in mesenchymal cell lineages., Dev. Biol., 232, p. 372, DOI: 10.1006/dbio.2001.0200</label>
          <listPosition>585</listPosition>
          <doi>10.1006/dbio.2001.0200</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45917029</mtid>
          <link>/api/reference/45917029</link>
          <label>586. Bendre 2017: Fam3c modulates osteogenic differentiation by down-regulating Runx2., Differentiation, 93, p. 50, DOI: 10.1016/j.diff.2016.11.005</label>
          <listPosition>586</listPosition>
          <doi>10.1016/j.diff.2016.11.005</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45917030</mtid>
          <link>/api/reference/45917030</link>
          <label>587. Waerner 2006: ILEI: a cytokine essential for EMT, tumor formation, and late events in metastasis in epithelial cells., Cancer Cell, 10, p. 227, DOI: 10.1016/j.ccr.2006.07.020</label>
          <listPosition>587</listPosition>
          <doi>10.1016/j.ccr.2006.07.020</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45917031</mtid>
          <link>/api/reference/45917031</link>
          <label>588. Chen 2017: Hepatic activation of the FAM3C-HSF1-CaM pathway attenuates hyperglycemia of obese diabetic mice., Diabetes, 66, p. 1185, DOI: 10.2337/db16-0993</label>
          <listPosition>588</listPosition>
          <doi>10.2337/db16-0993</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45917032</mtid>
          <link>/api/reference/45917032</link>
          <label>589. Robert-Cooperman 2010: Targeted disruption of pancreatic-derived factor (PANDER, FAM3B) impairs pancreatic beta-cell function., Diabetes, 59, p. 2209, DOI: 10.2337/db09-1552</label>
          <listPosition>589</listPosition>
          <doi>10.2337/db09-1552</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45917033</mtid>
          <link>/api/reference/45917033</link>
          <label>590. Yang 2005: Mechanisms of glucose-induced secretion of pancreatic-derived factor (PANDER or FAM3B) in pancreatic beta-cells., Diabetes, 54, p. 3217, DOI: 10.2337/diabetes.54.11.3217</label>
          <listPosition>590</listPosition>
          <doi>10.2337/diabetes.54.11.3217</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45917034</mtid>
          <link>/api/reference/45917034</link>
          <label>591. Cao 2003: Pancreatic-derived factor (FAM3B), a novel islet cytokine, induces apoptosis of insulin-secreting beta-cells., Diabetes, 52, p. 2296, DOI: 10.2337/diabetes.52.9.2296</label>
          <listPosition>591</listPosition>
          <doi>10.2337/diabetes.52.9.2296</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45917035</mtid>
          <link>/api/reference/45917035</link>
          <label>592. Lee 1981: Myocardial infarct size and location in relation to the coronary vascular bed at risk in man., Circulation, 64, p. 526, DOI: 10.1161/01.CIR.64.3.526</label>
          <listPosition>592</listPosition>
          <doi>10.1161/01.CIR.64.3.526</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45917036</mtid>
          <link>/api/reference/45917036</link>
          <label>593. Rochitte 2012: The myocardial area at risk., Heart, 98, p. 348, DOI: 10.1136/heartjnl-2011-301332</label>
          <listPosition>593</listPosition>
          <doi>10.1136/heartjnl-2011-301332</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45917037</mtid>
          <link>/api/reference/45917037</link>
          <label>594. Heusch 2015: Is MRI really the gold standard for the quantification of salvage from myocardial infarction?., Circ. Res., 117, p. 222, DOI: 10.1161/CIRCRESAHA.117.306929</label>
          <listPosition>594</listPosition>
          <doi>10.1161/CIRCRESAHA.117.306929</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45917038</mtid>
          <link>/api/reference/45917038</link>
          <label>595. Matsui 2008: Molecular mechanisms and physiological significance of autophagy during myocardial ischemia and reperfusion., Autophagy, 4, p. 409, DOI: 10.4161/auto.5638</label>
          <listPosition>595</listPosition>
          <doi>10.4161/auto.5638</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45917039</mtid>
          <link>/api/reference/45917039</link>
          <label>596. Kirshenbaum 2012: Regulation of autophagy in the heart in health and disease., J. Cardiovasc. Pharmacol., 60, p. 109, DOI: 10.1097/FJC.0b013e31825f6faa</label>
          <listPosition>596</listPosition>
          <doi>10.1097/FJC.0b013e31825f6faa</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45917040</mtid>
          <link>/api/reference/45917040</link>
          <label>597. Chen 2014: Cardiac mitochondria and reactive oxygen species generation., Circ. Res., 114, p. 524, DOI: 10.1161/CIRCRESAHA.114.300559</label>
          <listPosition>597</listPosition>
          <doi>10.1161/CIRCRESAHA.114.300559</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45917041</mtid>
          <link>/api/reference/45917041</link>
          <label>598. Kim 2011: Mitophagy selectively degrades individual damaged mitochondria after photoirradiation., Antioxidants Redox Signal., 14, p. 1919, DOI: 10.1089/ars.2010.3768</label>
          <listPosition>598</listPosition>
          <doi>10.1089/ars.2010.3768</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45917042</mtid>
          <link>/api/reference/45917042</link>
          <label>599. Turkieh 2022: Mitophagy regulation following myocardial infarction., Cells, 11, p. 199, DOI: 10.3390/cells11020199</label>
          <listPosition>599</listPosition>
          <doi>10.3390/cells11020199</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45917043</mtid>
          <link>/api/reference/45917043</link>
          <label>600. Scheffer 2022: Mitochondrial fusion, fission, and mitophagy in cardiac diseases: challenges and therapeutic opportunities., Antioxidants Redox Signal., 36, p. 844, DOI: 10.1089/ars.2021.0145</label>
          <listPosition>600</listPosition>
          <doi>10.1089/ars.2021.0145</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45917044</mtid>
          <link>/api/reference/45917044</link>
          <label>601. Luan 2021: Emerging role of mitophagy in the heart: therapeutic potentials to modulate mitophagy in cardiac diseases., Oxid. Med. Cell. Longev., 2021, DOI: 10.1155/2021/3259963</label>
          <listPosition>601</listPosition>
          <doi>10.1155/2021/3259963</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45917045</mtid>
          <link>/api/reference/45917045</link>
          <label>602. Stubbert 2014: Protein kinase G Ialpha oxidation paradoxically underlies blood pressure lowering by the reductant hydrogen sulfide., Hypertension, 64, p. 1344, DOI: 10.1161/HYPERTENSIONAHA.114.04281</label>
          <listPosition>602</listPosition>
          <doi>10.1161/HYPERTENSIONAHA.114.04281</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45917046</mtid>
          <link>/api/reference/45917046</link>
          <label>603. Prysyazhna 2019: Blood pressure-lowering by the antioxidant resveratrol is counterintuitively mediated by oxidation of cGMP-dependent protein kinase., Circulation, 140, p. 126, DOI: 10.1161/CIRCULATIONAHA.118.037398</label>
          <listPosition>603</listPosition>
          <doi>10.1161/CIRCULATIONAHA.118.037398</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45917047</mtid>
          <link>/api/reference/45917047</link>
          <label>604. Xu 2001: Calcium preconditioning inhibits mitochondrial permeability transition and apooptosis., Am. J. Physiol. Heart Circ. Physiol., 280, p. H899, DOI: 10.1152/ajpheart.2001.280.2.H899</label>
          <listPosition>604</listPosition>
          <doi>10.1152/ajpheart.2001.280.2.H899</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45917048</mtid>
          <link>/api/reference/45917048</link>
          <label>605. Hausenloy 2004: Transient mitochondrial permeability transition pore opening mediates preconditioning-induced protection., Circulation, 109, p. 1714, DOI: 10.1161/01.CIR.0000126294.81407.7D</label>
          <listPosition>605</listPosition>
          <doi>10.1161/01.CIR.0000126294.81407.7D</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45917049</mtid>
          <link>/api/reference/45917049</link>
          <label>606. Song 2014: Super-suppression of mitochondrial reactive oxygen species signaling impairs compensatory autophagy in primary mitophagic cardiomyopathy., Circ. Res., 115, p. 348, DOI: 10.1161/CIRCRESAHA.115.304384</label>
          <listPosition>606</listPosition>
          <doi>10.1161/CIRCRESAHA.115.304384</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>45917050</mtid>
          <link>/api/reference/45917050</link>
          <label>607. Elrod 2010: Cyclophilin D controls mitochondrial pore-dependent Ca2+ exchange, metabolic flexibility, and propensity for heart failure in mice., J. Clin. Invest., 120, p. 3680, DOI: 10.1172/JCI43171</label>
          <listPosition>607</listPosition>
          <doi>10.1172/JCI43171</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
      </references>
      <link>/api/publication/34189818</link>
      <label>Heusch Gerd et al. Health position paper and redox perspectives on reactive oxygen species as signals and targets of cardioprotection. (2023) REDOX BIOLOGY 2213-2317 67</label><template>&lt;div class=&quot;JournalArticle Publication short-list&quot;&gt; &lt;div class=&quot;authors&quot;&gt; &lt;span class=&quot;author-name&quot; &gt; Heusch, Gerd ✉ &lt;/span&gt; &lt;span class=&quot;author-type&quot;&gt; &lt;/span&gt; ; &lt;span class=&quot;author-name&quot; &gt; Andreadou, Ioanna &lt;/span&gt; &lt;span class=&quot;author-type&quot;&gt; &lt;/span&gt; ; &lt;span class=&quot;author-name&quot; &gt; Bell, Robert &lt;/span&gt; &lt;span class=&quot;author-type&quot;&gt; &lt;/span&gt; ; &lt;span class=&quot;author-name&quot; &gt; Bertero, Edoardo &lt;/span&gt; &lt;span class=&quot;author-type&quot;&gt; &lt;/span&gt; ; &lt;span class=&quot;author-name&quot; &gt; Botker, Hans-Erik &lt;/span&gt; &lt;span class=&quot;author-type&quot;&gt; &lt;/span&gt; ; &lt;span class=&quot;author-name&quot; &gt; Davidson, Sean M. &lt;/span&gt; &lt;span class=&quot;author-type&quot;&gt; &lt;/span&gt; ; &lt;span class=&quot;author-name&quot; &gt; Downey, James &lt;/span&gt; &lt;span class=&quot;author-type&quot;&gt; &lt;/span&gt; ; &lt;span class=&quot;author-name&quot; &gt; Eaton, Philip &lt;/span&gt; &lt;span class=&quot;author-type&quot;&gt; &lt;/span&gt; ; &lt;span class=&quot;author-name&quot; mtid=&quot;10010125&quot;&gt; &lt;a href=&quot;/gui2/?type=authors&amp;mode=browse&amp;sel=10010125&quot; target=&quot;_blank&quot;&gt;Ferdinandy, Peter&lt;/a&gt; &lt;/span&gt; &lt;span class=&quot;author-type&quot;&gt; &lt;/span&gt; ; &lt;span class=&quot;author-name&quot; &gt; Gersh, Bernard J. &lt;/span&gt; &lt;span class=&quot;author-type&quot;&gt; &lt;/span&gt; et al. &lt;/div &gt;&lt;div class=&quot;title&quot;&gt;&lt;a href=&quot;/gui2/?mode=browse&amp;params=publication;34189818&quot; mtid=&quot;34189818&quot; target=&quot;_blank&quot;&gt;Health position paper and redox perspectives on reactive oxygen species as signals and targets of cardioprotection&lt;/a&gt;&lt;/div&gt; &lt;div class=&quot;pub-info&quot;&gt; &lt;span class=&quot;journal-title&quot;&gt;REDOX BIOLOGY&lt;/span&gt; &lt;span class=&quot;journal-volume&quot;&gt;67&lt;/span&gt; &lt;span class=&quot;page&quot;&gt; Paper: 102894 , 46 p. &lt;/span&gt; &lt;span class=&quot;year&quot;&gt;(2023)&lt;/span&gt; &lt;/div&gt; &lt;div class=&quot;pub-end&quot;&gt;&lt;div class=&quot;identifier-list&quot;&gt; &lt;span class=&quot;identifiers&quot;&gt; &lt;span class=&quot;id identifier oa_none&quot; title=&quot;none&quot;&gt; &lt;a style=&quot;color:blue&quot; title=&quot;10.1016/j.redox.2023.102894&quot; target=&quot;_blank&quot; href=&quot;https://doi.org/10.1016/j.redox.2023.102894&quot;&gt; DOI &lt;/a&gt; &lt;/span&gt; &lt;span class=&quot;id identifier oa_none&quot; title=&quot;none&quot;&gt; &lt;a style=&quot;color:blue&quot; title=&quot;001093377200001&quot; target=&quot;_blank&quot; href=&quot;https://www.webofscience.com/wos/woscc/full-record/001093377200001&quot;&gt; WoS &lt;/a&gt; &lt;/span&gt; &lt;span class=&quot;id identifier oa_none&quot; title=&quot;none&quot;&gt; &lt;a style=&quot;color:blue&quot; title=&quot;85173716036&quot; target=&quot;_blank&quot; href=&quot;http://www.scopus.com/record/display.url?origin=inward&amp;eid=2-s2.0-85173716036&quot;&gt; Scopus &lt;/a&gt; &lt;/span&gt; &lt;span class=&quot;id identifier oa_none&quot; title=&quot;none&quot;&gt; &lt;a style=&quot;color:blue&quot; title=&quot;37839355&quot; target=&quot;_blank&quot; href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=37839355&amp;dopt=Abstract&quot;&gt; PubMed &lt;/a&gt; &lt;/span&gt; &lt;/span&gt; &lt;/div&gt; &lt;div class=&quot;short-pub-prop-list&quot;&gt; &lt;span class=&quot;short-pub-mtid&quot;&gt; Közlemény:34189818 &lt;/span&gt; &lt;span class=&quot;status-holder&quot;&gt;&lt;span class=&quot;status-data status-VALIDATED&quot;&gt; Egyeztetett &lt;/span&gt;&lt;/span&gt; &lt;span class=&quot;pub-core&quot;&gt;Forrás Idéző &lt;/span&gt; &lt;span class=&quot;pub-type&quot;&gt;Folyóiratcikk (Összefoglaló cikk ) &lt;/span&gt; &lt;!-- &amp;&amp; !record.category.scientific --&gt; &lt;span class=&quot;pub-category&quot;&gt;Tudományos&lt;/span&gt; &lt;div class=&quot;publication-citation&quot; style=&quot;margin-left: 0.5cm;&quot;&gt; &lt;span title=&quot;Nyilvános idézőközlemények összesen, említések nélkül&quot; class=&quot;citingPub-count&quot;&gt;Nyilvános idéző összesen: 117&lt;/span&gt; | Független: 89 | Függő: 28 | Nem jelölt: 0 | WoS jelölt: 111 | Scopus jelölt:&amp;nbsp;111 | WoS/Scopus jelölt:&amp;nbsp;117 | DOI jelölt:&amp;nbsp;117 &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt;</template><template2>&lt;div class=&quot;JournalArticle Publication long-list&quot;&gt;
&lt;div class=&quot;authors&quot;&gt;
	&lt;img title=&quot;Forrásközlemény&quot; style=&quot;float: left&quot; src=&quot;/frontend/resources/grid/publication-core-icon.png&quot;&gt;
	&lt;img title=&quot;Idézőközlemény&quot; style=&quot;float: left&quot; src=&quot;/frontend/resources/grid/publication-citation-icon.png&quot;&gt;

		&lt;div class=&quot;autype autype0&quot;&gt;				&lt;span class=&quot;author-name&quot; &gt;Heusch Gerd ✉
    &lt;/span&gt;
;&amp;nbsp;&amp;nbsp;&amp;nbsp;
							&lt;span class=&quot;author-name&quot; &gt;Andreadou Ioanna
    &lt;/span&gt;
;&amp;nbsp;&amp;nbsp;&amp;nbsp;
							&lt;span class=&quot;author-name&quot; &gt;Bell Robert
    &lt;/span&gt;
;&amp;nbsp;&amp;nbsp;&amp;nbsp;
							&lt;span class=&quot;author-name&quot; &gt;Bertero Edoardo
    &lt;/span&gt;
;&amp;nbsp;&amp;nbsp;&amp;nbsp;
							&lt;span class=&quot;author-name&quot; &gt;Botker Hans-Erik
    &lt;/span&gt;
;&amp;nbsp;&amp;nbsp;&amp;nbsp;
							&lt;span class=&quot;author-name&quot; &gt;Davidson Sean M.
    &lt;/span&gt;
;&amp;nbsp;&amp;nbsp;&amp;nbsp;
							&lt;span class=&quot;author-name&quot; &gt;Downey James
    &lt;/span&gt;
;&amp;nbsp;&amp;nbsp;&amp;nbsp;
							&lt;span class=&quot;author-name&quot; &gt;Eaton Philip
    &lt;/span&gt;
;&amp;nbsp;&amp;nbsp;&amp;nbsp;
							&lt;span class=&quot;author-name&quot; mtid=&quot;10010125&quot;&gt;&lt;a 
																				   href=&quot;/gui2/?type=authors&amp;mode=browse&amp;sel=10010125&quot; target=&quot;_blank&quot;&gt;Ferdinandy Peter
            (&lt;span class=&quot;authorship-author-name&quot;&gt;Ferdinandy Péter&lt;/span&gt;
            &lt;span class=&quot;authorAux-mtmt&quot;&gt; Farmakológia, molekuláris medicina&lt;/span&gt;)
			&lt;/a&gt;
    &lt;/span&gt;
&lt;span class=&quot;author-affil&quot;&gt;&lt;span title=&quot;Semmelweis Egyetem&quot;&gt;SE&lt;/span&gt;/&lt;span title=&quot;Általános Orvostudományi Kar&quot;&gt;AOK&lt;/span&gt;/&lt;span title=&quot;Intézet&quot;&gt;I&lt;/span&gt;/Farmakológiai és Farmakoterápiás Intézet&lt;/span&gt;
;&amp;nbsp;&amp;nbsp;&amp;nbsp;
							&lt;span class=&quot;author-name&quot; &gt;Gersh Bernard J.
    &lt;/span&gt;
;&amp;nbsp;&amp;nbsp;&amp;nbsp;
							&lt;span class=&quot;author-name&quot; &gt;Giacca Mauro
    &lt;/span&gt;
;&amp;nbsp;&amp;nbsp;&amp;nbsp;
							&lt;span class=&quot;author-name&quot; &gt;Hausenloy Derek J.
    &lt;/span&gt;
;&amp;nbsp;&amp;nbsp;&amp;nbsp;
							&lt;span class=&quot;author-name&quot; &gt;Ibanez Borja
    &lt;/span&gt;
;&amp;nbsp;&amp;nbsp;&amp;nbsp;
							&lt;span class=&quot;author-name&quot; &gt;Krieg Thomas
    &lt;/span&gt;
;&amp;nbsp;&amp;nbsp;&amp;nbsp;
							&lt;span class=&quot;author-name&quot; &gt;Maack Christoph
    &lt;/span&gt;
;&amp;nbsp;&amp;nbsp;&amp;nbsp;
							&lt;span class=&quot;author-name&quot; &gt;Schulz Rainer
    &lt;/span&gt;
;&amp;nbsp;&amp;nbsp;&amp;nbsp;
							&lt;span class=&quot;author-name&quot; &gt;Sellke Frank
    &lt;/span&gt;
;&amp;nbsp;&amp;nbsp;&amp;nbsp;
							&lt;span class=&quot;author-name&quot; &gt;Shah Ajay M.
    &lt;/span&gt;
;&amp;nbsp;&amp;nbsp;&amp;nbsp;
							&lt;span class=&quot;author-name&quot; &gt;Thiele Holger
    &lt;/span&gt;
;&amp;nbsp;&amp;nbsp;&amp;nbsp;
							&lt;span class=&quot;author-name&quot; &gt;Yellon Derek M.
    &lt;/span&gt;
;&amp;nbsp;&amp;nbsp;&amp;nbsp;
							&lt;span class=&quot;author-name&quot; &gt;Di Lisa Fabio ✉
    &lt;/span&gt;

				    &lt;/div&gt;
&lt;/div&gt;
&lt;div class=&quot;title&quot;&gt;&lt;a href=&quot;/gui2/?mode=browse&amp;params=publication;34189818&quot; target=&quot;_blank&quot;&gt;Health position paper and redox perspectives on reactive oxygen species as signals and targets of cardioprotection&lt;/a&gt;&lt;/div&gt;    &lt;div&gt;		&lt;span class=&quot;journal-title&quot;&gt;REDOX BIOLOGY&lt;/span&gt;

        &lt;span class=&quot;journal-issn&quot;&gt;( &lt;a target=&quot;_blank&quot; href=&quot;https://portal.issn.org/resource/ISSN/2213-2317&quot;&gt;2213-2317&lt;/a&gt;)&lt;/span&gt;:
		&lt;span class=&quot;journal-volume&quot;&gt;67&lt;/span&gt; 
&lt;span class=&quot;page&quot;&gt;
		Paper 102894.
	 46 p. 
&lt;/span&gt;		 &lt;span class=&quot;year&quot;&gt;(2023)&lt;/span&gt;  
    &lt;/div&gt;
&lt;div class=&quot;pub-footer&quot;&gt;
    

	&lt;span class=&quot;language&quot; xmlns=&quot;http://www.w3.org/1999/html&quot;&gt;Nyelv:
			Angol
		 |  &lt;/span&gt;

	&lt;span class=&quot;identifiers&quot;&gt;
						&lt;span class=&quot;id identifier oa_none&quot; title=&quot;none&quot;&gt;
							
							&lt;a style=&quot;color:blue&quot; title=&quot;10.1016/j.redox.2023.102894&quot; target=&quot;_blank&quot; href=&quot;https://doi.org/10.1016/j.redox.2023.102894&quot;&gt;
									DOI
							&lt;/a&gt;
						&lt;/span&gt;
						&lt;span class=&quot;id identifier oa_none&quot; title=&quot;none&quot;&gt;
							
							&lt;a style=&quot;color:blue&quot; title=&quot;001093377200001&quot; target=&quot;_blank&quot; href=&quot;https://www.webofscience.com/wos/woscc/full-record/001093377200001&quot;&gt;
									WoS
							&lt;/a&gt;
						&lt;/span&gt;
						&lt;span class=&quot;id identifier oa_none&quot; title=&quot;none&quot;&gt;
							
							&lt;a style=&quot;color:blue&quot; title=&quot;85173716036&quot; target=&quot;_blank&quot; href=&quot;http://www.scopus.com/record/display.url?origin=inward&amp;eid=2-s2.0-85173716036&quot;&gt;
									Scopus
							&lt;/a&gt;
						&lt;/span&gt;
						&lt;span class=&quot;id identifier oa_none&quot; title=&quot;none&quot;&gt;
							
							&lt;a style=&quot;color:blue&quot; title=&quot;37839355&quot; target=&quot;_blank&quot; href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=37839355&amp;dopt=Abstract&quot;&gt;
									PubMed
							&lt;/a&gt;
						&lt;/span&gt;
	&lt;/span&gt;


	&lt;OnlyViewableByAuthor&gt;&lt;div class=&quot;ratings&quot;&gt;
				&lt;div class=&quot;journal-subject&quot;&gt;Folyóirat szakterülete: Scopus - Biochemistry&amp;nbsp;&amp;nbsp;&amp;nbsp;SJR indikátor:&amp;nbsp;D1&lt;/div&gt;
				&lt;div class=&quot;journal-subject&quot;&gt;Folyóirat szakterülete: Scopus - Clinical Biochemistry&amp;nbsp;&amp;nbsp;&amp;nbsp;SJR indikátor:&amp;nbsp;D1&lt;/div&gt;
				&lt;div class=&quot;journal-subject&quot;&gt;Folyóirat szakterülete: Scopus - Organic Chemistry&amp;nbsp;&amp;nbsp;&amp;nbsp;SJR indikátor:&amp;nbsp;D1&lt;/div&gt;
    &lt;/div&gt;&lt;/OnlyViewableByAuthor&gt;


	&lt;div class=&quot;publication-citation&quot; style=&quot;margin-left: 0.5cm;&quot;&gt;
		&lt;span title=&quot;Nyilvános idézőközlemények összesen, említések nélkül&quot; class=&quot;citingPub-count&quot;&gt;Nyilvános idéző összesen: 117&lt;/span&gt;
		| Független: 89
		| Függő: 28
		| Nem jelölt: 0
		| WoS jelölt: 111 
		|  Scopus jelölt:&amp;nbsp;111 
		|  WoS/Scopus jelölt:&amp;nbsp;117 
		|  DOI jelölt:&amp;nbsp;117 
		
	&lt;/div&gt;
    
    
	&lt;div class=&quot;publication-citation&quot;&gt;
		&lt;a target=&quot;_blank&quot; href=&quot;/api/publication?cond=citations.related;eq;34189818&amp;sort=publishedYear,desc&amp;sort=title&quot;&gt;
			Idézett közlemények száma: 29
		&lt;/a&gt;
	&lt;/div&gt;



    &lt;div class=&quot;mtid&quot;&gt;&lt;span class=&quot;long-pub-mtid&quot;&gt;Közlemény: 34189818&lt;/span&gt;
    | &lt;span class=&quot;status-data status-VALIDATED&quot;&gt; 	Egyeztetett
  &lt;/span&gt;
        
	
	
Forrás	 Idéző
	
	
    | &lt;span class=&quot;type-subtype&quot;&gt;Folyóiratcikk
			( Összefoglaló cikk
			
			)
		&lt;/span&gt;
      		| &lt;span class=&quot;pub-category&quot;&gt;Tudományos&lt;/span&gt;
	| &lt;span class=&quot;publication-sourceOfData&quot;&gt;kézi felvitel&lt;/span&gt;
&lt;/div&gt;

&lt;div class=&quot;funder&quot;&gt; Nemzeti Kardiovaszkuláris Laboratórium(RRF-2.3.1-21-2022-00003) Támogató: NKFIH   &lt;/div&gt;
&lt;div class=&quot;lastModified&quot;&gt;Utolsó módosítás: 2023.11.24. 10:42 Szalóky-Siki Ágnes (SE_KK_Admin5_SZSA, admin)
&lt;/div&gt;




	&lt;pre class=&quot;comment&quot; style=&quot;margin-top: 0; margin-bottom: 0;&quot;&gt;&lt;u&gt;Megjegyzés&lt;/u&gt;: Institute for Pathophysiology, West German Heart and Vascular Center, University of Duisburg-Essen, Essen, Germany            
            Laboratory of Pharmacology, Faculty of Pharmacy, National and Kapodistrian University of Athens, Athens, Greece            
            The Hatter Cardiovascular Institute, University College London, London, United Kingdom            
            Chair of Ca...&lt;/pre&gt;
&lt;/div&gt;&lt;/div&gt;</template2>
    </publication>
  </content>
</myciteResult>
